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Summary
The majority of human neurological and psychiatric disorders are substantially her-
itable. Since these illnesses represent an increasing problem of public health, it is
vitally important to understand the underlying genetic mechanisms. The research on
genetic predisposition for neuropsychiatric diseases has achieved great progress with
the emergence of genome-wide association (GWA) studies. GWA studies enable the
comprehensive screening of genome-wide genetic polymorphisms for associations with
a quantitative or a binary disease trait. Typically, they focus on single-nucleotide poly-
morphisms (SNPs), the most common type of human genetic variation. Due to highly
heterogeneous clinical symptoms of most neuropsychiatric disorders, in GWA studies
it is often difficult to identify disease-associated variations. Disease-induced alterations
in brain anatomy and function are, however, much less heterogeneous. Consequently,
recent attention in genetic research focused on the usage of neuroimaging techniques,
such as magnetic resonance imaging (MRI), to search for genetic risk factors of neu-
ropsychiatric diseases.
The standard analysis approach in genetic neuroimaging research is the mass-univariate
linear modeling approach. From a statistical view, however, this approach is disadvan-
tageous, since it is computationally intensive, cannot account for dependencies among
collinear variables, and has to be corrected for multiple testing. In contrast, multi-
variate methods offer the opportunity to include combined information from multiple
variants simultaneously into the analysis, and can therefore account for the correla-
tion structure in both the neuroimaging and the SNP data. Partial Least Squares
Analysis and Canonical Correlation Analysis are common multivariate approaches to
analyze genotype-phenotype associations, and different variants have been established
for genetic neuroimaging. However, a comprehensive comparison with respect to data
characteristics and strengths and weaknesses of these methods, a statistical verifica-
tion of results, and a determination of comprehensible criteria for component number
selection was missing to date.
The present thesis examined the suitability of multivariate statistical methods for
data analysis in genetic neuroimaging. In the first part, three multivariate tech-
niques were introduced, Sparse Canonical Correlation Analysis (Sparse CCA), Bayesian
Inter-Battery Factor Analysis (Bayesian IBFA) and Partial Least Squares Correlation
(PLSC). The three approaches were elaborately compared in order to express a clear
statement on which method to choose depending on the properties of the underlying
data sets. In addition, tools for component number selection and verification of results
were supplied. The aim of this thesis was to provide application-oriented guidelines
to facilitate the decision on the selection of appropriate statistical methods based on
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data properties. These guidelines were targeted, in particular, at researchers working
in genetic neuroimaging, especially at those, who are no methods developer, but who
would like to properly analyze genotype-phenotype associations using multivariate ap-
proaches.
For comparison of Sparse CCA, Bayesian IBFA and PLSC, simulation data was consid-
ered, which enabled the examination of the performance of the three approaches based
on imposed properties. In a first simulation series, high-dimensional brain imaging
data, i.e. simulated MR images, and comparably low-dimensional SNPs were created.
The number of volumetric pixels in the MR images, named voxels, was stepwise in-
creased to resemble the total number of voxels in the brain. Neuroimaging data differs
from SNP data in that the covariance structure between the voxels in the brain is
much stronger than the covariance structure between the SNPs. To also provide an
outlook on how Sparse CCA, Bayesian IBFA and PLSC perform in more realistic ge-
netic neuroimaging settings, in a further simulation the dimensionality of the SNP
data was increased such that the number of SNPs resembled the number of SNPs in a
small human SNP array. Finally, a data set containing linearly independent phenotype
variables was generated, since it is equally conceivable to apply multivariate strate-
gies to search for associations of genetic variation with less correlated phenotypes. In
addition to the three simulation experiments, the suitability of the three multivariate
approaches was compared based on experimental genetic neuroimaging data containing
whole-brain functional MR images collected from patients with psychological disorders
and healthy controls, and genotype information on five SNPs. The determination of
the component number and the validation of Sparse CCA, Bayesian IBFA and PLSC
results was conducted by using both, a method for estimating the prediction perfor-
mance of the models named predictive squared correlation coefficient, and a model
selection procedure named CHull. For PLSC, a further measure for component num-
ber specification was included, the sum of squared cross-block correlations.
The evaluation of simulated data showed that the suitability of the investigated mul-
tivariate methods strongly depended on data properties, specifically on the degree of
collinearity between phenotype variables. For data sets comprising linearly indepen-
dent phenotypes, a preference for the usage of Bayesian IBFA was indicated, depending
on the condition that the ratio of dimensionality to sample size did not exceed a thresh-
old of 300. Bayesian IBFA automatically learned how many components to consider
and was the only method capable of detecting two independent causal patterns be-
tween simulated variables of the two data sets. For higher numbers of variables, the
evaluation of simulated data revealed that results must be interpreted with caution,
since the identification of causal patterns using model selection tools became difficult
for all three multivariate approaches.
For data sets containing highly collinear brain imaging variables, the use of Bayesian
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IBFA could not be recommended, since the component number was always excessively
high and additional post-processing steps were required to be able to differentiate be-
tween causal and non-informative components. In contrast, Sparse CCA and PLSC
were suitable for both simulated and experimental collinear genetic neuroimaging data.
Among the two, the use of Sparse CCA was recommended in situations with relatively
low-dimensional phenotype and SNP data, since its predictive power was higher when
data dimensionality was below 400 times sample size. For higher voxel numbers, the
predictive power of PLSC exceeded that of Sparse CCA. In addition, PLSC was the
only method for which it was possible to detect causal voxels and SNPs using model
selection tools in more realistic genetic neuroimaging settings containing both, high
numbers of voxels and high numbers of SNPs. Thus, for multivariate modeling of high-
dimensional brain-SNP-associations, a preference for the usage of PLSC was indicated.
Regarding the guidance on tools for component number determination and verifica-
tion of results, the evaluation of simulated data indicated that the predictive squared
correlation coefficient and CHull were equally well suited for model selection in Sparse
CCA and PLSC. In contrast, for Bayesian IBFA only the predictive squared correlation
coefficient was recommended. Furthermore, it was observed that the criterion
”
sum of
squared cross-block correlations“ for component number determination in PLSC was
only reasonable for a first data reduction if phenotype variables were highly collinear.
Thus, the recommendation on tools for appropriate model selection depended strongly
on the data properties and was based on the knowledge of which method to select for
multivariate statistical analysis.
The choice of an appropriate analytical method is a major step in any statistical anal-
ysis. By supplying specific criteria on the selection of multivariate methods based on
data properties, the first part of this thesis made a substantive contribution to the
analysis of the genetic risk of human neurological and psychiatric disorders. The re-
mainder of this work dealt with the improvement of the computational efficiency of
multivariate statistics in genetic neuroimaging. This is of importance, since it can be
expected that there will be a growth in cost- and time-efficient DNA sequencing as well
as neuroimaging techniques in the coming years, which will result in excessively long
computation times due to increasing data dimensionality. To accommodate this large
number of variables, in the second part of this thesis, a new and computational efficient
statistical approach named PLSC-RP was proposed, which incorporates a method for
dimensionality reduction named Random projection (RP) into traditional PLSC in
order to represent the originally high-dimensional data in lower dimensional spaces.
Subsequently, PLSC is used for multivariate analysis of compressed data sets. In a fi-
nal step, the results of PLSC-RP are transformed back to the original spaces to enable
the interpretation of original variables. RP is especially attractive for dimensionality
reduction in very high-dimensional settings such as in genetic neuroimaging, since it
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depends on sample size only and is independent of the number of variables in the data
sets.
To verify the suitability of PLSC-RP for different statistical data types, PLSC-RP was
used for integrative analysis of data sets containing either whole-brain neuroimaging
data together with small numbers of SNPs, or whole-genome SNP data together with
few quantitative phenotypes. Dimensionality reduction was performed such that RP
reduced the number of original voxels or SNPs, respectively. Neuroimaging data is
scaled metrically. In contrast, SNPs are recoded by counting the number of minor
alleles per person. Thus, SNP information statistically represents count data. It was
demonstrated that the usage of PLSC-RP reduced computation times from hours to
seconds compared to its state-of-the-art counterpart PLSC. Nonetheless, the accuracy
of the results was not impaired by the substantial savings in processing time, since
the results of PLSC-RP and PLSC were statistically equivalent, as indicated by three
different similarity measures. This was true for dimensionality reduction of both the
continuous neuroimaging data and the SNPs, which are counts. Consequently, the
application of PLSC-RP is independent of the statistical data type.
A special characteristic of genetic neuroimaging data is that both the brain imaging
and the SNP data set are naturally high-dimensional. Therefore, PLSC-RP was further
applied to reduce both the number of voxels and the number of SNPs. The results in-
dicated that PLSC-RP was able to detect causal voxels and SNPs with high accuracy,
despite slightly reduced similarity to the results provided by PLSC compared to the
applications of PLSC-RP and PLSC for either high-dimensional neuroimaging mea-
sures or high-dimensional SNPs. Again, PLSC-RP was significantly faster than PLSC.
Together, these results demonstrated that PLSC-RP is a computationally efficient anal-
ysis approach that enables a precise assessment of genotype-phenotype-associations
with very high time efficiency. Since the present thesis was particularly focused on sta-
tistical analyses in genetic neuroimaging, solely applications from genetic neuroimaging
research were considered. However, PLSC-RP is independent of statistical data type,
such that it is equally well suited for integrative analysis of other types of multimodal
data. With the present tendency towards ever increasing data quantities and the re-
sulting demand for combining very high-dimensional data from multiple sources in an
extending range of scientific disciplines, PLSC-RP will be of interest for a multitude of
applications. It enables researchers to analyze truly high-dimensional data sets, even
if there is no powerful compute server available in the lab.
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Zusammenfassung
Bei der Entstehung vieler neuropsychiatrischer Sto¨rungen spielt die genetische Ver-
anlagung eine große Rolle. Wegen der steigenden Pra¨valenz dieser Erkrankungen
und den damit verbundenen Komorbidita¨ten ist es von entscheidender Bedeutung,
die krankheitsverursachenden genetischen Mechanismen zu entschlu¨sseln. Mit dem
Aufkommen genomweiter Assoziationsstudien (GWAS) konnte die Erforschung genetis-
cher Risikofaktoren in den letzten Jahren große Fortschritte erzielen. GWAS unter-
suchen, ob bestimmte genetische Polymorphismen bei Tra¨gern eines Krankheitssymp-
toms ha¨ufiger auftreten als bei Kontrollprobanden. In den meisten Fa¨llen wird nach
Variationen sogenannter Einzelnukleotid-Polymorphismen (SNPs) gesucht. Die ha¨ufig
sehr variable Auspra¨gung von Symptomen neuropsychiatrischer Sto¨rungen kann die
Untersuchungen genetischer Assoziationen im GWAS jedoch erschweren. Krankheits-
bedingte Vera¨nderungen von Hirnstruktur und -funktion sind oft weniger variabel als
die klinische Symptomatik. Deshalb werden bei der Suche nach genetischen Markern
neuropsychiatrischer Sto¨rungen vermehrt neurobildgebende Verfahren, wie beispiels-
weise die Magnetresonanztomographie (MRT), eingesetzt.
Eine einfache Modellierungsmethode in Studien zur Neurobildgebung genetischer As-
pekte ist die Bestimmung aller univariaten linearen Regressionsmodelle. Statistisch
gesehen ist dieser Ansatz unvorteilhaft, da er die Abha¨ngigkeiten kollinearer Vari-
ablen nicht beru¨cksichtigt und fu¨r multiples Testen korrigiert werden muss. Um diese
Nachteile zu umgehen, mu¨ssen multivariate Verfahren eingesetzt werden, welche gleich-
zeitig den Einfluss multipler Marker und deren Korrelationsstruktur in der Analyse
betrachten. Die Partial Least Squares Analyse und die Kanonische Korrelationsana-
lyse sind fu¨r die Auswertung von Genotyp-Pha¨notyp-Beziehungen besonders geeignet
und verschiedene Varianten dieser Methoden sind fu¨r Studien zur Neurobildgebung
genetischer Aspekte vorgeschlagen worden. Was hingegen fehlt, ist ein systematischer
Vergleich dieser multivariaten Methoden hinsichtlich ihrer Vor- und Nachteile, eine
statistische Verifizierung der Ergebnisse sowie eine Festlegung nachvollziehbarer Krite-
rien bei der Bestimmung der Komponentenanzahl.
Die vorliegende Arbeit untersuchte die Eignung verschiedener multivariater Verfahren
fu¨r die Datenanalyse in Studien zur Neurobildgebung genetischer Aspekte. Im er-
sten Teil der Arbeit wurden drei multivariate Methoden eingefu¨hrt, die Sparse Cano-
nical Correlation Analysis (Sparse CCA), die Bayesian Inter-Battery Factor Analysis
(Bayesian IBFA) und die Partial Least Squares Correlation (PLSC). Diese drei Ver-
fahren wurden systematisch verglichen, um eine Aussage daru¨ber zu treffen, welche
Methode in Abha¨ngigkeit der Eigenschaften der zugrundeliegenden Daten zu wa¨hlen
ist. Zusa¨tzlich wurden Werkzeuge zur Bestimmung der Komponentenanzahl sowie zur
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Verifizierung der Ergebnisse bereitgestellt. Ziel der Arbeit war es, eine anwendungs-
orientierte Anleitung zur Verfu¨gung zu stellen, welche dem Nutzer die Entscheidung
u¨ber die Auswahl geeigneter Methoden auf Basis der Dateneigenschaften erleichtert.
Diese Anleitung ist vor allem an Wissenschaftler gerichtet, die selbst keine Methoden-
entwickler sind, die multivariate Verfahren allerdings bei der Auswertung von Genotyp-
Pha¨notyp-Beziehungen sachgema¨ß einsetzen wollen.
Der Vergleich der Eignung von Sparse CCA, Bayesian IBFA und PLSC erfolgte mittels
simulierter Daten, da bei Simulationsexperimenten die zugrundeliegenden Beziehungen
der Daten bekannt sind. Zuna¨chst wurden hochdimensionale Hirn-Bildgebungsdaten,
d.h. simulierte MRT-Bilder, und vergleichsweise niedrig-dimensionale SNP-Daten gene-
riert. Die Anzahl der Volumenelemente in den MRT-Bildern, genannt Voxel, wurde
dabei schrittweise erho¨ht, bis sie in etwa der Anzahl der Voxel im gesamten Gehirn
entsprach. MRT-Daten unterscheiden sich von SNP-Daten insbesondere dadurch, dass
die Korrelationsstruktur der Voxel im Gehirn viel sta¨rker ausgepra¨gt ist als die Kor-
relationsstruktur der SNPs. Um einen Abscha¨tzung fu¨r die Eignung der Sparse CCA,
Bayesian IBFA und PLSC fu¨r realistische Datensa¨tze aus Neurobildgebung und Genetik
zu liefern, wurde fu¨r eine weitere Untersuchung die Dimension der SNP Daten so erho¨ht,
dass sie der Anzahl der SNPs in einem humanen SNP Array entsprach. Es ist jedoch
auch denkbar, multivariate Verfahren einzusetzen, um nach genetischen Assoziationen
mit weniger hoch-korrelierenden pha¨notypischen Merkmalen zu suchen. Deshalb wurde
schließlich ein Pha¨notyp-Datensatz erstellt, welcher linear unabha¨ngige Variablen um-
fasste. Zusa¨tzlich zu den drei Simulationsexperimenten erfolgte der Eignungsvergleich
der drei multivariaten Methoden anhand eines realen Datensatzes, welcher das Zusam-
menspiel von Genetik und Neurobildgebung bei Patienten mit psychischen Sto¨run-
gen sowie gesunden Kontrollen untersuchte. Die Bestimmung der Komponentenanzahl
sowie die Validierung der Ergebnisse von Sparse CCA, Bayesian IBFA und PLSC er-
folgte mittels einer Methode zur Bewertung der Vorhersagekraft der Modelle namens
predictive squared correlation coefficient und eines Modellauswahlverfahrens namens
CHull. Fu¨r die PLSC wurde ein weiterer Ansatz zur Komponentenanzahl-Festlegung
beru¨cksichtigt, die sogenannte sum of squared cross-block correlations.
Die Auswertung simulierter Datensa¨tze zeigte, dass die Eignung der drei multivari-
aten Methoden vorwiegend von den zugrundeliegenden Dateneigenschaften, speziell
von der Kollinearita¨t pha¨notypischer Variablen, abhing. Fu¨r Datensa¨tze, welche li-
near unabha¨ngige pha¨notypische Merkmale beinhalteten, konnte eine Pra¨ferenz fu¨r den
Gebrauch der Bayesian IBFA nachgewiesen werden, allerdings nur, falls das Verha¨lt-
nis von Dimension zu Stichprobengro¨ße einen Schwellwert von 300 nicht u¨berschritt.
Die Bayesian IBFA war in der Lage, die Komponentenanzahl automatisch festzule-
gen. Zudem war sie die einzige Methode, die befa¨higt war, zwei unabha¨ngige, kausale
Beziehungen zwischen simulierten Variablen zu erfassen. Fu¨r Datensa¨tze mit einer
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ho¨heren Dimension ergaben die durchgefu¨hrten Analysen, dass die Ergebnisse generell
kritisch zu betrachten sind, da die Identifizierung kausaler Strukturen mittels statisti-
scher Verfahren erschwert war.
Fu¨r simulierte, stark kollineare MRT-Bilder konnte der Gebrauch der Bayesian IBFA
nicht empfohlen werden, da die Komponentenanzahl generell sehr hoch und eine zusa¨tz-
liche Datennachbearbeitung no¨tig war, um kausale Komponenten aufzudecken. Die
Eignung der Sparse CCA und der PLSC konnte hingegen sowohl anhand simulierter
als auch realer Daten nachgewiesen werden. Dabei war das Vorhersagepotential der
Sparse CCA am ho¨chsten, wenn das Verha¨ltnis von Dimension zu Stichprobengro¨ße
einen Schwellwert von 400 nicht u¨berschritt. Fu¨r eine ho¨here Anzahl simulierter Voxel
u¨berstieg die Vorhersagekraft der PLSC die der Sparse CCA. Zudem konnten kausale
Voxel und SNPs in einer realita¨tsna¨heren Simulation alleinig fu¨r die PLSC mittels
modellselektierender Verfahren detektiert werden. Damit wurde eine Pra¨ferenz fu¨r den
Einsatz der PLSC zur simultanen multivariaten Analyse hochdimensionaler Gehirn-
SNP-Beziehungen aufgezeigt.
Die Auswertung der Verfahren zur Bestimmung der Komponentenanzahl und zur Veri-
fizierung der Ergebnisse ergab, dass der predictive squared correlation coefficient und
CHull bei Einsatz der Sparse CCA oder PLSC gleichermaßen gut geeignet waren.
Dagegen konnte fu¨r die Bayesian IBFA ausschließlich der Gebrauch des predictive
squared correlation coefficients empfohlen werden. Weiterhin wurde beobachtet, dass
die Anwendung des Kriteriums sum of squared cross-block correlations zur Festlegung
der Komponentenanzahl in der PLSC nur dann sinnvoll war, wenn die pha¨notypi-
schen Variablen stark miteinander korrelierten. Eine Empfehlung fu¨r die Auswahl
modellselektierender Verfahren konnte also nur unter Kenntnis der Dateneigenschaften
und auf Basis der eingesetzten multivariaten Analysemethode gegeben werden.
Die Wahl eines geeigneten Analyseverfahrens ist ein grundlegender Schritt bei jeder
statistischen Auswertung. Durch die Bereitstellung konkreter Kriterien zur Auswahl
multivariater Methoden auf Basis der Dateneigenschaften lieferte der erste Teil dieser
Arbeit einen wesentlichen Beitrag fu¨r die Untersuchung genetischer Risikofaktoren
neuropsychiatrischer Erkrankungen. Im Weiteren befasste sich diese Arbeit mit der
Verbesserung der Berechnungseffizienz, da zu erwarten ist, dass sich Chip-Technologien
zur Genotypisierung von SNPs sowie hochauflo¨sende neurobildgebende Verfahren in
den na¨chsten Jahren rasant weiterentwickelen werden, was eine enorme Erho¨hung der
Rechenzeit bei der statistischen Auswertung zur Folge haben wird. Im zweiten Teil der
Arbeit wurde deshalb ein neues, rechnerisch effizientes statistisches Verfahren, genannt
PLSC-RP, entwickelt, welches eine dimensionsreduzierende Methode names Random
projection (RP) in die klassische PLSC einbindet, um die hochdimensionalen Origi-
naldaten in einem Raum mit geringerer Dimensionalita¨t darzustellen. Im Anschluss
an die Dimensionsreduktion mittels RP wird die PLSC zur multivariaten Analyse der
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komprimierten Datensa¨tze eingesetzt. Transformiert man die Ergebnisse der PLSC
dann zuru¨ck, ist eine Interpretation der urspru¨nglichen Variablen mo¨glich. Die RP ist
zur Dimensionsreduktion bei sehr hochdimensionalen Datensa¨tzen wie in Studien zur
Neurobildgebung genetischer Aspekte besonders geeignet, da sie in ihre Funktionalita¨t
ausschließlich von der Stichprobengro¨ße abha¨ngt und unabha¨ngig von der Anzahl der
Variablen im originalen Datensatz ist.
Um die Eignung der PLSC-RP fu¨r verschiedene statistische Datentypen zu u¨berpru¨fen,
wurde das Verfahren zuna¨chst zur Analyse von Gehirn-SNP-Assoziationsdaten einge-
setzt, die entweder im MRT- oder im SNP-Datensatz besonders hochdimensional waren.
Dabei wurde die RP verwendet, um die Dimension der Voxel bzw. SNPs zu reduzieren.
MRT-Daten sind metrisch skaliert. SNPs hingegen werden je nach Anzahl des sel-
teneren Allels der Sequenz mit 0, 1 oder 2 kodiert und sind damit beispielhaft fu¨r
Za¨hldaten. Es konnte gezeigt werden, dass sich der Zeitaufwand bei Einsatz der PLSC-
RP im Vergleich zur klassischen PLSC von Stunden auf Sekunden verringerte. Die
Ergebnisgenauigkeit war dabei nicht beeintra¨chtig, denn die Ergebnisse von PLSC-RP
und PLSC waren statistisch a¨quivalent. Dies war sowohl bei Dimensionsreduktion der
kontinuierlichen MRT- als auch der geza¨hlten SNP-Daten zu beobachten. Die PLSC-
RP ist in ihrer Eignung folglich unabha¨ngig vom statistischen Datentyp.
Realistische Genotyp-Pha¨notyp-Assoziationen umfassen meist sowohl hochdimensio-
nale MRT- als auch SNP-Daten. Deshalb wurde die PLSC-RP im Weiteren so einge-
setzt, dass gleichzeitig die Anzahl der Voxel und SNPs reduziert wurde. Es zeigte sich,
dass die Ergebnisse der PLSC-RP und die der klassischen PLSC trotz substanzieller
Zeitersparnisse hochgradig a¨hnlich waren, sodass eine Detektion kausaler Voxel und
SNP mo¨glich war. Verglichen mit den Anwendungen der PLSC-RP fu¨r Datensa¨tze,
die entweder hochdimensionale MRT-Bilder oder genomweite SNPs enthielten, war der
Grad der A¨hnlichkeit jedoch leicht verringert.
Die vorliegenden Analysen haben gezeigt, dass die PLSC-RP eine rechnerisch effiziente
Analysemethode ist, welche trotz ihrer Effizienz eine pra¨zise Bestimmung von Genotyp-
Pha¨notyp-Assoziationen ermo¨glicht. Da sich die Arbeit speziell mit der statistischen
Analyse in Studien zur Neurobildgebung genetischer Aspekte befasste, wurden aus-
schließlich Anwendungen aus diesem Gebiet vorgestellt. Die PLSC-RP ist allerdings
unabha¨ngig vom statistischen Datentyp, sodass davon ausgegangen werden kann, dass
sie auch fu¨r andere multimodale Daten zu empfehlen ist. Aufgrund des stetigen In-
formationszuwachses und der dadurch resultierenden Nachfrage, riesige Datenmengen
aus verschiedenen wissenschaftlichen Quellen zu kombinieren, hat die PLSC-RP das
Potential, sich zu einer Methode zu entwickeln, die vielfa¨ltigen Einsatz findet. Sie
befa¨higt den Anwender, hochdimensionale Datensa¨tze zu analysieren, selbst wenn kein
leistungsfa¨higer Mehrprozessor-Compute-Server zur Verfu¨gung steht.
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1 Introduction
1.1 About this work
Many neurological and psychiatric disorders are associated with genetic factors (Bigos
and Weinberger, 2010; Ge and others , 2013; Meyer-Lindenberg and Weinberger, 2006;
Plomin and others , 1994). Since these illnesses represent an increasing problem of pub-
lic health, a great deal of effort is expended in order to search for genetic variants across
the human genome that are, to a certain extent, involved in their development. Sub-
stantial progress has been achieved in recent years with the emergence of genome-wide
association (GWA) studies (Haines and others , 2005). However, a systematic alignment
of DNA sequences from individuals affected by the disease or not does not necessarily
reveal the variations that are major contributors. The discovery of the neural mecha-
nisms that arise from these DNA sequence variations requires the investigation of the
complex relationship between genotypes and biologically based phenotypes, a strategy
known as the intermediate phenotype concept (Gottesman and Shields, 1967; Gottes-
man and Gould, 2003). For neurological disorders, in particular, genetic variation has
been shown to be closely related to aspects of brain anatomy, function or connectivity
(Meyer-Lindenberg and Weinberger, 2006). Consequently, measures derived from in-
vivo brain imaging were increasingly introduced as intermediate phenotypes for genetic
association analyses. The first study combining brain imaging and genetic data was re-
ported by Bookheimer and others (2000). By monitoring brain activation in a specific
area of the brain, they discovered a risk allele for the development of Alzheimer’s dis-
ease in healthy elderly. Many subsequent studies successfully adopted their approach,
thus emphasizing the role of neuroimaging measures for identification of genetic risk
markers of neurological disorders. From a statistical viewpoint, however, combining
high-dimensional data from multiple sources is non-trivial. Several genetic variants
in the genome may jointly influence a particular brain imaging phenotype. Likewise,
neuroimaging phenotypes from different regions of the brain may be affected by the
same genetic marker. Traditional univariate approaches, addressing the evaluation of a
single genetic marker and a single neuroimaging phenotype at a time, are not suitable
for detecting these complex links.
The current thesis investigates multivariate methods for statistically powerful and bio-
logically meaningful analysis in genetic neuroimaging. Multivariate methods combine
information from multiple markers simultaneously into the analysis. They are thus able
to incorporate interdependencies between genetic variants in the genome and between
neuroimaging phenotypes in the brain, while preventing from multiple testing.
This thesis is organized as follows. The remainder of Chapter 1 presents a brief bi-
ological background. Since genetic neuroimaging is an interdisciplinary research field
1
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requiring a general knowledge about both genetics and brain imaging, important con-
cepts of the two scientific disciplines are introduced in order to ensure an overall un-
derstanding. Subsequently, a classification scheme for genetic neuroimaging studies
is presented, together with example studies for each category. A major issue in ge-
netic neuroimaging is how to address genotype-phenotype-associations using statisti-
cally powerful approaches. Therefore, in a further section, statistical analysis methods
that have been considered for genetic neuroimaging are reviewed, and dimensionality-
related problems are mentioned.
Chapter 2 is concerned with the application of multivariate methods in genetic neu-
roimaging. Though well established, a comprehensive comparison of existing ap-
proaches, in particular for genetic neuroimaging applications, as well as conscientious
verification of these methods using resampling techniques is outstanding. Therefore,
Chapter 2 provides elaborate guidelines on the use of three multivariate methods, Par-
tial Least Squares Correlation, Sparse Canonical Correlation Analysis and Bayesian
Inter-Battery Factor Analysis. Specifically, background information about method se-
lection criteria are provided, the exact statistical models are introduced and, using both
simulated and experimental genetic neuroimaging data, the three methods are compre-
hensively evaluated regarding their ability to detect multivariate genotype-phenotype
associations. The chapter largely follows the original publication
• Grellmann, C., Bitzer, S., Neumann, J., Westlye, L. T., Andreassen, O. A.,
Villringer, A. and Horstmann, A. (2015). Comparison of variants of Canonical
Correlation Analysis and Partial Least Squares for combined analysis of MRI and
genetic data. NeuroImage, Volume 107, pages 289-310.
In Chapter 3, the focus of the thesis shifts toward dimensionality-related problems in
genetic neuroimaging. In recent years, the advent of great technological advances has
produced a wealth of high-dimensional data. For example, combining neuroimaging
data with extensive genetic information is a rapidly growing research approach, en-
abling the integration of information from two of the major methodological advances
introduced in the past 30 years, namely sequencing of the entire human genome and
high-resolution brain imaging in humans. Multivariate techniques, though commonly
used and adequate for association analyses in genetic neuroimaging studies, often face
computational challenges. In Chapter 3, a new method named PLSC-RP is introduced
that integrates a dimensionality reduction technique called Random Projection into
multivariate association analysis. Importantly, PLSC-RP depends on sample size only
and is independent of the number of variables in the data sets. Thus, it is especially
attractive for very high-dimensional settings such as in genetic neuroimaging studies.
First, the fundamental methodology of PLSC-RP is described. Then it is applied for
association analysis of data sets containing high-dimensional brain imaging phenotypes,
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high-dimensional genetic variants, or both. The results of PLSC-RP are compared to
the results obtained using its state-of-the-art multivariate counterpart. The chapter is
mostly based on the original publication
• Grellmann, C., Neumann, J., Bitzer, S., Kovacs, P., To¨njes, A., Westlye, L.
T., Andreassen, O. A., Stumvoll, M., Villringer, A. and Horstmann, A. (2016).
Random projection for fast and efficient multivariate correlation analysis of high-
dimensional data: A new approach. Frontiers in Genetics - Section Bioinformatics
and Computational Biology, Volume 7, Article 102.
Finally, in Chapter 4, the findings of this thesis are summarized and concluded. Future
research questions arising from the present work are pointed out.
1.2 Biological background
1.2.1 Introduction to genetic neuroimaging
Most common neurological and psychiatric disorders are substantially heritable (Bigos
and Weinberger, 2010; Ge and others , 2013; Meyer-Lindenberg and Weinberger, 2006;
Plomin and others , 1994). By definition, heritability is the total variance in a popu-
lation for a particular measurement that can be attributed to inherited genetic rather
than environmental factors (Visscher and others , 2008). From twin studies, heritabil-
ity for neurological and psychiatric disorders has been estimated to range from 20% to
90% (Table 1).
Table 1: Heritability of behavioral disorders
Most neurological and psychiatric illnesses are substantially heritable. The table is adopted
from Glahn and others (2007) and Plomin and others (1994).
Behavioral disorder Illness heritability
Addictions 0.40-0.60 (Begleiter and Porjesz, 1999)
Alzheimer’s disease and dementia 0.50-0.70 (Bergem and others , 1997)
Attention deficit hyperactivity disorder 0.60-0.90 (Rhee and others , 1999)
Epilepsy and seizure disorders 0.60-0.88 (Berkovic and others , 1998)
Major depression and other mood disorders 0.37-0.59 (Merikangas and others , 2002;
Sullivan and others , 2000)
Posttraumatic stress disorder and anxiety disorders 0.20-0.66 (Stein and others , 2002)
Schizophrenia 0.70-0.83 (Cannon and others , 1998;
Sullivan and others , 2003)
Because of the high morbidity and mortality associated with neurological and psychi-
atric disorders, it is vitally important to identify underlying genetic influences (Glahn
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and others , 2007; Meyer-Lindenberg and Weinberger, 2006). Since 2005, when the
first genome-wide association (GWA) study was introduced (Haines and others , 2005),
research on genetic risk markers has achieved great progress. GWA analyses are
hypothesis-free approaches that investigate genetic variation in individuals associated
with a particular disease (Nature Education, 2014). A common approach is to compare
individuals from two groups, either healthy controls or patients affected by the disease,
in a case-control setup. Alternatively, researchers might examine the association be-
tween genetic variants and a quantitative phenotype. As quantitative phenotype, a
cognitive or clinical diagnostic measure is selected that is expected to reflect behav-
ioral abnormalities specific for the disease being studied.
Since GWA analyses do not require a twin or pedigrees design, they are intended to
facilitate the recruitment of a large number of participants (Ge and others , 2013; Poline
and others , 2010). In practice, however, it is difficult to identify an association between
genetic variants and cognitive or clinical diagnostic measures selected as phenotype of
interest. This is primarily due to highly heterogeneous clinical symptoms, which are
partly overlapping with other illnesses (Bigos and Weinberger, 2010). Another reason
is that carriers of genetic risk variants, as compared to non-carriers, often show a sim-
ilar performance in cognitive and clinical tests, since genotype effects are masked by
compensation strategies (Smit and others , 2012). A solution was offered by Gottesman
and Shields (1967) and Gottesman and Gould (2003) in terms of the so-called endophe-
notype or intermediate phenotype concept (more details are provided in Appendix A).
The endophenotype concept presumes that the effect of a gene on a biological marker
of the disease is far more consistent and penetrating than on behavioral level (Hibar
and others , 2011a; Meyer-Lindenberg and Weinberger, 2006; Poline and others , 2010).
In the case of neurological and psychiatric disorders, it is reasonable to expect that
aspects of brain anatomy, function or connectivity are affected. Thus, biomarkers de-
rived from in-vivo anatomical or functional neuroimaging were increasingly introduced
as intermediate phenotypes between genetic susceptibility and diagnosis, reducing the
phenotypic heterogeneity expressed by patients assigned to a diagnostic group and in-
creasing the power to detect relevant associations (Ge and others , 2013; Glahn and
others , 2007; Gottesman and Gould, 2003; Hibar and others , 2011a; Liu and Calhoun,
2014; Smit and others , 2012). This marked the birth of so-called genetic neuroimaging
studies. The principle is illustrated in Figure 1.
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Figure 1: Overview of genetic neuroimaging studies
In genetic neuroimaging studies, genotype and brain imaging phenotype measures are col-
lected for each subject. In most instances, the number of genotype and phenotype measures
greatly exceeds the available sample size. The goal is to search for genetic variants explaining
a certain amount of variance in the brain imaging measures relative to disease risk.
Since brain imaging measures are selected to reflect fundamental anatomical, cognitive
and behavioral processes that are altered in patients relative to healthy controls, genetic
neuroimaging studies enable to discover genetic risk variants that are linked to the
disease (Batmanghelich and others , 2013; Ge and others , 2013; Liu and Calhoun, 2014;
Meyer-Lindenberg, 2010). This knowledge can be used to predict an individual’s genetic
predisposition for developing a specific type of brain disorders, and to target an early
and optimized intervention (Ge and others , 2013; Roffman and others , 2006).
1.2.2 Genetic background
1.2.2.1 Single-nucleotide polymorphism
Genetic variation plays an important role in human diseases. It may appear at a num-
ber of different levels, the genome, the chromosome, the gene, or the single nucleotide
(Ge and others , 2013). The most common type of human genetic variation is the sin-
gle nucleotide polymorphism (SNP; Crawford and Nickerson, 2005; Tse and Cronican,
2009; Wang and others , 1998). By definition, a SNP is a variation of a single base pair
position at which different sequence alternatives, called alleles, appear in a significant
portion of the human population (Brooks, 1999; LaFramboise, 2009; Reich and oth-
ers , 2001). The majority of common SNPs have only two alleles. The more frequent
allele in the population is called the major allele and the rarer the minor allele (Ge
and others , 2013). Since humans are diploid, each SNP can be recoded by counting
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the number of minor alleles per person, i.e. in the form of a 0 for homozygous major
allele carriers, a 1 for heterozygous individuals and a 2 for homozygous minor allele
carriers. This corresponds to an additive genetic model (Ge and others , 2013; Lewis,
2002; Minelli and others , 2005; Potkin and others , 2009c).
A SNP may occur within a coding sequence of a gene, a non-coding region of a gene
or in an intergenic region (Ge and others , 2013; Roffman and others , 2006; Tse and
Cronican, 2009). Due to redundancy of genetic coding, SNPs within a coding sequence
do not necessarily change the amino acid sequence (synonymous polymorphism). How-
ever, a SNP might also result in a different amino acid (missense polymorphism) or in
a premature stop codon and therefore in truncation of the resulting protein (nonsense
polymorphism) (Ge and others , 2013; Tse and Cronican, 2009). Most SNP-related mu-
tations are transitions, i.e. a purine nucleotide is replaced by another purine nucleotide
(adenine (A) and guanine (G)) or a pyrimidine nucleotide is replaced by another pyrim-
idine nucleotide (cytosine (C) and thymine (T)) (Tse and Cronican, 2009).
In order to be classified as a SNP, the polymorphism has to be common in the pop-
ulation, i.e. the least frequent allele has to occur in more than one percent of the
population (Brooks, 1999; Reich and others , 2001; Tse and Cronican, 2009). SNPs are
distributed across the human genome by an average of one SNP per 1,000 base pairs
(Ahmadian and others , 2000; Landegren and others , 1998; Tse and Cronican, 2009;
Wang and others , 1998). Estimates suggest that there are in total about 10 million
common SNPs in the human genome (Kruglyak and Nickerson, 2001).
For discovery of a SNP, the SNP locus needs to be determined. From the first days
when the complete human genome sequence was presented by the International Human
Genome Sequencing Consortium (2004), researchers were able to identify new SNP loci
by alignment of individual sequences with the publicly available ones. To further de-
tect which SNPs are associated with a particular phenotype of interest, the SNPs need
to be genotyped, i.e it needs to be determined which allele an individual carries for a
given SNP locus. A number of methods are existing for SNP genotyping. Commonly
used are commercial probe-based SNP array platforms like the Affymetrix and Illu-
mina SNP array (Affymetrix, 2007; Illumina, 2009). The first commercial SNP array
was released in 1996 and was designed to genotype 1,494 SNPs on one chip (Wang and
others , 1998). In the current release, about one million SNPs can be genotype in one
assay (LaFramboise, 2009). Both, the Affymetrix and Illumina SNP array, rely on the
same working principle, assuming that nucleotide bases bind to their complementary
Watson-Crick base pair partners, i.e. A binds to T and C binds to G (LaFramboise,
2009).
SNPs can serve as biological markers for identification of genes that are associated
with a disease. To avoid spurious associations in GWA studies, SNP quality control
filtering is an essential step. Therefore, important quality control parameters will be
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overviewed in subsequent paragraphs.
1.2.2.2 Minor allele frequency
The first quality control parameter is the Minor allele frequency (MAF). The MAF
refers to the frequency of the less common allele in the population at a particular SNP
locus (Batmanghelich and others , 2013; Ge and others , 2013). For GWA studies with
a cognitive or clinical diagnostic measure as quantitative phenotype, only SNPs with
MAF > 1% are retained, because of the low power to detect an association (Sale and
others , 2009; Ziegler and others , 2008). In genetic neuroimaging studies, which are
considerably more expensive, stricter criteria are imposed, because of the small sample
sizes that additionally limit the power. Typically, SNPs with MAF > 20% are retained
(Bigos and Weinberger, 2010).
1.2.2.3 Hardy-Weinberg equilibrium
The Hardy-Weinberg equilibrium (HWE; Hardy, 1908; Weinberg, 1908) is a population
genetic principle, which describes the relationship between allele and genotype frequen-
cies. It states that in an idealized population, i.e. a population that is sufficiently large,
that exhibits random mating, that experiences no selection and mutation, and that has
no gene flow, genotype and allele frequencies remain stable from one generation to the
next. Furthermore, there is a fixed relationship between allele and genotype frequencies
(Lewis, 2002; Tse and Cronican, 2009; Ziegler and others , 2008). For a simple genetic
locus with two alleles, A and a, the HWE is expressed as p2 + 2pq+ q2 = 1, where p is
the frequency of allele A in the population, q is the frequency of allele a, and p+ q = 1.
At equilibrium, p2 and q2 represent the frequencies of the homozygous genotypes AA
and aa, respectively, and 2pq represents the frequency of the heterozygous genotype
Aa.
In GWA studies, the HWE is considered as quality control parameter to indicate sys-
tematic genotype miscalling. Typically, SNPs are excluded from analysis if the chi-
square test for deviation from the HWE yields a P -value less than 10−4 (Sale and oth-
ers , 2009; Samani and others , 2007; Wellcome Trust Case Control Consortium, 2007).
In GWA studies with a case-control design, it is recommended to monitor compliance
of the HWE only in the control group, since selection by disease status may affect the
HWE (Ziegler and others , 2008).
1.2.2.4 Call rate on the SNP level
A further criterion for quality control is the frequency of missing genotypes for a SNP,
called the call rate per SNP (Ziegler and others , 2008). Common cut-off values for
removal of SNPs are missing frequencies greater than 2% (Samani and others , 2007),
greater than 3% (Wellcome Trust Case Control Consortium, 2007), or greater than 5%
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(Breitfeld and others , 2013; Ousdal and others , 2012). Call rates should be investigated
separately for each group in case-control setups (Ziegler and others , 2008).
1.2.2.5 Call rate on the subject level
The complement of the call rate per SNP is the subject-wise frequency of missing
genotypes (Ziegler and others , 2008). Quality control is usually implemented, such
that individuals with call rates smaller than 97% are discarded.
1.2.2.6 Level of heterozygosity
A large number of heterozygous individuals for a given SNP might indicate that the
DNA has been contaminated (Ziegler and others , 2008). Therefore, the level of het-
erozygosity across all SNPs is commonly selected as quality control indicator. By defini-
tion, heterozygosity is the percentage of heterozygotes in a population (Frankham and
others , 2004). A typical approach is to estimate the mean and standard deviation of
the heterozygosity across all subjects and to remove individuals with outlying (greater
than three standard deviations from the mean) levels of heterozygosity (Ousdal and
others , 2012; Sale and others , 2009; Ziegler and others , 2008).
1.2.2.7 Population stratification
Population stratification, also termed confounding by ethnicity, occurs when a sample
collected for GWA analysis contains multiple populations that systematically differ in
their allele frequencies for a phenotype of interest due to ancestry differences or ethnic
background (Ge and others , 2013; Glahn and others , 2007; Lewis, 2002; Potkin and
others , 2009c; Ziegler and others , 2008). Population stratification leads to spurious
associations between genetic variants and phenotypic variation with excessive inflation
of false positive findings. Therefore, it is important that the samples included in GWA
studies are adequately adjusted for population stratification. If a population substruc-
ture arises nevertheless, appropriate statistical corrections should be implemented, us-
ing methods like genomic control (Bacanu and others , 2000; Devlin and Roeder, 1999),
structured association (Pritchard and Rosenberg, 1999), eigenstrat (Price and others ,
2006), or emmax (Kang and others , 2010).
1.2.2.8 Linkage Disequilibrium
Linkage Disequilibrium (LD) refers to statistical correlations among alleles at two or
more loci (Ge and others , 2013; Glahn and others , 2007; Poline and others , 2010;
Reich and others , 2001; Tse and Cronican, 2009; Ziegler and others , 2008). LD can be
due to the physical connection between adjacent loci, a phenomenon known as genetic
linkage. Genetic linkage describes the tendency of alleles that are located close to one
another on a chromosome to be inherited together during meiosis (Griffiths and others ,
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1993). More distant alleles have a higher probability of recombination. Therefore, LD
is expected to decrease the larger the physical distance between any two loci (Ge and
others , 2013).
LD can be measured by a parameter D, which describes the difference between observed
and expected allelic frequencies (Potkin and others , 2009c; Tse and Cronican, 2009). In
addition to D, two other statistical measures have been proposed, D′ and r2. The D′ is
a normalized version of D, which is constrained to be between zero and one (Lewontin,
1964). The normalization is achieved by division of D by a theoretical maximum of
the observed allele frequencies Dmax. The higher the D
′, the greater the LD. A value
of D′ = 1 is referred to as complete LD. In contrast to D and D′, r2 directly depends
on allele frequencies (Potkin and others , 2009c; Tse and Cronican, 2009). The r2 is the
square of the correlation coefficient between any two SNPs. A value of r2 = 1 indicates
that two SNPs are in perfect LD.
LD itself is usually not considered as quality control criterion in GWA studies. However,
a high LD indicates that the effective number of tests in whole-genome analyses is fewer
than the number of SNPs, since only the representative SNPs, called the
”
tag“ SNPs,
are needed to capture most of the genetic variability (Potkin and others , 2009c; Tse
and Cronican, 2009).
1.2.3 Endophenotypes derived from neuroimaging
By definition, endophenotypes are quantitative markers that are highly heritable and
reliably correlated with the disease (Gottesman and Gould, 2003). A number of twin
studies have indicated that measures of brain structure, function and connectivity
derived from Magnetic Resonance Imaging (MRI) satisfy the heritability criterion (as
elaborately reviewed by Jansen and others (2015)) and thus might be considered as
intermediate phenotypes in GWA analyses. To facilitate the identification of optimal
endophenotypes, Glahn and others (2012) proposed the endophenotype ranking value
(ERV), which is an index of the genetic utility of endophenotypes for an illness of
interest. The ERV is defined as the product of the square root of the heritability of
the illness (h2i ), the square root of the heritability of the endophenotype (h
2
e), and their
genetic correlation (ρg). It is expressed as ERVie =
√
h2i · h2e · |ρg|. The ERV varies
between zero and one. Higher values indicate that the endophenotype and the illness
are stronger influenced by shared genetic factors.
1.2.3.1 Endophenotypes derived from Magnetic Resonance Imaging
In principle, any brain measure derived from in-vivo structural or functional MRI
can be used as intermediate phenotype in genetic neuroimaging studies. MRI is a
non-invasive brain imaging technique, invented by Lauterbur (1973). Using a strong
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magnetic field, it maps the distribution of hydrogen nuclei in tissues containing water
molecules in the brain. The basic principle of MRI is as follows. When hydrogen
nuclei are exposed to a strong and static magnetic field, they tend to align with that
magnetic field (Shin and Buxton, 2015). If additionally a radio frequency magnetic
pulse is applied at the right frequency, they absorb energy, tilt away from the static
magnetic field and generate a so-called MR signal. Fourier transformation is used to
reconstruct the MR image from the signal (Garroway and others , 1974; Mansfield and
Grannell, 1973). By modifying parameters of the radio frequency magnetic pulse, it
is possible to highlight different characteristics of the tissue that is imaged (Matthews
and Jezzard, 2004). The two most important parameters are the repetition time (TR)
and the echo time (TE). TR is the time between consecutive radio frequency pulses.
TE is the time between the initial radio frequency pulse and the peak of the echo sig-
nal, i.e. the delay before detecting the MR signal (Shin and Buxton, 2015). The time
a hydrogen nucleus needs to revert back to its equilibrium position (along the static
magnetic field) after application of the radio frequency pulse is called relaxation time
(Matthews and Jezzard, 2004). Three relaxation times are of primary interest for MRI
and are used to distinguish between different tissue types. The first one is T1, also
known as spin-lattice or longitudinal relaxation time. It is defined as the time taken by
the hydrogen nuclei to realign with the external magnetic field (Magnetic Resonance -
Technology Information Portal, 2015). A T1-weighted MR image is characterized by
a short TR and a short TE, and emphasizes the contrast between gray matter (GM)
and white matter (WM) in the brain (Shin and Buxton, 2015). The second one, T2
(spin-spin or transverse relaxation time), relates to the decay of magnetization per-
pendicular to the static magnetic field, i.e. the exchange of energy with nearby nuclei
(Magnetic Resonance - Technology Information Portal, 2015). T2-weighted MR images
are created with long TR and long TE and enhance the contrast between brain tissue
and cerebrospinal fluid (CSF; Shin and Buxton, 2015). The last one is the T2* relax-
ation. It describes the decay of transverse magnetization caused by a combination of
spin-spin relaxation (T2 relaxation) and the inhomogeneity in the static magnetic field
(Chavhan and others , 2009). As for T2, T2*-weighted MR images are characterized by
a long TR and a long TE. They form the basis for functional MRI, since the local T2*
in the brain is affected by changes in oxygen saturation (Chavhan and others , 2009).
Whether T1-, T2- or T2*-weighted MR images are produced, depends on the imaging
modality. A number of genetic neuroimaging studies focus on structural Magnetic Res-
onance Imaging (sMRI). Structural MRI provides anatomical information about GM
(T1-weighted MR images) and WM (T2-weighted MR images) in the brain (Symms
and others , 2004). It is based on the knowledge that the MR signal varies across these
tissue types (Shin and Buxton, 2015). The GM is primarily composed of neuronal
cell bodies. In contrast, the WM mainly contains long-range nerve fibers (myelinated
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axons). Thus, sMRI allows to qualitatively and quantitatively describe the volume,
thickness or surface of GM and WM structures in the brain (Shin and Buxton, 2015;
Symms and others , 2004).
Besides sMRI, functional Magnetic Resonance Imaging (fMRI) plays an important role
for genetic neuroimaging. The basis for fMRI is the observation that the MR signal
slightly increases with neural activity in a particular area of the brain (Shin and Bux-
ton, 2015). However, what is detected in fMRI is only an indirect measure of brain
activity based on cerebral blood flow. Depending on the availability of oxygen in the
blood, the hemoglobin can be saturated with oxygen molecules (oxyhemoglobin), or de-
saturated with oxygen molecules (deoxyhemoglobin). Oxyhemoglobin is isomagnetic,
whereas deoxyhemoglobin is slightly paramagnetic relative to brain tissue (Pauling and
Coryell, 1936). Functional MRI measures the state of oxygenation of the hemoglobin
in blood, the so-called blood oxygenation level-dependent (BOLD) magnetic resonance
signal (Ogawa and others , 1990). More specifically, the increase in blood flow related to
neuronal activity in a particular area of the brain is accompanied by an increase in oxy-
hemoglobin concentration (Amaro Jr. and Barkera, 2006; Roy and Sherrington, 1890;
Shin and Buxton, 2015). This increase in oxyhemoglobin might appear contradictory,
as one would initially expect a decrease in oxyhemoglobin concentration triggered by
an increased consumption (Fiat and others , 1993). However, for neural stimulation,
blood flow needs to be increased to supply neurons with oxygen. The increased cerebral
blood flow causes vasodilation because of the balloon-like elasticity of the venules and
veins (Buxton and Frank, 1997). This results in an increase of cerebral blood volume
(Buxton and others , 1998), providing an increased oxygen supply (Fox and Raichle,
1986). Changes in the ratio between oxyhemoglobin and deoxyhemoglobin concentra-
tion cause slight local inhomogeneities in the magnetic field, leading to a high signal in
the BOLD images (Hyder and others , 1998; Kwong and others , 1992). The BOLD sig-
nal increase is proportional to the underlining neural activity (Logothetis and Pfeuffer,
2004). This relationship reflects what is actually measured in fMRI.
Functional MRI can be performed by repeatedly presenting stimuli or a series of cog-
nitive tasks to the subjects, while taking BOLD images of the entire brain every one
to two seconds (task fMRI). Alternatively, the brain can be studied at rest in order
to investigate how neural activity in different brain regions is functionally connected
(resting state fMRI). These so-called resting state networks might be altered in a num-
ber of psychiatric diseases (Amaro Jr. and Barkera, 2006).
In addition to methods providing anatomical information about GM and WM in the
brain (sMRI) or detecting brain activation (fMRI), MRI can also be utilized for map-
ping of white matter fiber tracts using Diffusion Weighted Imaging (DWI). DWI mea-
sures the self-diffusion of water, i.e. the random motion of water molecules in the
brain (Symms and others , 2004). More specifically, acquiring images with differing
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amounts of diffusion weighting allows the production of maps that show the princi-
pal direction of diffusion in any voxel (Symms and others , 2004). On basis of these
maps, various parameters can be extracted, such as the mean diffusivity (MD) or the
fractional anisotropy (FA). The MD describes the rotationally invariant magnitude of
water diffusion within the brain (Clark and others , 2011). An increase in MD might
reflect, e.g., an increase in global CSF, whereas a decrease might be related to cell
proliferation (Alexander and others , 2007). The FA, originally developed by Basser
and Pierpaoli (1996), reflects the overall directionality of water diffusion in the brain
(Koay and others , 2006). It can take scalar values between zero and one. A value of
zero means that diffusion is isotropic, i.e. not restricted in any direction. A value of
one reflects that diffusion is anisotropic, i.e. occurs along a major axis and is fully
restricted in any other direction (Clark and others , 2011).
A main application of DWI is tractography, i.e. mapping of fiber orientation in the
brain. Tractography is based on the knowledge that the water diffusion in WM fiber
tracts is much greater along the direction of the fibers than in a perpendicular direction
(Shin and Buxton, 2015). This knowledge can be used to trace fiber tracts connecting
brain regions (Assaf and Pasternak, 2008) and to visualize these tracts using probability
maps (Symms and others , 2004).
1.2.3.2 Endophenotypes derived from Radionuclide Imaging
Apart from brain imaging measures derived from MRI, Radionuclide Imaging tech-
niques are commonly considered for genetic neuroimaging. Radionuclide Imaging pro-
vides non-invasive measures of the distribution of radio-labeled compounds in tissues of
the brain, which can be used to monitor biological activity (Sorenson and Phelps, 1987).
Three different procedures are currently used, Planar Imaging, Single-Photon Emission
Computed Tomography (SPECT) and Positron Emission Tomography (PET). The
technical details of these techniques vary considerably. However, the general princi-
ples are similar. All three techniques require the delivery of a tracer that is labeled
with a gamma-emitting radioisotope to the subject, typically through injection into
the bloodstream (Fischman and others , 2002). The radioisotope decays inside the sub-
ject’s body by emitting high-energy gamma radiation that can be detected by external
imaging.
1.2.3.3 Influence of non-genetic factors
The contribution of single genes to the explanation of variance observed in brain struc-
ture, function or connectivity is presumably small (Bigos and Weinberger, 2010). In
contrast, non-genetic effects, such as age, gender, education, handedness, smoking or
medication status, are typically large and can easily obscure the smaller gene effects.
In genetic neuroimaging studies, it is therefore mandatory to account for non-genetic
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factors by either appropriately matching participants in order to minimize group differ-
ences or by using these factors as covariates in the model (Roffman and others , 2006).
For fMRI studies it is additionally essential to carefully consider the task-performance
level between groups, since differences in brain activity might be more related to task
performance itself than to genetic influences (Bigos and Weinberger, 2010; Roffman
and others , 2006).
1.2.3.4 Neuroimaging as messenger
In genetic neuroimaging studies it is crucial to keep in mind that neuroimaging itself is
not the endophenotype. It is rather the variation in structure, function, connectivity
or biological activity of the brain that is intermediate between genetic susceptibility
and diagnosis. As has already been stated by Bigos and Weinberger (2010), imaging
is the messenger, not the message.
1.3 Classification of genetic neuroimaging studies
1.3.1 Classification based on the dimensionality of the imag-
ing and the genetic data set
Depending on the dimensionality of the imaging and the SNP data searched for asso-
ciation, genetic neuroimaging studies can be classified into four main categories (Liu
and Calhoun, 2014; Vounou and others , 2010).
1.3.1.1 Candidate phenotype - candidate gene association studies
Genetic neuroimaging studies are statistically and computationally challenging due to
the relatively small number of subjects compared to the high dimensionality of the
imaging and the genetic data set (Batmanghelich and others , 2013). To address the
problem of high dimensionality and small sample size, researchers have often considered
only a few imaging candidates (e.g. voxels within a specific region of interest (ROI))
and only a few genetic markers (e.g. SNPs within a specific chromosomal region) in
so-called candidate phenotype - candidate gene association studies (CP-CGA).
The first CP-CGA study based on fMRI was reported by Bookheimer and others (2000).
During a memory-activation task in which subjects had to memorize and recall unre-
lated pairs of words, they explored how the apolipoprotein E (APOE) gene increases
the risk for Alzheimer’s disease (AD) in healthy elderly. They found that in carriers of
the APOE 4 allele both the magnitude and the extent of brain activation were greater
than in those homozygous for the APOE 3 allele in regions affected by AD, includ-
ing the left hippocampal, parietal, and prefrontal regions. Similarly, Small and others
(2000) searched for associations with the APOE gene in healthy elderly using PET.
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Carriers of a single copy of the APOE 4 allele had a lowered inferior parietal, lateral
temporal and posterior cingulate metabolic rate. Heinz and others (2000) examined
the in-vivo availability of the striatal dopamine transporter (DAT) protein in caudate
and putamen, as quantified by SPECT, together with the variable number tandem
repeat (VNTR) polymorphism of the dopamine transporter SLC6A3 gene in abstinent
alcoholics and healthy control subjects. Individuals with the 9-repeat/10-repeat geno-
type were shown to have a reduced DAT protein availability in putamen compared
with 10-repeat-homozygous individuals. Similarly, Hariri and others (2002) explored
how genetic variation in the serotonin transporter gene (SLC6A4; short allele and long
allele) affects neuronal activity in the amygdala in response to fearful stimuli, as mea-
sured by fMRI, in two independent cohorts of healthy volunteers. Individuals with one
or two copies of the short allele were found to have greater amygdala activity compared
with individuals homozygous for the long allele. Behavioral measures of normal fear or
pathological anxiety did not statistically differ between groups, emphasizing the role of
neuroimaging endophenotypes to identify genetic risk markers (Section 1.2.1). The rela-
tionship of the Val108Met polymorphism (rs4680) in the catechol-O-methyltransferase
(COMT) gene with prefrontal cortical physiology, measured using fMRI during two-
back working memory task (more details are provided in Appendix A), was investigated
by Egan and others (2001) in patients with schizophrenia and a group of unaffected
siblings. Carriers of the Val allele, who have relatively increased cortical dopamine
catabolism and therefore less cortical dopamine, exhibited an increased activation in
dorsolateral prefrontal and anterior cingulate cortex in a dose-dependent manner com-
pared to Met allele carriers. Behavioral performance was, however, not impaired in
Val allele carriers, again confirming the use of measures derived from neuroimaging
as intermediate phenotypes (Section 1.2.1). More recently, Joyner and others (2009)
studied the relation between four summary brain structure measures (intracranial vol-
ume, parenchymal volume, cortical surface area and mean cortical thickness), extracted
from T1-weighted MR images, and 11 SNPs located in and around the methyl CpG
binding protein 2 (MECP2) gene in two independent cohorts, a discovery sample of
healthy controls and patients with psychotic disorders (schizophrenia disorder, affective
disorder and severe psychotic disorder) and a replication sample from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI; more details are provided in Appendix A). In
the male population, the minor allele of SNP rs2239464 was significantly associated
with reduced cortical surface area in both populations. Nymberg and others (2013)
examined how striatal and inferior frontal activation patterns, as measured by fMRI,
contribute to attention-deficit/hyperactivity disorder (ADHD) symptoms depending
on the genotype of the monoamine oxidase A (MAOA) gene in a sample of adolescent
boys. They found that in A-homozygous individuals of the SNP rs12843268, ADHD
symptoms were associated with lower ventral striatal brain activation during the mon-
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etary incentive delay task (more details are provided in Appendix A) and lower inferior
frontal gyrus brain activation during the stop signal task (more details are provided in
Appendix A). In contrast, G-homozygous individuals showed increased inferior frontal
gyrus brain activation during the stop signal task in the presence of increased ventral
striatal brain activation during the monetary incentive delay task. In a recent publica-
tion, Loth and others (2014) searched for associations of 23 SNPs across the oxytocin
receptor (OXTR) gene region and fMRI activity in the ventral striatum and amygdala
in response to animated angry faces in adolescents. C-homozygous individuals of the
SNP rs237915 had a significantly lower activity in ventral striatum than heterozygous
and T-homozygous individuals.
CP-CGA studies provide an opportunity to check for biologically plausible links be-
tween specific genetic variants and defined anatomical, functional or metabolic alter-
ations in the brain. Therefore, they emphasize the role of neuroimaging endopheno-
types in genetic association studies. At the same time, it should be noted that prior
physiological or pathophysiological knowledge is needed to select characteristic genetic
variants and neuroimaging measures (Ge and others , 2013; Potkin and others , 2009c).
This evidence is, however, not always available. CP-CGA studies are at risk to miss
potential associations.
1.3.1.2 Candidate phenotype - genome-wide association studies
In the candidate phenotype - genome-wide association (CP-GWA) category, brain
imaging phenotypes are limited to a few candidates of interest that are known to
be biomarkers for a particular biological process. They are tested for association with
a large number of SNPs obtained during whole-genome screening (Ge and others , 2013;
Hibar and others , 2011a; Le Floch and others , 2012; Vounou and others , 2010).
A typical CP-GWA study was conducted by Potkin and others (2009a). In subjects
with chronic schizophrenia and healthy controls, they selected the mean BOLD signal
in the dorsal lateral prefrontal cortex during the Sternberg item recognition paradigm
(more details are provided in Appendix A) as intermediate phenotype and performed
a genome-wide screening for genes associated with schizophrenia. SNPs in two genes
(RSRC1 and ARHGAP18) were identified that had not been previously associated with
schizophrenia. For validation, they conducted a case-control study in a larger, inde-
pendent sample and corroborated an association of these two genes with schizophrenia
diagnosis (Potkin and others , 2009a). Six additional genes or chromosomal regions
(ROBO1-ROBO2, TNIK, CTXN3-SLC12A2, POU3F2, TRAF and GPC1) were dis-
covered in a further CP-GWA study (Potkin and others , 2009b). Similarly, Stein and
others (2010a) examined the relation of genome-wide SNPs and two imaging pheno-
types, temporal lobe volume and hippocampal volume measures, extracted from T1-
weighted MR images, in patients with AD or Mild Cognitive Impairment (MCI) and
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healthy elderly. Two SNPs (rs10845840 in the GRIN2B gene and rs2456930, an inter-
genic SNP) were found to be associated with bilateral temporal lobe volume. Ousdal
and others (2012) searched for SNPs across the entire genome that underlie individ-
ual variability in adult amygdala activity, as quantified using fMRI during emotional
face-matching task (more details are provided in Appendix A). They discovered a SNP
(rs10014254) located in a regulatory region upstream of the paired-like homeobox 2b
(PHOX2B) gene, which regulates the expression of enzymes necessary for the synthesis
of monoamines.
For CP-GWA studies, the neuroimaging endophenotypes do not necessarily need to be
restricted to a single brain measure. Shen and others (2010) used T1-weighted MR
images of individuals from the ADNI to split the brain into 142 cortical and subcor-
tical regions. They extracted summary measures of GM density, volume and cortical
thickness for all regions, followed by a genome-wide search for associations. Several
previously known SNPs (located in genes such as APOE, TOMM40, EPHA4, TP63
and NXPH1), but also some new SNPs (rs12531488, rs7526034, rs7647307, rs4692256)
were significantly related to structural changes in multiple brain regions.
1.3.1.3 Brain-wide - candidate gene association studies
Brain-wide - candidate gene association (BW-CGA) studies describe the opposite ap-
proach. A confined number of candidate SNPs from a specific chromosome or region
are searched for potential associations with imaging phenotypes that cover whole-brain
or many regions of it (Ge and others , 2013; Glahn and others , 2007; Le Floch and oth-
ers , 2012; Meyer-Lindenberg, 2012; Vounou and others , 2010).
Filippini and others (2009) and Ho and others (2010) used T1-weighted MR images
along with genetic information. Filippini and others (2009) aimed to define the rela-
tionship between the APOE gene and whole-brain GM volume in subjects with mild
AD. They observed that GM volume decreased additively with the number of APOE
4 alleles in medial and anterior temporal lobes bilaterally. Ho and others (2010)
identified, how a variant (rs3751812) within the obesity-related fat mass and obesity-
associated (FTO) gene influences brain structure in healthy elderly subjects. FTO
risk allele carriers (T) versus non-carriers (homozygous for G) were found to have 8%
lower GM volume in the frontal lobes and 12% lower GM volume in the occipital lobes.
These brain differences were not attributable to differences in cholesterol levels or hy-
pertension (Ho and others , 2010).
In order to evaluate white matter integrity, Braskie and others (2011) considered DWI
to search for associations of the SNP rs11136000 in the AD risk gene clusterin (CLU)
with voxel-wise FA measures in young healthy adults. Each C-allele copy of rs11136000
was associated with lower FA in frontal, temporal, parietal, occipital, and subcortical
white matter. Strongest effects were found in splenium of the corpus callosum, the
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fornix, cingulum, and superior and inferior longitudinal fasciculi in both brain hemi-
spheres.
APOE-related alterations in resting-state fMRI connectivity were explored by Westlye
and others (2011) and Trachtenberg and others (2012). Westlye and others (2011)
studied healthy middle-aged and elderly individuals and found significantly increased
hippocampal default-mode network (DMN) synchronization in carriers of the APOE 4
allele compared with non-carriers. Whole-brain analysis revealed additional effects on
posterior cingulate cortex, parietal cortex and parahippocampal regions. Trachtenberg
and others (2012) compared resting-state networks between healthy middle-aged par-
ticipants with different APOE genotypes (2/3, 3/3, 3/4 and 4/4). The 4 allele
is known to increase the risk of developing AD, while the 2 appears to protect against
AD. Both 4 and 2 allele carriers demonstrated increased connectivity between the
anterior hippocampal network and a variety of parietal and frontal areas, decreased
connectivity between the posterior hippocampal network and a variety of posterior
regions, decreased connectivity between the auditory network and several regions in
the frontal, temporal and parietal lobes, and increased connectivity between the left
frontalparietal network and the anterior cingulate cortex, lateral parietal cortex and
basal ganglia, relative to 3-homozygous individuals. Thus, changes in functional con-
nectivity were similar in 4 and 2 carriers and the effects of APOE on the brain were
not reflective of the link between APOE and AD risk.
In healthy individuals, Rose and others (2012) explored how the schizophrenia risk SNP
rs12807809, located upstream of the neurogranin (NRGN) gene, affects brain structure
and brain function (fMRI during a spatial working memory task; more details are pro-
vided in Appendix A). There was no effect of rs12807809 on behavioral performance or
brain structure. However, carriers of the non-risk C-allele exhibited a load-independent
decrease in left superior frontal gyrus activity, while those homozygous for the risk T-
allele failed to show a decrease in activity.
1.3.1.4 Brain-wide - genome-wide association studies
Both candidate gene and candidate phenotype association studies provide insights into
how genetic variants influence cognitive processes that are related to disorders in the
brain. However, by significantly reducing one or both data types, important relation-
ships, such as gene-gene-interactions or the strong covariance structure between imag-
ing variables (Kovacevic and others , 2013), might be missed. Consequently, researchers
were increasingly interested in brain-wide, genome-wide association (BW-GWA) stud-
ies, where both the entire genome and the entire brain are searched for non-random
associations (Hibar and others , 2011a; Vounou and others , 2010). The assumption is
that only a handful of voxels is associated with a handful of genetic markers.
An example for the BW-GWA category is the voxel-wise genome-wide association study
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(vGWAS) by Stein and others (2010b). Six billion univariate association tests were
performed between 448,293 SNPs across the entire genome and 31,622 voxels across
the entire brain in a huge sample of 740 subjects from the ADNI, including patients
with AD and MCI as well as healthy elderly controls. The authors introduced a novel
method to accommodate the huge number of statistical tests performed by only keep-
ing the P -value for the most associated SNP at each voxel. No SNP passed the strict
correction for multiple comparison, but several genetic variants were identified with
biological interest, such as rs476463, located within an intronic region of the CSMD2
gene, and rs2429582, located within an intronic region of the CADPS2 gene.
By hypothesis-free searching for novel genetic variants and their effects on the brain,
BW-GWA studies might fundamentally improve our current understanding of neuro-
logical and psychiatric disorders. However, the high dimensionality of both data sets
imposes many statistical and computational challenges, and often requires a very large
cohort (Ge and others , 2013; Poline and others , 2010; Potkin and others , 2009c).
1.3.2 Classification into forward and backward models
According to the perspective that guides the design of genetic neuroimaging studies
and the knowledge that is taken for granted, Meyer-Lindenberg (2006; 2010; 2012)
differentiated two strategies, forward modeling and backward modeling.
Forward modeling observes a collection of brain imaging measures, which are regarded
as given, to identify novel genetic variants implicated in neurological or psychiatric
disorders. Thus, forward models are gene discovery approaches from the point of view
of geneticists, and examples are overlapping with those introduced in Section 1.3.1.2.
Likewise, backward models consider genes known to be associated with psychiatric
disorders to discover related neural mechanisms, and are performed from the point of
view of neuroimagers. Example studies can be adopted from Section 1.3.1.3.
1.4 Statistical analysis in genetic neuroimaging
1.4.1 Univariate analysis
In genetic neuroimaging research, the standard approach to jointly examine the brain
and the genome is the so-called mass-univariate linear modeling (MULM) approach
(Vounou and others , 2010). MULM consists of fitting univariate linear regression
models at each SNP in the genome and each voxel in the brain, independently of each
other. SNPs are usually recoded using an additive genetic model, counting the number
of minor alleles per person (Section 1.2.2.1). Evidence for an association between a
SNP and a voxel is provided, if the null hypothesis of no association is rejected.
The MULM approach is appealing in genetic neuroimaging because of its simplicity. In
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addition, univariate linear regression models can easily be fitted even if the number of
variables exceeds the available sample size (Vounou and others , 2010). However, despite
its advantages, MULM presents major limitations. At first, MULM ignores interde-
pendencies between genetic variants due to LD (Ge and others , 2013). Several SNPs
with relatively small individual effects that are possibly located on different genes may
jointly influence a particular brain imaging phenotype (Ge and others , 2013; Vounou
and others , 2010). Such interactive effects are defined as epistasis (Miko, 2008). In vivo
evidence of biological epistasis in the human brain was provided by Pezawas and oth-
ers (2008). Using T1-weighted MR images of healthy participants, they explored how
functional polymorphisms of the serotonin transporter SLC6A4 (5-HTTLPR) and the
brain-derived neurotrophic factor (BDNF; Val66Met) impact corticolimbic circuitry.
The Met allele of BDNF was shown to protect against 5-HTTLPR short allele-induced
reductions of anterior cingulate volume, while a Val/Val background exaggerated this
effect.
Similarly, MULM ignores the strong correlation structure of brain imaging variables
(Kovacevic and others , 2013). If a SNP explains phenotype variance at one brain loca-
tion, it is expected to also affect other neighboring brain regions (Le Floch and others ,
2012; Vounou and others , 2010), a phenomenon known as pleiotropy (Lobo, 2008).
The warrior/worrier model (Goldman and others , 2005; more details are provided in
Appendix A) of the Val108Met polymorphism (rs4680) in COMT is an example for
behavioral pleiotropy. Specifically, Goldman and others (2005) showed that the Val
allele in the COMT gene (warrior) leads to better stress resiliency, but also modest
reduction of executive cognitive performance, while the Met allele (worrier) predicts
a progressively lower pain threshold. Meta-analytical evidence on the level of brain
function was provided by Mier and others (2010). They found a significant positive
association between COMT genotype and prefrontal activation in studies focusing on
cognitive processing (i.e. reduced prefrontal cortex efficiency in Val allele carriers).
Equally, a significant negative association was detected in studies focusing on emo-
tional processing (i.e. reduced prefrontal cortex efficiency in Met allele carriers).
A further limitation of MULM is related to the need to determine an experiment-wide
significance level that accounts for the multiple testing problem (Vounou and others ,
2010). MULM amounts to running as many tests as there are SNPs in the genome and
voxels in the brain. By repeatedly performing statistical tests, there is an increase in
the type I error rate. To limit the problem of multiple testing, candidate phenotype
and/or candidate gene association studies (Sections 1.3.1.1 to 1.3.1.3) have often been
used, thereby reducing the number of voxels and SNPs. However, strong prior evidence
is needed to select characteristic candidates. Another strategy to compensate for in-
flated type I errors is to statistically correct for multiple testing. This is typically done
using a family-wise error rate approach (FWER; more details are provided in Appendix
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A), such as the Bonferroni procedure (Dunn, 1959). In genetic neuroimaging studies,
however, the Bonferroni correction is very conservative, since it does not account for
dependencies of genetic variants or voxels in the brain that limit the effective num-
ber of tests (Potkin and others , 2009c). Other, potentially more powerful methods to
control for false positives have been developed, such as the false discovery rate (FDR;
Benjamini and Hochberg, 1995; more details are provided in Appendix A). However,
they still address the evaluation of a single SNP and a single voxel at a time.
The numerous limitations of MULM call for dedicated multivariate methods that com-
bine information from multiple markers simultaneously into the analysis, therefore re-
ducing the number of statistical tests performed. Since multivariate methods account
for the correlation structure in both the imaging and genetic data, they are expected
to discover meaningful associations, and to be powerful, even if the number of variables
heavily exceeds the available sample size (Ge and others , 2013).
1.4.2 Multivariate analysis
When facing a very large number of SNPs and a very large number of voxels in the
brain, researchers in genetic neuroimaging typically focus on three multivariate anal-
ysis techniques (Liu and Fieguth, 2012): Partial Least Squares Analysis (PLS; Wold,
1975), Canonical Correlation Analysis (CCA; Hotelling, 1936) and parallel Independent
Component Analysis (paraICA; Liu and others , 2009). PLS and CCA are correlation
techniques that analyze the association between two sets of variables, such as the neu-
roimaging and the genetic data, by building orthogonal linear combinations of the
observed variables of each modality (so-called latent variables). PLS aims at maximiz-
ing, at each step, the covariance between latent variables. In contrast, CCA maximizes
the correlation between latent variables. In high-dimensional data analysis, when the
number of variables greatly exceeds the number of observations, linear combinations of
the entire set of variables are biologically implausible, since the majority of SNPs and
voxels are not expected to be affected by the neurological disorder under study (Med-
land and others , 2014; Vounou and others , 2010). These problems might be solved
by adding L1 or L2 regularization (Ng, 2004) to the PLS or the CCA model in order
to perform variable selection. Sparse linear combinations increase interpretability and
strengthen the stability of results by avoiding over-fitting (Liu and Calhoun, 2014). In
the past years a multitude of different (sparse) PLS (Chun and Keles, 2010; Leˆ Cao and
others , 2008; Konukoglu and others , 2016) and (sparse) CCA (Akaho, 2001; Bach and
Jordan, 2002; Friman and others , 2001a; Friman and others , 2001b; Hardoon and oth-
ers , 2004; Ketterling, 1971; Leˆ Cao and others , 2009; Parkhomenko and others , 2007,
2009; Soneson and others , 2010; Waaijenborg and others , 2008; Witten and others ,
2009) variants have been proposed. Some of these models have already been applied
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to detect multivariate genotype-phenotype associations, e.g. for fusion of simulated
imaging and SNP data by Boutte and Liu (2010) and Chi and others (2013), for fusion
of T1-weighted MR images and SNP data in healthy subjects (Hardoon and others ,
2009) and MCI and AD patients (Wan and others , 2011; Du and others , 2016), and for
fusion of functional magnetic resonance imaging data and SNP data in schizophrenia
patients (Fang and others , 2016).
In contrast to PLS and CCA, ICA (He´rault and Ans, 1984; He´rault and others , 1985)
builds latent variables, so-called components, that are maximally independent from
each other (Hyva¨rinen and Oja, 2000). Independence of components is optimized by
either minimizing the mutual information or maximizing the non-Gaussianity (Langlois
and others , 2010). A common algorithm that uses minimization of mutual informa-
tion is called InfoMax (Amari and others , 1996; Bell and Sejnowski, 1995a; Bell and
Sejnowski, 1995b). A well-known algorithm for maximization of non-Gaussianity is
the FastICA algorithm (Hyva¨rinen, 1999). Parallel ICA is an extension of ICA, which
enables the joint analysis of two data sets by maximizing both the independence of
components and the correlations between projection vectors of each modality (Liu and
others , 2008; Liu and Calhoun, 2014). The algorithm works by first performing Princi-
pal component analysis (PCA; Pearson, 1901) on each data set, followed by a simulta-
neous extraction of independent factors for each data set using a correlation measure
(Hibar and others , 2011a). Parallel ICA has been applied for combined analysis of
fMRI and SNP data in schizophrenia by Liu and others (2009). Similarly, it has been
used to reveal relationships between brain structure and SNP data in schizophrenia
(Jagannathan and others , 2010) and AD (Meda and others , 2012).
1.5 Dimensionality-related problems in genetic neu-
roimaging
Correlation based multivariate analysis techniques are commonly used to study genetic
influences on brain structure, function, connectivity and biological activity. Since these
methods account for the correlation structure in both the imaging and genetic data,
they are expected to be powerful and to discover meaningful associations. However,
with the advent of great technological advances in an extending range of scientific dis-
ciplines, multivariate techniques are facing computational challenges. Taking genomics
as an example, the introduction of high-throughput sequencing enabled the delivery of
DNA sequences of the entire human genome. At the same time, high-resolution brain
imaging is increasingly becoming available. Genetic neuroimaging research, which in-
tegrates information from both sources, is thus experiencing a rapid growth in dimen-
sionality.
On the one hand, big data collections hold great promises since they shed light towards
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new scientific discoveries. However, the more variables are considered the more chal-
lenging is the analysis from a statistical point of view. In addition, computation times
become excessively long with increasing data dimensionality, posing a serious practi-
cal problem for many applications (e.g. Konukoglu and others , 2016). This relates
to a phenomenon known as the curse of dimensionality, which states that obtaining
a statistically reliable result requires the sample size to grow exponentially with the
dimension (Bellman, 1957, 1960).
One approach for mitigating high-dimensional data analysis is dimensionality reduc-
tion. A statistically meaningful dimension reduction technique reduces the number of
dimensions as much as possible without loss of information while being computation-
ally efficient. In general, dimensionality reduction is based on two paradigms: feature
extraction and feature selection (Le Floch and others , 2012). Feature extraction re-
duces the amount of original variables by representing the data in a lower dimension
(Guyon and Elisseeff, 2006). The coordinates of data points in the lower dimension
are then used for further analysis. In contrast, feature selection methods aim to rank
variables according to their individual relevance using an evaluation criterion (Guyon
and Elisseeff, 2006).
Various dimensionality reduction techniques have been proposed for pre-processing in
genetic neuroimaging. In a whole-genome setup including 85,772 SNPs and 34 brain
locations of interest, Le Floch and others (2012) used univariate filters with different
thresholds in order to identify a subset of SNPs that were considerably correlated to
the neuroimaging data. The reduced set of SNPs was further searched for association
with the neuroimaging data using two multivariate strategies, penalized Partial Least
Squares regression (Wold, 1975) and regularized Kernel Canonical Correlation Anal-
ysis (Hotelling, 1936). The authors showed that a relatively large number of SNPs
was needed after filtering in order to comprise all true positives. However, to avoid
over-fitting, irrelevant SNPs had to be filtered out although the authors did not define
a clear threshold for the filters. In addition to univariate filtering, Le Floch and others
(2012) applied Principal component analysis (PCA; Pearson, 1901) for dimensionality
reduction. PCA is a feature extraction technique that builds orthogonal linear com-
binations of the original variables, called principal components (PC), that are then
ranked in descending order based on the amount of the variance in the data they
explain (Jolliffe, 2002). Le Floch and others (2012) performed PCA on both the neu-
roimaging and the SNP data set and kept as many components as necessary to explain
99% of the variance in each modality. However, all methods based on PCA failed to
identify generalizable associations.
PCA-based dimensionality reduction was also conducted in a study by Hibar and others
(2011b; 2011c). The authors searched for associations between 448,293 genome-wide
SNPs and 31,662 whole-brain voxels in a large sample of 731 subjects from the ADNI
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(the data set has previously been introduced by Stein and others (2010b)). To reduce
the total number of tests, SNPs were grouped into 18,044 genes based on gene mem-
bership. Principal component regression (PCReg) was then implemented to search for
the combined effect of multiple SNPs on the brain. Hibar and others (2011b; 2011c)
named their technique voxel-wise gene-wide association study (vGeneWAS). However,
no genes identified were significant after correction for multiple .
Using the same data set of genome-wide SNPs and whole-brain neuroimaging voxels
from the ADNI, in a recent study, Hua and others (2015) performed dimensionality
reduction by selecting 119 brain regions of interest based on an anatomical brain atlas.
Distance covariance (Sze´kely and others , 2007) was applied to infer the relationship
between the single SNP predictors from the entire genome and the average voxel values
at the 119 brain regions, utilized as multivariate response. In order to overcome the
multiple testing problem, Hua and others (2015) also introduced a local false discovery
rate (FDR) modeling algorithm. The authors showed that by using their method, they
were able to find 23,128 significant SNPs at α-level 0.05, while simple linear regression
yielded no significant SNPs.
A far less common technique for dimensionality reduction is Random projection (RP)
(Johnson and Lindenstrauss, 1984). RP uses a random matrix with unit Euclidean
column norms to find a lower-dimensional subspace that approximately preserves the
distances between all pairs of data points in the original space (Bingham and Mannila,
2001; Dasgupta, 2000; Kaski, 1998; Lin and Gunopulos, 2003; Vempala, 2004). In many
data mining applications, including information retrieval of text documents and image
processing, RP has been shown to provide good results. For example, Papadimitriou
and others (1998) used RP prior to Latent Semantic Indexing (LSI) for document
categorization and classification. The authors identified that RP significantly speeded
up LSI without affecting its quality. A comparison of several dimensionality reduc-
tion methods, including PCA, RP, Singular value decomposition (SVD) and Discrete
Cosine Transform (DCT)), was performed by Bingham and Mannila (2001) on large-
dimensional noiseless and noisy image data and on the Newsgroup text data set, a
collection of approximately 20,000 newsgroup documents, partitioned across 20 differ-
ent newsgroups. RP was demonstrated to be computationally simple while providing a
high degree of accuracy. Goel and others (2005) applied RP in face recognition research
to represent faces in a low-dimensional subspace. Using three popular face databases,
they compared the performance of RP and PCA. As previously declared by Bingham
and Mannila (2001), they illustrated that the overall performance of RP was compa-
rable to that of PCA while having lower computational requirements and being data
independent. Sulic´ and others (2010) employed RP in the context of embedded vision
systems using a standard database consisting of 20 different objects. Like in previous
applications, RP preserved the structure of the data without significant distortion. Re-
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cently, Liu and Fieguth (2012) described a classification method based on RP, suitable
for large texture database applications. Textures were represented as a small set of
random measurements and learning and classification were carried out directly in the
compressed domain. Using three databases, the authors showed that their approach
outperformed four state-of-the-art texture classification methods, but with significant
reductions in processing time.
In addition to a large number of data mining applications, RP has very recently been
reported for mass spectrometry imaging (MSI) data by Palmer and others (2015). In
MSI, clustering methods are usually applied to group similar tissue regions accord-
ing to their similarity in the mass spectrum, a process known as segmentation. The
calculation of distances for the clustering is, however, computationally costly in high-
dimensional MS images. Because of its distance preservation properties, the authors
established RP for dimensionality reduction prior to k-Means clustering. They were
able to detect histological changes in diseased human livers with high accuracy.
The examples from literature presented in the previous paragraphs indicate that RP is
a very fast and efficient method for dimensionality reduction. In particular the study
by Palmer and others (2015) demonstrates its potential for truly high-dimensional ap-
plications such as biological imaging. However, for combined analysis of neuroimaging
and genetic data RP has never been considered. What is special about genetic neu-
roimaging is that both data modalities are naturally high-dimensional. Therefore it is
even more important to add a first step of dimensionality reduction. As Liu and Cal-
houn (2014) argue in a recent review article, none of the existing methods for genetic
neuroimaging can really address genome-wide and whole-brain associations without
filtering or dimension reduction.
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2 Systematic comparison of variants of Ca-
nonical Correlation Analysis and Partial
Least Squares for combined analysis of
MRI and genetic data1
2.1 Objectives
Motivated by the evidence that many neurological and psychiatric disorders are asso-
ciated with genetic factors and that brain imaging measures derived from MRI might
serve as intermediate phenotypes between genetic susceptibility and diagnosis, the goal
of this work is to simultaneously analyze brain imaging and SNP information using so-
phisticated statistical techniques. Statistical inferences using traditional univariate
approaches are problematic since dependencies among collinear variables are ignored
and massive multiple testing is performed (Section 1.4.1). Multivariate techniques are
well established for genetic neuroimaging and have been applied to detect multivariate
genotype-phenotype associations in a number of studies (Boutte and Liu, 2010; Chi
and others , 2013; Hardoon and others , 2009; Le Floch and others , 2012; Wan and oth-
ers , 2011; Fang and others , 2016). However, a comprehensive comparison with respect
to sample size, data characteristics and strengths and weaknesses of these methods
is outstanding. Furthermore, verification of results using resampling techniques (Yu,
2003) such as permutation testing (Fisher, 1971), cross-validation (Krus and Fuller,
1982; Kurtz, 1948; Mosier, 1951) or bootstrapping (Efron, 1979, 1981, 1982; Efron and
Tibshirani, 1993) is often neglected and guidance on the choice of component numbers
needs to be discussed (Liu and Calhoun, 2014). One study addressing these issues com-
pared penalized PLS regression and regularized Kernel CCA to search for associations
between simulated SNP and brain imaging data (Le Floch and others , 2012). Sys-
tematically, the authors accessed the generalizability of multivariate associations using
cross-validation and their significance using permutation tests. However, for compu-
tational purposes, examination was limited to the first two pairs of latent variables,
such that exact evaluation criteria are lacking. Furthermore, the authors addressed the
use of their selected methods in the context of high-dimensional SNP and comparably
low-dimensional brain imaging data (sample size 500 with 85,772 SNPs and 34 brain
locations of interest). It is therefore of interest to discover how multivariate approaches
perform on whole-brain imaging data, since the covariance structure between imaging
variables is expected to be much stronger than the covariance structure between vari-
1The chapter largely follows the original publication (Grellmann and others, 2015).
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ous SNPs (Kovacevic and others , 2013).
For the first part of the current thesis, I selected three multivariate methods suitable
for high-dimensional association analyses such as in genetic neuroimaging (Section
1.4.2). My goal was to elaborately compare these three approaches with respect to
their ability to detect genotype-phenotype associations depending on data properties.
The first method I selected is a variant of PLS called Partial Least Squares Correlation
(PLSC; Bookstein, 1982, 1994; McIntosh and others , 1996). It was first introduced
as Tucker Inter-battery Analysis by Tucker (1958). I decided on PLSC, because Sin-
gular Value Decomposition (SVD) is directly applied to the cross-product matrix of
the neuroimaging and the genetic data. In contrast to the penalized PLS regression
applied by Le Floch and others (2012), it is a non-iterative strategy, which is quite
fast especially for high-dimensional data sets. Moreover, PLSC has been shown to be
particularly suited to the analysis of the relationship between measures of brain activ-
ity and of behavioral data or experimental design (Krishnan and others , 2011; McIn-
tosh and Lobaugh, 2004). In addition to PLSC, two variants of CCA were included,
namely Sparse Canonical Correlation Analysis (Sparse CCA; Witten and others , 2009)
and Bayesian Inter-Battery Factor Analysis (Bayesian IBFA; Klami and others , 2013).
Sparse CCA includes a L1 penalization of canonical weights such that highly correlated
sparse linear combinations of the brain imaging and the genetic variables are identi-
fied. Sparse canonical weights are beneficial for the users of the method since they
facilitate the differentiation between important and less important variables. Sparse
CCA was further chosen, because it has repeatedly been shown to give good results
in genotype-phenotype association studies (Avants and others , 2010; Wan and others ,
2011; Witten and others , 2009; Witten and Tibshirani, 2009), even though these stud-
ies are lacking exact performance evaluation criteria. I further decided on a Bayesian
CCA approach, because treating CCA as a generative model is expected to be more
robust than the classical linear algebraic solution (Klami and others , 2013). However,
most Bayesian CCA implementations break down for large dimensionalities with com-
parably small sample sizes. In contrast, the Bayesian IBFA model presented in this
work is computationally efficient and works for high-dimensional data (Virtanen and
others , 2011). It imposes a group-wise sparsity to estimate the posterior of the model
and is therefore able to reliably separate the correlated effects from non-shared ones
(Virtanen and others , 2011) and to automatically determine the component number.
The latter is particularly important if underlying relations are not known a priori. For
genotype-phenotype associations, Bayesian IBFA has never been considered. However,
it has already been applied to co-occurring gene expression and copy number data in
cancer (Klami and others , 2013).
A further common multivariate technique in genetic neuroimaging research is parallel
ICA (Section 1.4.2). I did not select parallel ICA for my applications, since it has been
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shown to exhibit certain drawbacks. First, it requires an initial round of PCA, which
hampers the interpretability of results, since the original SNPs and voxels need to be
recovered (Hibar and others , 2011a). In addition, it is based upon the InfoMax algo-
rithm (Section 1.4.2), which assumes that the available data has a non-normal, either
super- or sub-Gaussian distribution (Bell and Sejnowski, 1995b; Lee and others , 1999).
If the distribution is, however, Gaussian, parallel ICA builds spurious non-Gaussian
components (Eichele and others , 2008). Thus, the more noisy the input data, e.g.
by including genome-wide SNPs and whole-brain voxels, the higher the number of in-
dependent components extracted by parallel ICA and the lower the power to detect
reliable associations.
To demonstrate characteristics of PLSC, Sparse CCA and Bayesian IBFA, I first consid-
ered simulated data. Simulations allow researchers to construct variables with known
distribution and known relationship to each other. Thus, statistical models can be
evaluated regarding their ability to reveal the imposed properties (Blejec, 2002). To
elaborately compare PLSC, Sparse CCA and Bayesian IBFA with respect to their use in
genetic neuroimaging research, three simulation experiments were conducted. At first,
I considered the performance of these methods in the context of simulated whole-brain
imaging data, when some prior knowledge on the involvement of certain SNPs of inter-
est is existing (backward model, Section 1.3.2). The use of multivariate approaches for
simulated whole-genome SNP data and candidate phenotypes has already been stud-
ied by Le Floch and others (2012). However, backward models need to be considered
separately since the covariance structure between imaging variables is expected to be
much stronger than the covariance structure between various SNPs, which might be
methodologically challenging for some statistical approaches. To discuss whether the
failure of any method in the first simulation was related to the dimensionality of the
brain imaging data set or to the degree of collinearity between voxels, a second sim-
ulation series consisting of linearly independent phenotype variables was created. As
one might take advantage of multivariate strategies for other data sets that are not
assumed to comprise many dependencies, but are expected to be associated with ge-
netic variation (e.g. cognitive or clinical diagnostic measures), the results will also be
of interest. Finally, to compare PLSC, Sparse CCA and Bayesian IBFA with respect
to their performance in more realistic genetic neuroimaging settings, I extended my
simulations by also considering high-dimensional SNP array data. In order to verify
my findings from the simulation experiments, I considered a real data application in
addition to the simulation series.
By systematically explaining the PLSC, the Sparse CCA and the Bayesian IBFA model
and by elaborately comparing these techniques for simulated and experimental genetic
neuroimaging data, I aimed for addressing the following questions:
• How many non-informative variables may be included in addition to causal vari-
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ants to still be able to discover meaningful associations between imaging and
genetic data?
• If such relations are represented by the methods, are they also statistically sig-
nificant and reliable?
• How many components need to be considered to detect all causal relations?
• Which methods are suitable for performance evaluation?
• Do PLSC, Sparse CCA and Bayesian IBFA yield comparable performances or
where do they differ?
Responding these questions, the goal was to provide application-oriented guidelines for
researchers working in the field of genetic neuroimaging, especially for those who are no
methodologists but who would like to analyze their data using multivariate approaches
to detect statistically powerful associations between the brain imaging and the genetic
variants. These guidelines were supposed to include practical suggestions for the use of
PLSC, Sparse CCA and Bayesian IBFA in genetic neuroimaging studies depending on
the properties of the data set (e.g. the ratio of sample size to the number of considered
voxels and SNPs) and to supply tools for performance evaluation and interpretation of
results. An application-orientated comparative collection of methods for detection of
multivariate genotype-phenotype associations was not available at the time I started
my scientific work. It indicates in which direction the development of new or enhanced
analytical methods for genetic neuroimaging could be heading.
2.2 Materials and methods
2.2.1 Multivariate statistical methods
2.2.1.1 Canonical Correlation Analysis
Canonical Correlation Analysis (CCA; Hotelling, 1936) is a correlation technique that
analyzes the association between two sets of variables X1 ∈ RN×d1 and X2 ∈ RN×d2 .
In my application, matrixX1 collects in each column the endophenotype measures, e.g.
the brain activity at each voxel in the brain. Matrix X2 stores the genotype measures
in each column, e.g. the number of minor alleles for a given SNP. The number of rows
corresponds to the sample size. To model the relationship between X1 and X2, CCA
successively builds orthogonal linear combinations of the observed variables (so-called
latent variables), such that at each step the correlation between the pair of latent
variables is maximal. The following criterion is optimized in each step:
max
|w1i |=|w2i |=1
corr(X1w1i, X2w2i), (1)
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where w1i and w2i , i = 1, . . . , p, p = min(d1, d2), are weight vectors, which describe
the contribution of each variable in X1 and X2 to the construction of the linear com-
binations Z1 = X1W1 and Z2 = X2W2. Assuming that the variables of each data
set are standardized column-wise, the function’s result to be maximized is
max
|w1i |=|w2i |=1
w
′
1i
X
′
1X2w2i√
w
′
1i
X
′
1X1w1i ·
√
w
′
2i
X
′
2X2w2i
. (2)
The matrices X
′
1X2, X
′
1X1 and X
′
2X2 are estimates of the cross-product and prod-
uct matrices, respectively. The total number of canonical correlations is equal to the
number of variables in the smaller data set, i.e. min(d1, d2).
The solution to equation (2) is not affected by rescaling w1i or w2i , i = 1, . . . , p,
p = min(d1, d2), either together or independently. The CCA optimization problem for-
mulated in equation (2) is therefore equivalent to maximizing the numerator subject
to w
′
1i
X
′
1X1w1i = w
′
2i
X
′
2X2w2i = 1, i = 1, . . . , p, p = min(d1, d2). The solution to
equation (2) may be obtained by solving the generalized eigenproblem
(X
′
1X1)
−1X
′
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−1X
′
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2
iw1i
(X
′
2X2)
−1X
′
2X1(X
′
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−1X
′
1X2w2i = δ
2
iw2i
(3)
where δi denotes the canonical correlation of component i, i = 1, . . . , p, p = min(d1, d2).
In high-dimensional data analysis, when the number of variables exceeds the number
of observations, CCA results in weight vectors that are not uniquely defined, because
it involves the computation of two inverses, (X
′
1X1)
−1 and (X
′
2X2)
−1. To overcome
these problems, I used two alternative approaches, which are introduced in subsequent
paragraphs.
2.2.1.2 Sparse Canonical Correlation Analysis
One possibility to solve the non-invertibility issue of CCA in high-dimensional settings
is to apply regularization based on L1 penalization to the canonical weights. L1 reg-
ularization uses a penalty term, which encourages the sum of the absolute values of a
parameter to be minimal, i.e. P (θ) = ‖θ‖1 =
n∑
i=1
|θi|, where P (θ) is the regularization
term that forces the values of parameter θ to be small (Ng, 2004). Several CCA models
including L1 penalization have been proposed (Parkhomenko and others , 2007, 2009;
Waaijenborg and others , 2008; Wiesel and others , 2008; Witten and others , 2009).
Witten and others (2009) introduced penalized matrix decomposition (PMD) on the
cross-product matrix aimed at identifying sparse linear combinations of the two sets of
variables that are highly correlated with each other. The algorithm was made available
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as R package (Witten and others , 2011). PMD solves the optimization problem
max
|w1i |=|w2i |=1
w
′
1i
X
′
1X2w2i − λ1 · P1(w1i)− λ2 · P2(w2i) (4)
subject to w
′
1i
X
′
1X1w1i ≤ 1, w
′
2i
X
′
2X2w2i ≤ 1, i = 1, . . . , p. The number of compo-
nents p is defined by the user. Note that the equality constraints have been relaxed to
inequality constraints to make the sets convex. P1 and P2 are convex penalty functions,
which can take on a variety of forms. A useful example is the LASSO (least absolute
shrinkage and selection operator) proposed by Tibshirani (1996).
P1(w1i) =
d1∑
j=1
|w1ji | = ‖w1i‖1.
Dudoit and others (2001) and Tibshirani and others (2003) showed that in high-
dimensional settings, treating product matrices as diagonal can yield good results.
Therefore, substituting I1 = X
′
1X1 and I2 = X
′
2X2 gives the so-called diagonal
penalized CCA, in short Sparse CCA,
max
|w1i |=|w2i |=1
w
′
1i
X
′
1X2w2i − λ1‖w1i‖1 − λ2‖w2i‖1 (5)
subject to |w1i |2 ≤ 1, |w2i|2 ≤ 1.
Since the objective function is biconvex, i.e. it is convex in w1i with w2i fixed and vice
versa, the Sparse CCA criterion may be iteratively solved by updating w1i , holding
w2i fixed, and vice versa until convergence. The update for w1i is given by
1. wˆ1i = argmin
|w1i |=1
1
2
|X ′1X2w2i −w1i|2 + λ1‖w1i‖1
2. Normalize w∗1i =

wˆ1i
|wˆ1i|
if |wˆ1i | > 0
0 otherwise.
The update for w2i is similar.
For Sparse CCA, λ1 and λ2 are not set directly. Witten and others (2009) proposed an
algorithm to select tuning parameters c1 and c2 for the number of variables in each data
set that should take on a non-zero weight. This algorithm is based on permutation.
Alternatively, values of c1 and c2 can be chosen to result in desired sparsity of w1i and
w2i .
Several extensions of the Sparse CCA model have been proposed by Witten and Tib-
shirani (2009). Sparse supervised CCA searches for variables in the two data sets that
are highly correlated with each other and simultaneously associated with an outcome
measure. Sparse multiple CCA enables to detect associations between more than two
data sets. Since I was only interested in the relation of brain imaging and genetic data,
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I did not consider any of these extensions.
Recently, Chi and others (2013) introduced an extension to the work on PMD for
Sparse CCA algorithms. The authors weakened the identity product matrix assump-
tions to account for possible correlation structures within both data sets. The objective
function they maximize is the same as for Sparse CCA,
max
|w1i |=|w2i |=1
w
′
1i
X
′
1X2w2i − λ1‖w1i‖1 − λ2‖w2i‖1. (6)
Alterations were done to the constraints, such that full product matrices are included.
This will be realized in future.
2.2.1.3 Bayesian Inter-Battery Factor Analysis
The second method I considered for coping with large dimensionality in CCA-like
models is a Bayesian treatment of the inter-battery factor analysis (IBFA) model, ini-
tially introduced by Browne (1979), and published by Klami and others (2013). The
IBFA model has two particular characteristics. It extracts the correlation between two
data sets and also decomposes the data into shared and data set-specific components.
The term CCA therefore emphasizes the search for correlations (shared components),
whereas IBFA accentuates the decomposition into shared and data set-specific compo-
nents.
Assume that x1i ∈ Rd1×1 and x2i ∈ Rd2×1 are two multivariate random variables,
which are considered to be generated by the same unobserved latent variable zi ∈ Rd×1,
i = 1, . . . , N . Data samples are observed as matrices Xm = [xm1 , . . . ,xmN ], m = 1, 2,
with N observations, which are assumed to be mean centered. By feature-wise con-
catenation Y =
[
X1
X2
]
, the Bayesian IBFA model is given by
Zc ∼ N (0, I)
Y ∼ N (WZc,Σ)
(7)
with Zc =
 ZZ1
Z2
, W = [ W1 V1 0
W2 0 V2
]
and diagonal noise covariance Σ =
[
σ21I 0
0 σ22I
]
∈ Rd×d, d = d1 + d2, indicating independence of the noise over the
features. The notation N (µ,Σ) corresponds to the normal distribution with mean µ
and covariance Σ. The algorithm was made available as R package (Virtanen and
Klami, 2013).
The model in (7) is a simplified factor analysis model with a specific form of sparse
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structure for the linear projection matrix W . For the first data set, it implies X1 ∼
N (W1Z + V1Z1, σ21I), and for the second, respectively X2 ∼ N (W2Z + V2Z2, σ22I).
The shared latent variables Z capture the variation common in both data sets. The
remaining variation specific to each data set is modeled by latent variables Zm. Thus,
the actual observations are generated by the sum of the two matrix factorizations, fol-
lowed by adding up noise as covariance matrix with a low-rank structure. Note that the
probabilistic IBFA model in (7) results in a single latent variable Z, whereas classical
CCA gives two separate variables Z1 = X1W1 and Z2 = X2W2 that are maximally
correlated. However, to compare the results of classical CCA and Bayesian IBFA, it
is possible to either average the canonical scores Z1 and Z2 of classical CCA or to
produce two separate latent variables by estimating the distribution of Z conditional
on each view p(Z|X1) and p(Z|X2).
For Bayesian analysis, the model in (7) needs to be complemented with priors for the
model parameters. To automatically learn the group-wise sparsity structure of W , an
automatic relevance determination prior (ARD prior; Neal, 1996) is implemented in a
group-wise manner
p(W ) =
d∏
l=1
[
d1∏
p1=1
N (wp1,l|0, α−11,l )
d1+d2∏
p2=d1+1
N (wp2,l|0, α−12,l )
]
αm,l ∼ Gamma(α0, β0).
(8)
For each weight wpm,l of the lth component, m = 1, 2, the prior infers the posterior of
the αm,l, whose elements each have a non-informative Gamma prior with small values
for the hyperparameters α0 and β0. Shared components will have small αm,l (large
variance), whereas components specific to either data view will have small αm,l only
for the active view. The model automatically infers the total number of components
by setting unnecessary components wpm,l as inactive for both views.
The noise precision parameters τm = σ
−2
m of the covariance matrix, m = 1, 2, are
provided with Gamma priors
τm ∼ Gamma(ατ0 , βτ0 ). (9)
For inference, a mean-field approximation q(Θ) =
∏
j
q(θj) for the posterior p(Θ) is
used, factorized over all elements of the model (7).
q(W , τm, αm,Zc) =
N∏
n=1
q(zcn) ·
2∏
m=1
(q(τm)q(αm)) ·
d1+d2∏
p=1
q(wp,:). (10)
The separate terms q(·) are updated alternatingly to minimize the Kullback-Leibler
divergence DKL(p, q) between q(W , τm, αm,Zc) and p(W , τm, αm,Zc|Y ) to obtain an
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approximation that best matches the true posterior. This is equivalent to maximizing
the lower bound
L(q) = log p(Y )−DKL(p, q) =
∫
q(W , τm, αm,Zc) · log p(W , τm, αm,Zc,Y )
q(W , τm, αm,Zc)
. (11)
The model in (7) is invariant to any linear transformation, since the likelihood of the
model is invariant to any invertible matrix H ∈ RL×L: W ∗Z∗ = (WH)(H−1Z) =
WZ. Thus, probabilistic CCA finds the same subspace as the classical solution, but
interpretation of components is limited and requires further constraints or postprocess-
ing. For Bayesian IBFA, this problem is solved by maximizing the variational lower
bound with respect to H . Given a fixed likelihood, the only way the variational bound
can improve is by rotating the components such that the posterior p(Θ) best matches
the prior distribution, which assumes independent latent variables. Hence, the model
is forced to find latent variables that are a posteriori maximally independent of each
other, which improves interpretability and convergence speed.
2.2.1.4 Partial Least Squares Correlation
Similar to CCA, Partial Least Squares (PLS; Wold, 1975) builds linear combinations
of the original variables X1 ∈ RN×d1 and X2 ∈ RN×d2 , so-called latent variables. X1
and X2 are both standardized column-wise. In contrast to CCA, PLS maximizes at
each step the covariance between latent variables of the two modalities,
max
|w1i |=|w2i |=1
cov(X1w1i, X2w2i), (12)
where i = 1, . . . , p, p = min(d1, d2). There are two basic types of PLS methods,
which are called Partial Least Squares Regression (PLSR; Wold, 1975) and Partial
Least Squares Correlation (PLSC; Bookstein, 1982, 1994; McIntosh and others , 1996).
PLSR is a regression technique that predicts one data set from the other (Abdi, 2010;
Abdi and Williams, 2013; Krishnan and others , 2011). In contrast, PLSC is a corre-
lation technique which analyzes the association between two sets of variables (Abdi
and Williams, 2013; Krishnan and others , 2011). It was initially introduced as Tucker
Inter-battery Analysis (Tucker, 1958) and refined by Bookstein (1982, 1994), who also
used it in a study of neurobehavioral sequelae of prenatal exposure to alcohol (Samp-
son and others , 1989). PLSC was first applied to functional neuroimaging data and
behavioral outcome measures by McIntosh and others (1996).
PLSC assumes that the relationship between the columns of X1 and X2 is stored in
a cross-product matrix A = X
′
1X2. Singular Value Decomposition (SVD) is used to
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decompose A into three matrices,
A = X
′
1X2 = USV
′
= s1u1v
′
1 + s2u2v
′
2 + . . .+ spupv
′
p, (13)
where p = min(d1, d2). The coefficients of the PLSC, W1 =
[
w11 , . . . ,w1p
]
and
W2 =
[
w21 , . . . ,w2p
]
, equal the matrices of left and right singular vectors U and V .
They describe the contribution of each variable in X1 and X2 to the construction of
the linear combinations Z1 = X1W1 and Z2 = X2W2 and are called saliences, if it
is known a priori that there is a causal relation between X1 and X2. The singular
values si, i = 1, . . . , p, in the SVD provide the covariance between the latent variables
z1i and z2i , i = 1, . . . , p, also called scores. In contrast to CCA, which forces latent
variables of each modality to be mutually orthogonal, PLSC requires the orthogonality
between latent variables z1i and z2j for i 6= j.
For PLSC, the salience of a certain variable, w1j , j = 1, . . . , d1, is proportional to the
covariance of the corresponding variable x1j with the scores for the other block Z2,
w1j ∝ cov(x1j ,Z2), and likewise w2k ∝ cov(x2k ,Z1), k = 1, . . . , d2. Hence, adding
or removing a further variable x1(j+1) (or x2(k+1)) has only a small effect on w1j (or
w2k) (Wegelin, 2000). In contrast, the coefficients of CCA are computed as multiple
regression coefficients, such that adding and deleting of variables has a huge effect.
2.2.1.5 Summary of multivariate methods
Table 2 summarizes characteristics of the three multivariate methods, Sparse CCA,
Bayesian IBFA and PLSC. Displayed are, together with the actual model, the criterion,
which is maximized by each method, and the number of latent variables. Bayesian IBFA
results in a single latent variable, whereas Sparse CCA and PLSC give two separate
variables for each data set that are maximally correlated with each other. Moreover,
Table 2 contrasts the orthogonality of latent variables, influencing the interpretability
of components, and the number of components, since a method is preferable if the
number of components is automatically determined and does not need to be set by the
user prior to analysis. Finally, it is shown which methods are iterative, since iterative
approaches might be computationally expensive, whether resulting weights are sparse,
since sparsity facilitates users to differentiate between important and less important
variables, and whether the approaches are susceptible to resampling, which influences
permutation testing and bootstrapping.
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Table 2: Overview of multivariate methods
The table gives an overview of main characteristics of Sparse CCA, Bayesian IBFA and PLSC.
Sparse CCA Bayesian IBFA PLSC
criterion to max
|w1i |=|w2i |=1
corr(X1w1i, X2w2i) max|w1i |=|w2i |=1
cov(X1w1i, X2w1i)
maximize
model
max
|w1i |=|w2i |=1
(w
′
1i
X
′
1X2w2i Zc =
 ZZ1
Z2
 ∼ N (0, I), A = X ′1X2 = W1SW ′2
−λ1‖w1i‖1 − λ2‖w2i‖1) Y =
[
X1
X2
]
∼ N (WZc,Σ)
s.t. |w1i|2 ≤ 1, |w2i|2 ≤ 1 with W =
[
W1 V1 0
W2 0 V2
]
,
and Σ =
[
σ21I 0
0 σ22I
]
latent
Z1 = X1W1, Z2 = X2W2 Zc = W
′
Y Z1 = X1W1, Z2 = X2W2variables
orthogonality
z
′
1i
z1j = 0 and z
′
2i
z2j = 0, i 6= j z′1iz2j = 0, i 6= jof latent
variables
number of
defined by user
automatic determination
min(d1, d2)components by group-wise application
of the ARD prior
iterative √ √
x
approach
sparsity of √ √
x
weights
influence of
susceptible susceptible not susceptible
resampling
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2.2.2 Performance evaluation
2.2.2.1 Resampling techniques
For verification of the results provided by Sparse CCA, Bayesian IBFA and PLSC, I
applied three resampling techniques: permutation testing (Fisher, 1971), bootstrap-
ping (Efron, 1979, 1981, 1982; Efron and Tibshirani, 1993) and cross-validation (Krus
and Fuller, 1982; Kurtz, 1948; Mosier, 1951).
Permutation testing
Permutation testing assesses the significance of the correlation (CCA) and covariance
(PLSC) of latent variables, respectively. For this purpose, observations, i.e. rows of
input matrices X1 and X2, are randomly reassigned without replacement and CCA
and PLSC are recalculated. At each permutation, the statistic (i.e. the correlation and
covariance of latent variables) is then compared to the statistic obtained on the original
data with probability value equal to the number of times the statistic of permuted data
exceeds the original value.
For association analyses such as in genetic neuroimaging, for which the involved data
matrices are expected to exhibit only a weak cross-correlation structure, it has been
shown that the rate of false positives is quite high (Kovacevic and others , 2013). There-
fore, it is often more important to detect reliable rather than significant associations.
Kovacevic and others (2013) showed that the reliability of associations can be mea-
sured by the stability of pairings between left and right singular vectors of the SVD
for any set of observations. For PLSC, the authors recently introduced a split-half
reliability testing as an alternative to significance testing. The split-half resampling
starts by decomposing the cross-product matrix A using SVD, A = USV
′
. To test
the stability of the pairings between left and right singular vectors, observations are
randomly split and SVD is used to decompose the split cross-product matrices A1 and
A2. The original matrices U and V are then projected onto each half of A to obtain
half-sample matching pairings,
U1 = A1V S
−1 andU2 = A2V S−1
V1 = A
′
1US
−1 and V2 = A
′
2US
−1.
(14)
The correlations of U1 and U2, as well as V1 and V2, are taken as mean correlations
across split-halves. The procedure is repeated many times. By randomly permuting
observations and repeating the split-half correlation estimation for each permuted data
set, a null distribution for the split-half correlations pUcorr and pVcorr is created, which
is used to estimate the probability of exceeding the correlations from the originally
un-permuted data set.
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Bootstrapping
Bootstrapping was applied for evaluation of the reliability of weights provided by Sparse
CCA and PLSC, respectively. Compared to permutation testing, the bootstrap method
employs resampling with replacement. That is, observations are randomly reassigned
with replacement in both data sets X1 and X2, such that the assignment of observa-
tions is maintained, whereas their contribution is changed. For each bootstrap sample,
particular statistics (i.e. Sparse CCA and PLSC weights) are calculated and the pro-
cedure is repeated many times. The histograms of the sets of computed values are
referred to as the bootstrap distributions of the statistics, which provide estimates of
their variation based on the original data (Hesterberg, 2011).
In contrast to Sparse CCA and PLSC, the output of Bayesian IBFA does not con-
tain the actual canonical weights but their posterior, i.e. mean weights as well as the
covariances of the weights, which can be used directly to assess the contribution of
each variable. Hence, the time-consuming bootstrapping can be replaced by directly
evaluating the credibility of the weights.
Cross-validation
Cross-validation (CV) is a technique for estimating the prediction performance of a
model (Kohavi, 1995). In k-fold CV, the original data set is randomly split into k
equally sized subsets (so-called folds). Of the k folds, k − 1 subsets are employed as
training data. The remaining subset is used for testing the model. This process is
repeated k times, such that each of the k subsets is used once for validation.
2.2.2.2 Predictive squared correlation coefficient
A further method for estimating the prediction performance of a model is the predictive
squared correlation coefficient (Q2; Cramer, 1980). It describes the ratio of the sum
of squared differences between the observed variable xobs and the predicted variable
xpred (the so-called predictive residual sum of squares PRESS), and the sum of squared
differences between the observed variable and its mean (the sum of squares SS),
Q2 = 1−
N∑
i=1
(xobsi − xpredi )2
N∑
i=1
(xobsi − x¯obs)2
= 1− PRESS
SS
. (15)
In case of an ideal prediction, we obtain Q2 = 1. For bad predictions, the PRESS
is greater than the SS. Thus, the predictive squared correlation coefficient can even
be negative, which means that in prediction the model performs worse than the mean
response.
For Bayesian IBFA, which results in a single latent variable Z, the predictive squared
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correlation coefficient Q2 can be computed directly. In contrast, for Sparse CCA and
PLSC, the average of the canonical scores Z1 and Z2 was used.
2.2.2.3 CHull
As third method for model selection, I adopted CHull (Wilderjans and others , 2013).
CHull identifies a model that balances model fit and model complexity. For each model,
a goodness of fit or misfit value f and a complexity value c is computed. CHull then
determines the convex hull of the fit-measure-by-complexity-measure plot and identifies
a model by computing a scree-test value st that indicates how much better a solution is
compared to a less complex one, relative to how much better a solution is in comparison
with a more complex one,
sti =
fi − fi−1
ci − ci−1
fi+1 − fi
ci+1 − ci
, (16)
for all models mi located on the upper (goodness of fit) or lower (misfit) boundary of
the convex hull. Finally, the model with the largest st-value is selected. Note that for
the first and last complexity measure (i.e. the first and last components of the CCA
and PLSC models, respectively) there is no less complex or more complex solution for
comparison and st will equal zero.
As goodness of fit measure for CHull, I estimated the out-of-sample correlation coef-
ficient (CCA) and out-of-sample covariance (PLSC), respectively, by 10-fold CV, as
suggested by Le Floch and others (2012). At each fold of the CV, I calculated train-
ing weights W train1 and W
train
2 on the training set and by linear mapping Z
test
1 =
Xtest1 W
train
1 and Z
test
2 = X
test
2 W
train
2 estimated the latent variables of the test set.
The out-of-sample correlation coefficient (CCA) is the correlation between the Ztest1
and Ztest2 variables. The same holds for the out-of-sample covariance of PLSC. Note
that the out-of-sample correlation coefficient and the out-of-sample covariance might
be negative, since they reflect an average correlation or covariance of test samples over
folds.
2.2.2.4 Proportion of summed squared cross-block correlations
PLSC maximizes the covariance between latent variables. Thus, a further useful
statistic can be derived from its model, which is the proportion of summed squared
cross-block correlations explained by the latent variables z1i and z2i , i = 1, . . . , p =
min(d1, d2) (Bookstein, 1994; McIntosh and others , 1996). The proportion of explained
summed squared cross-block correlations is given by the ratio of the squared singular
value of component i, i.e. s2i , divided by the sum of the squared correlations of all
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components, i.e.
p∑
i=1
s2i
d1∑
j=1
d2∑
l=1
a2jl
, (17)
where A = X
′
1X2 and p = min(d1, d2). For performance evaluation, I used this ratio
such that I examined all PLSC components that were necessary to explain at least 80%
of summed squared cross-block correlations.
2.3 Data sets
2.3.1 Simulated data
To demonstrate characteristics of PLSC, Sparse CCA and Bayesian IBFA, simulated
data was considered, since simulations enable to examine the performance of these
models based on imposed properties. Specifically, I created two independent simula-
tion series to elaborately discuss potential difficulties related to statistical inferences in
genetic neuroimaging as a kind of two steps approach. In a first simulation series, I eval-
uated whether multivariate techniques such as PLSC, Sparse CCA or Bayesian IBFA
are able to overcome the limitations of traditional MULM. For genetic neuroimaging,
MULM is problematic since dependencies among collinear variables are ignored and
massive multiple testing is performed. Therefore, brain imaging data of increasing
dimensionality, containing highly collinear variables, was created. The brain imag-
ing variables served as intermediate phenotypes of genetic susceptibility. To discuss
whether the failure of any method in the highly collinear simulations was related to the
dimensionality of the imaging data set or to the degree of collinearity between voxels,
I created a second simulation series including linearly independent endophenotypes.
For genetic neuroimaging this might be irrelevant. However, as one might also take
advantage of multivariate strategies for data sets that are not assumed to comprise
many dependencies, the results are relevant to scientific analyses of researchers from
multiple disciplines.
2.3.1.1 Simulation containing highly collinear endophenotypes
I simulated brain imaging and genetic data, as described by Le Floch and others (2012).
In contrast to Le Floch and others (2012), who addressed the use of multivariate ap-
proaches for high-dimensional SNPs and comparably low dimensional brain imaging
variables, I evaluated the performance of PLSC, Sparse CCA and Bayesian IBFA with
respect to whole-brain imaging data. Since the covariance structure between imaging
variables is expected to be much stronger than the covariance structure between various
SNPs (Kovacevic and others , 2013), the statistical approaches might face methodolog-
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ical challenges in my application.
I generated brain imaging data of increasing dimensionality (100, 1,000, 10,000, 20,000,
30,000, 40,000, 50,000, 70,000 and 90,000 voxels) using multivariate normal distribu-
tion with mean and covariance parameters estimated from experimental fMRI contrast
images. The simulated genotype data set consisted of 50 SNPs that were generated
using the gs algorithm, introduced by Li and Chen (2008), based on phase III HapMap
data. HapMap III is the third phase of the International HapMap project (HapMap
Consortium, 2003). It includes 11 populations. I considered a sample collected by the
Centre d’Etude du Polymorphisme Humain (CEPH) in 1980 from people living in Utah
with ancestry from northern and western Europe (CEU). SNPs were recoded using the
additive genetic model, counting the number of minor alleles per person. The sample
size of the brain imaging and the SNP data was chosen to be 100.
For each simulated dimensionality of the imaging data set, a linear relationship be-
tween one randomly selected voxel and three SNPs with MAF greater 0.2 was induced,
such that the pairwise correlation between that voxel, voxels in collinearity with the se-
lected voxel and the selected SNPs was on average 0.3. In other simulation studies, the
authors usually controlled for the correlation between causal imaging endophenotypes
and causal SNPs at a value of, on average, 0.5 (e.g. Boutte and Liu, 2010; Le Floch
and others , 2012). However, I selected an average correlation of 0.3, since a weaker
association might be more realistic and is in line with P -values reported in studies
considering univariate associations between specific SNPs and brain regions of interest
(e.g. Filippini and others , 2009; Ousdal and others , 2012; Potkin and others , 2009b).
Figure 2 displays a schematic representation of the simulated data.
Figure 2: Simulated data set
For the first simulation, the brain imaging data set consisted of 100 voxels, and 50 SNPs were
generated. One voxel and three SNPs were randomly selected and a causal relation between
that voxel, voxels in collinearity with the selected voxel, and the selected SNPs, as shown in
red, was induced. The dimensionality of the brain imaging data was stepwise increased from
100 to 90,000 voxels.
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2.3.1.2 Simulation containing linearly independent endophenotypes
I simulated two data sets consisting of 100 samples as I did for the first simulation series
containing highly collinear brain imaging variables. This time, the endophenotypes
were generated using standard multivariate normal distribution, and dimensionality
was stepwise increased from 1,000 to 10,000, 20,000, 30,000, 40,000, 50,000 and finally
100,000 variables. The genotype data set consisted again of 50 simulated SNPs.
For each simulated dimensionality of the phenotype data set, five SNPs with MAF
greater 0.2 and 300 phenotype variables were randomly selected. In contrast to the
first simulation series, I induced two independent causal patterns between the selected
SNPs and phenotypes, since for linearly independent data this might be more realistic.
For the first causal pattern, the first two SNPs were averaged and associated with the
first 100 phenotype variables, such that their pairwise correlation was on average 0.3.
Similarly, the remaining three SNPs and 200 phenotypes were linked to each other to
account for the second causal pattern.
2.3.1.3 Simulation containing highly collinear endophenotypes and high-
dimensional SNPs
To provide an outlook on how PLSC, Sparse CCA and Bayesian IBFA perform in more
realistic genetic neuroimaging settings, I extended my simulation on highly collinear
endophenotypes by also considering a large number of SNPs. Therefore, brain imaging
data containing 90,000 highly collinear voxels and a genotype data set consisting of
10,000 SNPs was simulated. I chose that dimensionality to resemble the number of
SNPs genotyped on a small human SNP array (LaFramboise, 2009). As described in
Section 2.3.1.1, I then induced a causal relation between one randomly selected voxel
and three SNPs with MAF greater 0.2, such that the pairwise correlation between
that voxel, voxels in collinearity with the selected voxel, and the selected SNPs was on
average 0.3.
2.3.2 Experimental data
In order to verify my findings on simulated data, I considered an experimental ge-
netic neuroimaging data set that has been published previously by Ousdal and others
(2012). The original study was performed to test the hypothesis that monoamines such
as dopamine, serotonin and norepinephrine are important modulators of amygdala ac-
tivity (LeDoux, 2007). Therefore, the authors combined whole-genome microarray
SNPs with fMRI data recorded during emotional face-matching task (more details are
provided in Appendix A). Since amygdala was selected as region of interest, the orig-
inal study is a CPGWA study and the authors used MULM to detect relevant SNPs
explaining variability in amygdala activity. In contrast, for the application of Sparse
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CCA, Bayesian IBFA and PLSC, I included whole-brain imaging measures to detect
further brain regions involved during the face-matching task that are not accessible in
ROI analyses.
The original study was designed as follows. During MRI scanning, participants (healthy
controls and patients with diagnosis of schizophrenia spectrum disorder, bipolar disor-
der or other psychosis) performed a face-matching task. Patients were recruited from
the psychiatric unit of Oslo University Hospital and were diagnosed via Structural Clin-
ical Interview for DSM-IV Axis I disorders. Healthy control subjects were randomly
selected from the Norwegian citizen registration. Genotyping was done using an array-
based whole-genome assay and SNPs were recoded using an additive genetic model.
For quality control, SNPs with call rates below 97% (Section 1.2.2.4) and MAF smaller
5% (Section 1.2.2.2) were removed. In addition, individuals with call rates below 97%
(Section 1.2.2.5) or outlying levels of heterozygosity (Section 1.2.2.6) were eliminated.
After this, information on 224 individuals (including 107 women) and 546,381 SNPs
was available.
The original analysis was performed using SPM2 (Friston and others , 2007) following
standard preprocessing pipelines and controlling for diagnosis type. Gender and age
were not significantly different across subject groups. To search for genome-wide SNPs
modulating amygdala activity, individual contrast values for the right and left amygdala
peak voxel were tested for association with each SNP separately. The authors reported
a significant association between activation of the left amygdala peak voxel and three
SNPs in high linkage disequilibrium, namely rs10014254 (P = 4.16×10−8), rs11722038
(P = 4.20 × 10−8) and rs17529323 (P = 4.66 × 10−8). The relation was strongest for
rs10014254 with P = 0.045 after adjustment for multiple testing. This SNP is located
in a regulatory region upstream of the Paired-like homeobox 2b (PHOX2B) gene. A
significant interaction between SNP and diagnosis type was not reported (P = 0.28).
The top SNP, rs10014254, was further analyzed with respect to differences in amyg-
dala BOLD response between CC-homozygous individuals and T-allele carries (CT and
TT). T-allele carriers exhibited a significantly increased activation in right (x = 16,
y = −8, z = −16) and left (x = −26, y = −4, z = −14) amygdala compared to
homozygous CC-individuals. A more detailed description of recruitment, experimen-
tal task, fMRI data acquisition, genotyping, quality control and statistical analysis is
provided in the original publication (Ousdal and others , 2012).
In order to verify the applicability of Sparse CCA, Bayesian IBFA and PLSC in ex-
perimental genetic neuroimaging settings, I used updated fMRI images that have been
preprocessed using FSL software (Smith and others , 2004) and genotype information
on five SNPs (rs10014254, rs11722038, rs17529323, rs382013 and rs437633). Instead
of focusing on amygdala as region of interest, I considered whole-brain neuroimag-
ing measures in order to detect further brain regions involved in the face-matching
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task. After removing missing data for all SNPs, I was left with 208 subjects (including
97 women). Statistical analysis was performed as follows. At first, I corrected for
diagnosis type (schizophrenia, bipolar disorder or other psychosis) as in the original
publication. Then, I applied the three multivariate methods PLSC, Sparse CCA and
Bayesian IBFA, in which I particularly considered whole-brain voxels, and I compared
my results to the findings in the original publication (Ousdal and others , 2012).
2.4 Results
2.4.1 Results on simulated data
2.4.1.1 Highly collinear endophenotypes and candidate SNPs
First, I compared the performance of Sparse CCA, Bayesian IBFA and PLSC on sim-
ulated brain imaging data of increasing dimensionality and candidate SNPs (Section
2.3.1.1). The results of this study have been published in Grellmann and others (2015).
For Sparse CCA, the number of components needs to be set by the user prior to analy-
sis (Section 2.2.1.5). I computed ten components at each dimensionality, respectively,
and applied the model selection procedures CHull and the predictive squared corre-
lation coefficient to detect causal components, i.e. components comprising the linear
relationship between selected voxels and SNPs. In contrast, the Bayesian IBFA au-
tomatically determines how many components to detect by implementing sparsity by
groupwise application of an ARD prior, which sets unnecessary components as inactive
for both data sets. For PLSC, as many components as necessary to explain at least
80% of summed squared cross-block correlations were computed. Since some of the
Bayesian IBFA and PLSC components were not carrying causal information, I also
applied CHull and the predictive squared correlation coefficient for model selection.
The advantage of Sparse CCA compared to PLSC is that regularization based on L1
penalization is applied to the canonical weights, which facilitates the user to differen-
tiate between important and less important variables (Section 2.2.1.2). The Bayesian
IBFA does not output the actual canonical weights but their posterior, such that the
mean weights as well as the covariances of weights were used to assess the credibility of
variables and to exclude less important voxels and SNPs from the model. PLSC does
not involve the computation of any inverse matrices and therefore works without any
further preprocessing. SVD only needs to be computed once, so compared to Sparse
and Bayesian CCA, which are iterative strategies, PLSC is quite fast especially for
higher dimensions.
A summary of the results on simulated highly collinear brain imaging data is given
in Table 3. For Sparse CCA and PLSC, causal voxels and SNPs were represented
in the first component, which is associated with the highest canonical correlation or
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covariance, for all simulated dimensionalities of the imaging data set. This result was
confirmed by both the cumulative out-of-sample correlation coefficient, which was used
as measure of fit for model selection with CHull, and the predictive squared correlation
coefficient. In terms of PLSC, Table 3 further illustrates that the causal component
might be identified by the percentage of summed squared cross-block correlations it
explains. The first component already explained 30% to 60% of summed squared cross-
block correlations for high and low dimensions, respectively. In contrast, the number
of components learned by the Bayesian IBFA was high even if the number of vox-
els equaled sample size and the causal pattern was usually represented in any of the
backmost components.
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Table 3: Sparse CCA, Bayesian IBFA and PLSC results for simulated collinear brain
imaging data and candidate SNPs
The dimensionality of the brain imaging data was increased stepwise from 100 voxels, equal-
ing sample size, to 90,000 voxels, exceeding sample size by a multiple. The number of SNPs
was kept constant. For Sparse CCA, ten components were computed at each dimensionality,
respectively. In contrast, for Bayesian IBFA the component number was automatically deter-
mined and for PLSC, as many components as necessary to explain at least 80% of summed
squared cross-block correlations were considered. For each dimensionality of the imaging
data set, the table illustrates the P -value of permutation testing. 5000 permutations were
performed in order to get a good estimate of the empirical P -values. For PLSC, the table
also indicates the P -values PW1corr and PW2corr of latent variable reliability based on split-half
resampling. For each split-half reliability test performed, 100 half-splits and 100 permuta-
tions were considered. Furthermore, the table shows, which component is representing the
causal pattern, the canonical correlation (CCA) or covariance (PLSC) of that component as
well as the out-of-sample correlation (CCA) or out-of-sample covariance (PLSC), estimated
on the test data by 10-fold CV. For PLSC, the percentage of summed squared cross-block
correlations the causal component explains is also given. Finally, it is displayed, how many
components are selected by CHull and Q2 and whether it is possible to detect the causal
pattern considering model selection procedures.
dimen-
method
number P -value correlation out-of-sample comp. comp.
detectability
sionality of of perm. causal (CCA) / correlation / number number
of MRI compo- (PW1corr comp. covariance out-of-sample by by
data nents PW2corr ) (PLSC) covariance CHull Q
2
100
Sparse
10 0.0000∗∗∗ 1 0.6751 0.5223 1 1 P/CHull/Q2
CCA
Bayesian
11 0.0340∗ 3 0.6346 0.2454 4 3 P/Q2
IBFA
PLSC 3
0.0238∗
1
6.2615
2.0734 1 1 P/CHull/Q2
(0.02, 0.00) (60.99%)
1,000
Sparse
10 0.0004∗∗∗ 1 0.7090 0.5147 1 1 P/CHull/Q2
CCA
Bayesian
20 0.0080∗∗ 1 0.6643 0.1280 17 1 P/Q2
IBFA
PLSC 4
0.0024∗∗
1
18.2164
7.2065 1 1 P/CHull/Q2
(0.02, 0.0) (49.99%)
10,000
Sparse
10 0.0176∗ 1 0.6098 0.2963 1 1 P/CHull/Q2
CCA
Bayesian
25 0.0880 3 0.6025 0.1921 7 3 Q2
IBFA
PLSC 6
0.0133∗
1
44.1569
12.1333 1 1 P/CHull/Q2
(0.01, 0.02) (36.68%)
20,000
Sparse
10 0.0072∗∗ 1 0.6748 0.4251 1 1 P/CHull/Q2
CCA
Bayesian
24 0.0780 1 0.6997 0.1839 1 1 CHull / Q2
IBFA
PLSC 6
0.0002∗∗∗
1
73.5203
37.2138 1 1 P/CHull/Q2
(0.02, 0.00) (42.16%)
30,000
Sparse
10 0.0144∗ 1 0.6846 0.3342 1 1 P/CHull/Q2
CCA
Bayesian
16 0.3690 1 0.6570 0.1475 2 1 Q2
IBFA
PLSC 7
0.0114∗
1
74.1553
30.3046 1 1 P/CHull/Q2
(0.05, 0.04) (32.84%)
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
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dimen-
method
number P -value correlation out-of-sample comp. comp.
detectability
sionality of of perm. causal (CCA) / correlation / number number
of MRI compo- (PW1corr comp. covariance out-of-sample by by
data nents PW2corr ) (PLSC) covariance CHull Q
2
40,000
Sparse
10 0.0140∗ 1 0.5995 0.4142 1 1 P/CHull/Q2
CCA
Bayesian
19 0.3911 3 0.6532 0.0740 19 3 Q2
IBFA
PLSC 7
0.0116∗
1
82.6020
28.1449 1 1 P/CHull/Q2
(0.36, 0.06) (30.06%)
50,000
Sparse
10 0.0098∗∗ 1 0.6941 0.3830 8 1 P/Q2
CCA
Bayesian
61 0.7460 4 0.6824 0.0810 30 4 Q2
IBFA
PLSC 10
0.0006∗∗∗
1
101.4630
80.2084 1 1 P/CHull/Q2
(0.02, 0.00) (35.67%)
70,000
Sparse
10 0.0576 1 0.6930 0.2501 1 1 CHull/Q2
CCA
Bayesian
64 0.3530 7 0.6797 0.0361 30 (7) x
IBFA
PLSC 11
0.0040∗∗
1
111.8040
78.6747 1 1 P/CHull/Q2
(0.08, 0.00) (31.81%)
90,000
Sparse
10 0.0738 1 0.6843 0.3205 1 1 CHull/Q2
CCA
Bayesian
68 0.2830 4 0.7037 0.0177 1 (4) x
IBFA
PLSC 11
0.0132∗
1
123.7516
84.5184 1 1 P/CHull/Q2
(0.02, 0.02) (30.04%)
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
To identify causal components, I used CHull with the cumulative out-of-sample corre-
lation coefficient (out-of-sample covariance) as measure of fit (Figure 3) as well as the
predictive squared correlation coefficient (Figure 4). For Sparse CCA and PLSC, the
cumulative out-of-sample correlation coefficient (cumulative out-of-sample covariance)
steeply increased for the first component and leveled out for higher component num-
bers for all simulated dimensionalities. Consequently, according to the model selection
procedure CHull, one should consider only the first Sparse CCA and PLSC component,
with one exception in terms of Sparse CCA for 50,000 simulated voxels. In Figure 3 this
is highlighted by blue dots. The green dots mark the components truly carrying causal
information. Note that in Table 3 and Figure 3, the covariance and out-of-sample co-
variance of the causal PLSC component are increasing with higher dimensionality in
contrast to the correlation and out-of-sample correlation of Sparse CCA. However, the
covariance (and the out-of-sample covariance) is an unbounded measure of association,
which cannot be compared across data sets of increasing voxel numbers. The actual
strength of the association of latent variables was comparable for PLSC and Sparse
CCA.
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Figure 3: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated collinear brain imaging data and candidate SNPs using out-of-
sample correlation or out-of-sample covariance
The number of voxels was increased stepwise from 100 to 1,000, 10,000, 20,000, 30,000, 40,000,
50,000, 70,000 and finally 90,000. The y-axis depicts the cumulative average out-of-sample
correlation coefficient (Sparse CCA and Bayesian IBFA) or the cumulative average out-of-
sample covariance (PLSC) for all components, respectively. Blue dots are used to highlight
how many components should be considered according to the model selection procedure
CHull. For higher component numbers, the model fit does not considerably improve. The
green dots mark the components truly carrying causal information. For Sparse CCA and
PLSC, the first component carries causal information for all simulated dimensionalities and,
using CHull, it is possible to detect that component. For Bayesian IBFA, only 30 components
are plotted, since the out-of-sample correlation coefficient levels out for higher component
numbers. In general, CHull fails to detect the causal component. For visualization purpose,
the variance of the out-of-sample correlation coefficient (standard deviation of the out-of-
sample covariance) across folds is not shown. It is small for low dimensions and increases
with the number of considered voxels.
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The performance of Sparse CCA and PLSC was further evaluated using the predictive
squared correlation coefficient Q2. Figure 4 illustrates that Q2 decreased after the first
component for all simulated dimensionalities, giving further evidence for considering
only the first Sparse CCA and PLSC component, which was indeed carrying the causal
information.
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Figure 4: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated collinear brain imaging data and candidate SNPs using the
predictive squared correlation coefficient
The y-axis depicts the predictive squared correlation coefficient when the number of voxels is
stepwise increased from 100 (top left) to 90,000 (bottom right) brain imaging endophenotypes.
In contrast to Sparse CCA and PLSC, Figure 3 shows that for Bayesian IBFA, CHull
was not able to detect the causal component. Since the number of Bayesian IBFA
components was high for all simulations, the representation of the causal pattern var-
ied strongly across folds. The predictive squared correlation coefficient Q2, however,
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was suitable for model selection in Bayesian IBFA (Figure 4). When 100 brain imag-
ing endophenotypes were considered, Q2 steeply increased for the third component
and reached a plateau for further components, revealing that component three was
the causal one. The same held true for 10,000 and 40,000 simulated voxels. For
simulations of 1,000, 20,000 and 30,000 voxels, Q2 already leveled out after the first
component, which was truly representing causal voxels and SNPs. For 50,000 brain
imaging endophenotypes or more it became difficult to differentiate between causal and
non-informative components using the predictive squared correlation coefficient.
An illustration of voxel and SNP weights of Sparse CCA, Bayesian IBFA and PLSC for
1,000 and 90,000 simulated voxels is provided in Figure 5 and 6, respectively. The com-
ponent selected by the predictive squared correlation coefficient (and CHull in terms
of Sparse CCA and PLSC) is shown. For the brain imaging data set voxels defined as
causal received the highest weights. This was true for the causal voxel itself, as shown
in red, and voxels correlated to the causal voxel at a value of 0.8 or higher (yellow).
However, the weight difference between causal and non-causal voxels was small, due to
the fact that many voxels were collinear to the causal voxel and the threshold to define
a causal voxel (pairwise correlation ≥ 0.8) was very strict. Nevertheless, all voxels
defined as causal were reliable according to the bootstrap method. In contrast to the
voxel weight profiles, causal SNPs, as shown in red, were clearly most contributing to
the SNP weight profiles of Figure 5 and 6. Note that in Figure 6 there is a SNP (SNP
33) that was detected by neither Sparse CCA nor Bayesian IBFA nor PLSC. However,
its association to the causal voxel was weaker than for the other two causal SNPs,
such that by chance other SNPs, which were not intended to be defined as causal,
received higher weights. Overall, Sparse CCA, Bayesian IBFA and PLSC provided
higher weights for causal voxels and SNPs as compared to non-causal voxels and SNPs
(Table 4).
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Figure 5: Sparse CCA (top), Bayesian IBFA (middle) and PLSC (bottom) weights for
1,000 simulated collinear voxels and candidate SNPs
(a) Voxel weight profile and (b) SNP weight profile of the causal Sparse CCA component.
(c) Voxel weight profile and (d) SNP weight profile of the causal Bayesian IBFA component.
(e) Voxel weight profile and (f) SNP weight profile of the causal PLSC component. Sparse
CCA, Bayesian IBFA and PLSC provide a weight for each voxel and each SNP. The causal
voxel and causal SNPs (red), and voxels in collinearity with the causal voxel (yellow), receive
higher weights than non-causal voxels and SNPs (blue). For visualization purpose, the voxel
weight profiles (a,c,e) are zoomed in on a range of 100 voxels around the causal voxel.
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Figure 6: Sparse CCA (top), Bayesian IBFA (middle) and PLSC (bottom) weights for
90,000 simulated collinear voxels and candidate SNPs
(a) Voxel weight profile and (b) SNP weight profile of the causal Sparse CCA component. (c)
Voxel weight profile and (d) SNP weight profile of the causal Bayesian IBFA component. (e)
Voxel weight profile and (f) SNP weight profile of the causal PLSC component. The causal
voxel and causal SNPs are illustrated in red. Voxels in collinearity with the causal voxel are
shown in yellow. For visualization purpose, the voxel weight profiles (a,c,e) are zoomed in on
a range of 100 voxels around the causal voxel.
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Table 4: Average Sparse CCA, Bayesian IBFA and PLSC weights for simulated
collinear brain imaging data and candidate SNPs
The table shows average Sparse CCA, Bayesian IBFA and PLSC weights of causal voxels and
causal SNPs as compared to non-causal voxels and non-causal SNPs for all simulated dimen-
sionalities. Causal voxels and causal SNPs receive higher weights than non-causal voxels and
SNPs.
dimensionality
method
|w¯MRI| for |w¯MRI| for |w¯SNP| for |w¯SNP| for
of MRI data causal voxels non-causal voxels causal SNPs non-causal SNPs
100
Sparse CCA 0.1087 0 0.5127 0.0224
Bayesian IBFA 0.8677 0.7924 0.1268 0
PLSC 0.1220 0.0822 0.3857 0.0882
1,000
Sparse CCA 0.0749 0.0096 0.4287 0.0479
Bayesian IBFA 1.0537 0.6057 0.1562 0.0021
PLSC 0.0503 0.0256 0.3395 0.0976
10,000
Sparse CCA 0.0178 0.0018 0.5315 0.0212
Bayesian IBFA 1.2830 0.5207 0.1187 0
PLSC 0.0152 0.0078 0.3863 0.0901
20,000
Sparse CCA 0.0165 0.0014 0.4650 0.0355
Bayesian IBFA 0.8915 0.4862 0.1468 0.0065
PLSC 0.0116 0.0054 0.3440 0.0934
30,000
Sparse CCA 0.0121 0.0035 0.4068 0.0793
Bayesian IBFA 0.9127 0.3917 0.1704 0
PLSC 0.0104 0.0044 0.3877 0.0881
40,000
Sparse CCA 0.0107 0.0008 0.5500 0
Bayesian IBFA 0.8230 0.3779 0.1108 0
PLSC 0.0089 0.0041 0.3663 0.0928
50,000
Sparse CCA 0.0152 0.0019 0.4476 0.0366
Bayesian IBFA 1.4404 0.6350 0.1517 0.0055
PLSC 0.0084 0.0039 0.3143 0.0993
70,000
Sparse CCA 0.0078 0.0026 0.3865 0.0806
Bayesian IBFA 0.1105 0.1052 0.1024 0.0062
PLSC 0.0061 0.0033 0.3325 0.1005
90,000
Sparse CCA 0.0076 0.0023 0.3366 0.0838
Bayesian IBFA 1.3861 0.5918 0.0620 0.0044
PLSC 0.0058 0.0029 0.2873 0.1074
For Sparse CCA and Bayesian IBFA, canonical correlations were significant by per-
mutation testing for up to 50,000 and 1,000 simulated voxels, respectively (Table 3).
The reason is that for CCA-like models, canonical weights are computed as multiple
regression coefficients, such that adding and deleting of variables has a huge effect on
the canonical correlation. In addition, if there are much more variables relative to the
number of observations, CCA is in general exposed to overfitting issues, such that noise
is described instead of underlying relationships. Hence, with increasing voxel numbers,
resampling had an incremental influence on the canonical correlation. In contrast to
the CCA methods, PLSC is less prone to effects of resampling and, using permutation
tests, covariances of latent variables were significant for all simulated dimensionalities.
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However, using permutation tests, the rate of false positives might be high in searching
for associations between brain imaging and SNP measures. To detect the reliability
of latent variables, the split-half reliability testing procedure introduced by Kovace-
vic and others (2013) was used (the strategy is only available for PLSC). In split-half
reliability testing, latent variables are considered as reliable, when both PW1corr and
PW2corr are smaller than 0.05. Accordingly, for PLSC, latent variables were reliable for
all simulated voxel numbers other than 40,000 and 70,000 voxels.
To directly compare Sparse CCA, Bayesian IBFA and PLSC results for simulated
collinear brain imaging data and candidate SNPs, the ratio of the out-of-sample corre-
lation (out-of-sample covariance), estimated by 10-fold CV, to the overall correlation
(covariance) of latent variables was computed (Figure 7). Relative to the overall cor-
relation, the out-of-sample correlation was highest for Sparse CCA till up to 40,000
voxels. For higher voxel numbers, the ratio was highest for PLSC. For Bayesian IBFA
the ratio decreased when 10,000 voxels or more were considered. For 40,000 simulated
brain imaging phenotypes or more, it was below 10%. Thus, the prediction perfor-
mance of Bayesian IBFA was very low and, using model selection tools, I was not able
to detect causal components any more. Note that in Figure 7, PLSC exhibits a raise
in predictive power when 50,000 voxels or more are considered. However, it cannot be
expected that the PLSC performance increases with dimensionality. Since I worked on
randomly generated data sets, the association of causal voxels and SNPs was simply
stronger for 50,000 simulated voxels or more, which is in line with the P -values of
permutation testing reported in Table 3. In general, it is not possible to compare the
prediction performance of individual methods across dimensionalities. On the contrary,
the performance of PLSC might be compared with the performance of Sparse CCA or
Bayesian IBFA for a given voxel number.
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Figure 7: Ratio of out-of-sample correlation (out-of-sample covariance) to overall cor-
relation (covariance) of latent variables for Sparse CCA, Bayesian IBFA and PLSC on
simulated collinear brain imaging data and candidate SNPs
For PLSC (blue) the ratio of the out-of-sample covariance to the overall covariance of latent
variables is shown. For Sparse CCA (red) and Bayesian IBFA (green) it is the relation of the
out-of-sample correlation to the overall correlation of latent variables.
2.4.1.2 Linearly independent endophenotypes and candidate SNPs
To discuss whether the failure of any method in Section 2.4.1.1 was related to the di-
mensionality of the imaging data set or to the degree of collinearity between voxels, the
performance of Sparse CCA, Bayesian IBFA and PLSC was compared on linearly inde-
pendent endophenotypes of increasing dimensionality (Section 2.3.1.2). As described
in Section 2.4.1.1, I computed ten components for Sparse CCA and as many compo-
nents as necessary to explain at least 80% of summed squared cross-block correlations
for PLSC, respectively. Model selection was performed using CHull and the predic-
tive squared correlation coefficient. A summary of results is provided in Table 5. For
both Sparse CCA and PLSC, the SNPs and the endophenotypes of the second causal
pattern, which was the stronger one, were contributing most to the first component,
which is associated with the highest canonical correlation or covariance, respectively,
for all simulated dimensionalities. However, the representation of the less strong first
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causal pattern varied depending on the dimensionality of the endophenotype data set.
When 1,000 endophenotypes were considered, it was displayed, as expected, in the sec-
ond component, related to the second highest canonical correlation or covariance. For
Sparse CCA, increasing the dimensionality of the phenotype data led to a shift of the
representation to the fifth component (10,000 variables) or seventh component (more
than 20,000 variables). PLSC was more stable, since variables were weighted approx-
imately equally for all simulated dimensionalities and the representation of the less
strong first causal pattern was shifted to the seventh component for 10,000 endophe-
notypes or more. However, in contrast to highly collinear brain imaging data (Section
2.4.1.1), many components were in general necessary to account for 80% of summed
squared cross-block correlations. Table 5 further shows that the number of components
learned by Bayesian IBFA increased from two, as expected knowing ground truth, to
eleven with the number of simulated endophenotypes, and causal patterns were mostly
represented in any of the backmost components.
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Table 5: Sparse CCA, Bayesian IBFA and PLSC results for simulated linearly inde-
pendent endophenotypes and candidate SNPs
The dimensionality of endophenotypes was increased stepwise from 1,000 to 100,000. The
number of SNPs was constant. For Sparse CCA, ten components were computed at each
dimensionality, respectively. In contrast, Bayesian IBFA automatically learned how many
components to select. For PLSC, as many components as necessary to explain at least 80%
of summed squared cross-block correlations were considered. Illustrated are the P -value ob-
tained by performing 5000 permutations for each dimensionality and, for PLSC, the P -values
PW1corr and PW2corr of latent variable reliability based on split-half resampling (100 half-splits
and 100 permutations). In addition, it is shown which components are representing the two
causal patterns, the canonical correlation (CCA) or covariance (PLSC) of those components
as well as the out-of-sample correlation (CCA) or out-of-sample covariance (PLSC), estimated
on the test data by 10-fold CV. Furthermore, the table displays how many components are
selected by CHull and the predictive squared correlation coefficient Q2 and whether it is
possible to detect the two causal patterns considering model selection procedures. In terms
of Bayesian IBFA, canonical weights were no longer significant for 40,000 endophenotypes or
more and corresponding columns in the result table are empty.
dimen-
method
number P -value
comp.
correlation out-of-sample comp. comp.
detectability
sionality of of perm. causal (CCA) / correlation / number number
of pheno- compo- (PW1corr pattern covariance out-of-sample by by
types nents PW2corr ) (PLSC) covariance CHull Q
2
1,000
10 2 1
Sparse 0.0000∗∗∗ 1 2 0.9483 0.9341 P/CHull
CCA 0.0000∗∗∗ 2 1 0.9818 0.9687 P/CHull/Q2
3 2 1,2
Bayesian 0.0200∗ 1 2 0.8975 0.6585 P/CHull/Q2
IBFA 0.0150∗ 2 1 0.9108 0.8043 P/CHull/Q2
PLSC 21
0.00∗∗∗
1 2
7.1408
2.0454
2 1
P/CHull
(0.00, 0.19) (8.38%)
0.00∗∗∗
2 1
11.7506
2.9912 P/CHull/Q2
(0.00, 0.00) (22.68%)
10,000
10 2 1
Sparse 0.0530 1 5 0.9725 0.3012 x
CCA 0.0150∗ 2 1 0.9858 0.9501 P/CHull/Q2
8 7 5,6
Bayesian 0.0970 1 6 0.8751 0.6895 Q2
IBFA 0.0857 2 5 0.8992 0.6516 Q2
PLSC 25
0.02∗
1 7
14.2899
0.1195
1 1
P
(0.07, 0.73) (3.96%)
0.00∗∗∗
2 1
18.2599
1.1887 P/CHull/Q2
(0.00, 0.99) (6.46%)
20,000
10 1 1
Sparse 0.8842 1 7 0.9774 0.0272 x
CCA 0.8422 2 1 0.9875 0.9070 CHull/Q2
10 9 8,9
Bayesian 0.5211 1 9 0.8994 0.1752 CHull/Q2
IBFA 0.3132 2 8 0.8996 0.3130 CHull/Q2
PLSC 25
0.08
1 7
19.9202
0.2040
1 1
x
(0.12, 0.71) (3.89%)
0.00∗∗∗
2 1
24.0979
0.7011 P/CHull/Q2
(0.00, 0.97) (5.69%)
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
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dimen-
method
number P -value
comp.
correlation out-of-sample comp. comp.
detectability
sionality of of perm. causal (CCA) / correlation / number number
of pheno- compo- (PW1corr pattern covariance out-of-sample by by
types nents PW2corr ) (PLSC) covariance CHull Q
2
30,000
10 1 1
Sparse 1.0000 1 7/9 0.9844/0.9865 0.3302/0.2615 x
CCA 0.9856 2 1 0.9883 0.7600 CHull/Q2
11 10 9
Bayesian 0.5981 1 9 0.9076 0.2257 Q2
IBFA 0.5498 2 - - - x
PLSC 25
0.17
1 7
24.3343
0.0765
1 1
x
(0.13, 0.31) (3.88%)
0.00∗∗∗
2 1
28.8167
0.5180 P/CHull/Q2
(0.00, 1.00) (5.44%)
40,000
10 8 1
Sparse 1.0000 1 7 0.9982 0.2475 x
CCA 1.0000 2 1 0.9937 0.2770 Q2
9 6 -
Bayesian 0.6224 1 - - - x
IBFA 0.2126 2 - - - x
PLSC 25
0.14
1 7
28.0766
0.0865
2 1
x
(0.05, 0.53) (3.88%)
0.00∗∗∗
2 1
32.9296
0.2415 P/Q2
(0.00, 0.66) (5.34%)
50,000
10 8 1
Sparse 1.0000 1 7 0.9876 0.3094 x
CCA 1.0000 2 1 0.9629 0.2345 Q2
9 6 -
Bayesian 0.8411 1 - - - x
IBFA 0.4082 2 - - - x
PLSC 25
0.05
1 7
31.4143
0.0334
19 1
x
(0.04, 0.28) (3.89%)
0.00∗∗∗
2 1
36.6167
0.0843 P/Q2
(0.00, 0.78) (5.28%)
100,000
10 7 0.9935 0.3587 - 1 x
Sparse 1.0000 1
CCA 1.0000 2
2 - -
Bayesian 0.8812 1 - - - x
IBFA 0.5512 2 - - - x
PLSC 25
0.64
1 7
44.1608
0.0280
4 1
x
(0.77, 0.32) (3.86%)
0.12
2 1
51.2970
0.0473 Q2
(0.04, 0.17) (5.20%)
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
To identify causal components, I used CHull with the cumulative out-of-sample corre-
lation coefficient (CCA) or cumulative out-of-sample covariance (PLSC) as measure of
fit, and the predictive squared correlation coefficient Q2, as shown in Figure 8 and 9,
respectively. For Sparse CCA and PLSC, using model selection procedures, I was able
to detect both causal patterns only for 1,000 simulated endophenotypes. For higher
dimensionalities, both CHull and Q2 suggested to consider only the first component,
which was carrying the stronger causal pattern. This was related to the shift of the less
strong causal pattern to backmost components. In contrast to Sparse CCA and PLSC,
for Bayesian IBFA CHull was inappropriate for model selection for 10,000 simulated
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endophenotypes or more, since the representation of causal relations varied strongly
across folds. However, using the predictive squared correlation coefficient, both causal
patterns were identifiable for up to 30,000 variables. For larger data sets, Bayesian
IBFA weights were no longer significant (i.e. different from zero).
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Figure 8: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated linearly independent endophenotypes and candidate SNPs us-
ing out-of-sample correlation or out-of-sample covariance
The y-axis depicts the cumulative average out-of-sample correlation coefficient (Sparse CCA
and Bayesian IBFA) or the cumulative average out-of-sample covariance (PLSC) for all com-
ponents, respectively. The dashed lines show the variance of the out-of-sample correlation
coefficients (standard deviation of the out-of-sample covariances). Blue dots are used to high-
light how many components should be considered according to the model selection procedure
CHull. The green dots mark the components truly carrying causal information. For 1,000
simulated endophenotypes, both causal patterns can be detected using CHull in all three
methods. For Sparse CCA and PLSC, increasing the dimensionality results in choosing only
the first component, which is representing the stronger causal pattern. Using Bayesian IBFA,
CHull generally fails to identify causal components for more than 1,000 variables.
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Figure 9: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated linearly independent endophenotypes and candidate SNPs us-
ing the predictive squared correlation coefficient
The y-axis depicts the predictive squared correlation coefficient when the number of endophe-
notypes was stepwise increased from 1,000 to 100,000.
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Figure 10 provides an illustration of Sparse CCA, Bayesian IBFA and PLSC weights
for 1,000 simulated endophenotypes. Components selected by CHull (Sparse CCA and
PLSC) or by the predictive squared correlation coefficient (Bayesian IBFA) are shown.
In general, variables of the stronger second causal pattern, as shown in green, were
represented in the first component and those of the less strong first causal pattern (red)
were most contributing to the second component. Bootstrapping was used to verify the
reliability of endophenotype and SNP weights. All causal endophenotypes and SNPs
were reliable and received on average higher weights than non-causal endophenotypes
and SNPs (Table 6). Compared to the voxel weight profiles presented in Figure 5, in
Figure 10 it is also easier to differentiate between causal and non-causal endophenotypes
due to independence of individual variables.
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Figure 10: Sparse CCA (top), Bayesian IBFA (middle) and PLSC (bottom) weights
for 1,000 simulated linearly independent endophenotypes and candidate SNPs
(a) Phenotype weight profile and (b) SNP weight profile of causal Sparse CCA components.
(c) Phenotype weight profile and (d) SNP weight profile of causal Bayesian IBFA compo-
nents. (e) Phenotype weight profile and (f) SNP weight profile of causal PLSC components.
Variables of the stronger second causal pattern (green) are represented in the first component
and those of the less strong first causal pattern (red) are displayed in the second one.
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Table 6: Average Sparse CCA, Bayesian IBFA and PLSC weights for simulated linearly
independent endophenotypes and candidate SNPs
For all simulated dimensionalities, the table shows average Sparse CCA, Bayesian IBFA
and PLSC weights of causal endophenotypes and SNPs related to the less strong first causal
pattern, of causal endophenotypes and SNPs related to the stronger second causal pattern and
of non-causal endophenotypes and SNPs. For Sparse CCA and PLSC, causal endophenotypes
and SNPs related to the second causal pattern received highest weights in the first component
and those related to the first causal pattern received highest weights in the second (1,000
simulated phenotypes), fifth (10,000 simulated phenotypes) or seventh (higher dimensions)
component. For Bayesian IBFA, canonical weights were no longer significant for 40,000
simulated phenotypes or more and corresponding columns in the table are empty.
dimen-
method comp.
|w¯Ph| for |w¯Ph| for |w¯Ph| for |w¯SNP| for |w¯SNP| for |w¯SNP| for
sionality causal causal non-causal causal causal non-causal
of pheno- phenotypes phenotypes phenotypes SNPs of SNPs of SNPs
types of pattern 1 of pattern 2 pattern 1 pattern 2
1,000
Sparse CCA
1 0 0.0474 0 0 0.5596 0.0098
2 0.0944 0.0001 3.36 · 10−5 0.6685 0.0957 0.0110
Bayesian IBFA
1 0.0794 0.3116 0.0185 0.1086 0.2661 0.0067
2 0.3384 0.0033 0.0141 0.2965 0.0716 0
PLSC
1 0.0181 0.0651 0.0095 0.1460 0.4506 0.0699
2 0.0823 0.0143 0.0148 0.5253 0.2027 0.0704
10,000
Sparse CCA
1 0.0022 0.0634 0.0018 0 0.5570 0.0100
5 0.0779 0.0033 0.0022 0.6283 0.1448 0.0096
Bayesian IBFA
5 0.0039 0.0842 9.32 · 10−5 0.1398 0.2557 0.0118
6 0.0599 0 6.39 · 10−5 0.2557 0.0717 0.0026
PLSC
1 0.0117 0.0380 0.0067 0.1316 0.3395 0.0955
7 0.0183 0.0093 0.0079 0.1843 0.0865 0.1129
20,000
Sparse CCA
1 0.0019 0.0585 0.0015 0 0.5475 0.0106
7 0.0632 0.0017 0.0018 0.5494 0.1685 0.0115
Bayesian IBFA
8 0 0.0077 0 0 0.2471 0.0172
9 0.0183 0 0 0.2954 0.0544 0.0048
PLSC
1 0.0088 0.0255 0.0053 0.1215 0.2686 0.1060
7 0.0123 0.0088 0.0056 0.1915 0.1099 0.1122
30,000
Sparse CCA
1 0.0016 0.0549 0.0014 0 0.5354 0.0114
7 0.0472 0.0016 0.0016 0.4357 0.1825 0.0156
Bayesian IBFA 9 0.0009 0 0 0.2946 0.0885 0.0094
PLSC
1 0.0069 0.0198 0.0044 0.1072 0.2345 0.1096
7 0.0101 0.0075 0.0046 0.2260 0.1452 0.1078
40,000
Sparse CCA
1 0.0052 0.0186 0.0034 0.0717 0.2241 0.0919
7 0.0102 0.0047 0.0035 0.2319 0.1158 0.0920
PLSC
1 0.0060 0.0162 0.0039 0.1036 0.2108 0.1115
7 0.0082 0.0070 0.0040 0.2168 0.1289 0.1079
50,000
Sparse CCA
1 0.0048 0.0495 0.0008 0 0.4290 0.0081
7 0.0431 6.14 · 10−5 0.0010 0.4703 0.1046 0.0088
PLSC
1 0.0054 0.0139 0.0035 0.1041 0.1966 0.1117
7 0.0076 0.0058 0.0036 0.2366 0.1420 0.1069
100,000
Sparse CCA 7 0.0209 0.0188 0.0009 0.2824 0.2309 0.0192
PLSC
1 0.0037 0.0078 0.0025 0.0983 0.1430 0.1153
7 0.0054 0.0036 0.0025 0.2641 0.1594 0.1045
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For Sparse CCA and Bayesian IBFA, canonical correlations were significant by permu-
tation testing only for 1,000 (both causal patterns) and 10,000 (the stronger second
causal pattern) simulated endophenotypes (Table 5). In contrast, PLSC was signifi-
cant for up to 50,000 variables (the stronger second causal pattern only). To detect
the reliability of latent variables of PLSC, split-half reliability testing was used and la-
tent variables were considered as reliable, if both PW1corr and PW2corr were smaller than
0.05. Accordingly, the less strong first causal pattern was not reliable for all simulated
dimensionalities. The stronger second causal pattern, however, was reliable for 1,000
simulated endophenotypes.
As for simulated highly collinear brain imaging data (Section 2.4.1.1), I compared the
performance of Sparse CCA, Bayesian IBFA and PLSC by computing the ratio of the
out-of-sample correlation (out-of-sample covariance), estimated by 10-fold CV, to the
overall correlation (covariance) of latent variables. This is illustrated in Figure 11. For
the stronger second causal pattern, the ratio was highest using Sparse CCA for all
simulated dimensionalities. However, for 40,000 endophenotypes or more, it dropped
below the 50% threshold, such that model selection by CHull failed to detect the causal
component. For Bayesian IBFA, the ratio was identifiable only for data sets contain-
ing no more than 20,000 simulated endophenotypes, since respective weights were no
longer significant for higher dimensions. Applying PLSC, the ratio of out-of-sample
covariance to overall covariance was poor even for low dimensionalities, which resulted
from the high number of components that was needed to account for at least 80%
of summed squared cross-block correlations in the data sets. As a consequence, the
covariance of the first component, which carried the second causal pattern, was low,
just as the out-of-sample covariance.
Using Sparse CCA for the less strong first causal pattern, the ratio of the out-of-sample
correlation to the overall correlation dropped below the 50% threshold for 10,000 sim-
ulated endophenotypes or more, such that using model selection tools it was not iden-
tifiable any more. In contrast to the stronger second causal pattern, Bayesian IBFA
outperformed the other strategies with regard to the first causal pattern. The ratio
of the out-of-sample correlation to the overall correlation was highest using Bayesian
IBFA for data sets of 20,000 simulated endophenotypes at maximum. Hence, both
the stronger second and the less strong first causal pattern were identifiable. As for
the stronger second causal pattern, the ratio of out-of-sample covariance to overall co-
variance of PLSC was poor even for low dimensionalities considering the first causal
pattern.
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Figure 11: Ratio of out-of-sample correlation (out-of-sample covariance) to overall
correlation (covariance) of latent variables for Sparse CCA, Bayesian IBFA and PLSC
on simulated linearly independent endophenotypes and candidate SNPs
For PLSC (blue) the ratio of the out-of-sample covariance to the overall covariance of latent
variables is shown. For Sparse CCA (red) and Bayesian IBFA (green) it is the relation of the
out-of-sample correlation to the overall correlation of latent variables.
2.4.1.3 Highly collinear endophenotypes and high-dimensional SNP array
data
To provide an outlook on how Sparse CCA, Bayesian IBFA and PLSC perform in more
realistic genetic neuroimaging settings, I extended my simulations on highly collinear
endophenotypes by also considering a large number of SNPs (Section 2.3.1.3). As in
Section 2.4.1.1 and 2.4.1.2, I computed ten components for Sparse CCA and as many
components as necessary to explain at least 80% of summed squared cross-block cor-
relations for PLSC. Bayesian IBFA automatically determined the component number.
Model selection was performed using CHull and the predictive squared correlation co-
efficient. A summary of results for highly collinear brain imaging and high-dimensional
SNP array data is provided in Table 7.
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Table 7: Sparse CCA, Bayesian IBFA and PLSC results for simulated collinear brain
imaging and high-dimensional SNP array data
A data set containing 90,000 highly collinear voxels and 10,000 SNPs was simulated. For
Sparse CCA, ten components and for PLSC, as many components as necessary to explain at
least 80% of summed squared cross-block correlations were computed. In contrast, Bayesian
IBFA automatically determined the component number. The table illustrates the P -value
of permutation testing, and for PLSC the P -values PW1corr and PW2corr of latent variable
reliability based on split-half resampling. Note that only 200 permutations were performed,
which might be insufficient to achieve a confident precision of the test. However, for data sets
with very high dimensionalities, a much larger number of permutations is infeasible without
having access to powerful compute servers. Furthermore, the table displays the canonical
correlation (CCA) or covariance (PLSC) of the causal component as well as the out-of-sample
correlation (CCA) or out-of-sample covariance (PLSC) for that component. For PLSC, the
percentage of summed squared cross-block correlations the causal component explains is also
given. Finally, the detectability using CHull and the predictive squared correlation coefficient
Q2 is indicated.
method
number P -value correlation out-of-sample comp. comp.
detectability
of of perm. causal (CCA) / correlation / number number
compo- (PW1corr comp. covariance out-of-sample by by
nents PW2corr ) (PLSC) covariance CHull Q
2
Sparse
10 0.3918 (1) (0.9416) (0.1889) 1 1 x
CCA
Bayesian
62 0.2080 27 0.9923 0.0530 26 57 x
IBFA
PLSC 18
0.0288∗
1
1365.6188
98.4432 1 1 P/CHull/Q2
(0.08, 0.0) (20.54%)
∗P < 0.05
Table 7 illustrates that PLSC was the only method that was able to detect causal
variables when both brain imaging and SNP dimensionalities were high. The causal
pattern was represented in the first component, which is associated with the highest
covariance. This result was confirmed by both the cumulative out-of-sample covari-
ance, which was used as measure of fit for model selection with CHull, and the pre-
dictive squared correlation coefficient, as shown in Figure 12 and 13. Specifically, the
cumulative out-of-sample covariance steeply increased only for the first component,
and the predictive squared correlation coefficient decreased after the first component.
Using permutation testing, latent variables of PLSC were significant, and using split-
half reliability testing, latent variables were close to reliable with PW1corr = 0.08 and
PW2corr = 0.0. In contrast, using Sparse CCA, model selection using both the cu-
mulative out-of-sample correlation coefficient and the predictive squared correlation
coefficient provided evidence that the first component was the causal one (Figure 12
and 13). However, knowing ground truth, neither the causal voxel nor the causal SNPs
were highly weighted in that component. Specifically, causal SNPs were provided with
medium weights, whereas the causal voxel was weighted by a zero. Latent variables
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were non-significant according to permutation testing. For Bayesian IBFA, there was
a component (component 27) representing causal voxels and SNPs. However, it was
difficult to detect that component using model selection tools, since the number of com-
ponents learned by the ARD prior was very high. CHull suggested that component 26
was the causal one. The representation of the causal pattern varied, however, strongly
across folds (Figure 12). The predictive squared correlation coefficient had its steepest
positive slope for the 57th component, although it was difficult to pick a defined causal
component according to Figure 13. Thus, the causal Bayesian IBFA component was
untraceable without knowing ground truth. The P -value of permutation testing for
Bayesian IBFA was non-significant.
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Figure 12: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated collinear brain imaging and high-dimensional SNP array data
using out-of-sample correlation or out-of-sample covariance
The y-axis depicts the cumulative average out-of-sample correlation coefficient (Sparse CCA
and Bayesian IBFA) or the cumulative average out-of-sample covariance (PLSC). Dashed
lines indicate the variance of the out-of-sample correlation coefficient (standard deviation of
the out-of-sample covariance). Blue dots are used to highlight how many components should
be considered according to the model selection procedure CHull. The green dots mark the
components truly carrying causal information. According to CHull, for Sparse CCA and
PLSC the first component carries causal information. However, only PLSC was able to
truly detect causal associations. For Bayesian IBFA, the cumulative average out-of-sample
correlation coefficient varies strongly across folds.
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Figure 13: Comparison of Sparse CCA (top left), Bayesian IBFA (top right) and PLSC
(bottom) for simulated collinear brain imaging and high-dimensional SNP array data
using the predictive squared correlation coefficient
The y-axis depicts the predictive squared correlation coefficient. For Sparse CCA and PLSC,
it indicates that the first component carries causal information. For Bayesian IBFA it is
difficult to pick a defined causal component.
An illustration of voxel and SNP weights of the causal Sparse CCA and PLSC com-
ponent (i.e. component one according to CHull and Q2) is provided in Figure 14 and
15, respectively. For visualization purpose, the voxel weight profiles are zoomed in
on a range of 100 voxels around the causal voxel. SNP weights are only displayed for
causal SNPs. For Sparse CCA, the causal voxel received a zero weight and causal SNPs
were provided with medium weights. The highest SNP weight was given to SNP 9150,
which was, however, not strongly correlated to the causal voxel (Pearson correlation
rSNP 9150 = 0.2608). For PLSC, causal voxels (including the causal voxel itself (red)
and voxels correlated to the causal voxel at a value of 0.8 or higher (yellow)) and two
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out of the three causal SNPs (SNP 1584 and SNP 7074) received in general the high-
est weights. The third causal SNP (SNP 2410) was not detected by PLSC, which is,
however, reasonable, since its association to the causal voxel was weaker than for the
other two causal SNPs by chance. In addition to the causal SNPs, five other SNPs
were provided with high weights by PLSC, including SNP 885, SNP 1176, SNP 1216,
SNP 6935 and SNP 6961. All of these SNPs were actually linked to the causal voxel,
as revealed by means of Pearson correlation (rSNP 885 = 0.3259, rSNP 1176 = 0.3016,
rSNP 1216 = 0.2617, rSNP 6935 = 0.3184 and rSNP 6961 = −0.3465). For Bayesian IBFA,
voxel and SNP weights of the component representing causal associations (i.e. com-
ponent 27) are illustrated in Figure 16. Note that without knowing ground truth the
causal Bayesian IBFA component was untraceable, since both CHull and Q2 were not
able to detect it. An overview of Sparse CCA, Bayesian IBFA and PLSC weights for
causal and non-causal voxels and SNPs is given in Table 8.
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Figure 14: Sparse CCA weights for simulated collinear brain imaging and high-
dimensional SNP array data
(a) Voxel weight profile and (b) SNP weight profiles of the causal Sparse CCA component.
The causal voxel (red) is weighted by a zero and the causal SNPs (red) receive medium
weights. Sparse CCA provides the highest SNP weight for SNP 9150 (yellow), which is, how-
ever, not strongly correlated to the causal voxel. SNPs are named according to their number
in the simulated data set.
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Figure 15: PLSC weights for simulated collinear brain imaging and high-dimensional
SNP array data
(a) Voxel weight profile and (b) SNP weight profiles of the causal PLSC component. The
causal voxel (red) and voxels correlated to the causal voxel at a value of 0.8 or higher (yellow)
receive the highest weights. In the SNP weight profiles, two out of the three causal SNPs
(SNP 1584 and SNP 7074), as shown in red, and five additional SNPs (SNP 885, SNP 1176,
SNP 1216, SNP 6935 and SNP 6961), as shown in yellow, are most contributing. SNP 2410,
a causal one, receives only a medium weight. SNPs are named according to their number in
the simulated data set.
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Figure 16: Bayesian IBFA weights for simulated collinear brain imaging and high-
dimensional SNP array data
(a) Voxel weight profile and (b) SNP weight profiles of the 27th Bayesian IBFA component.
The causal voxel (red), collinear voxels (yellow) and causal SNPs (red) receive the highest
weights. The component was not detectable using model selection tools.
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Table 8: Average Sparse CCA, Bayesian IBFA and PLSC weights for simulated
collinear brain imaging and high-dimensional SNP array data
The table shows average Sparse CCA, Bayesian IBFA and PLSC weights of causal voxels and
causal SNPs as compared to non-causal voxels and non-causal SNPs. For Sparse CCA and
PLSC, weights of the first component are provided. In addition to the causal SNPs, some
other SNPs received high weights (SNP 9150 for Sparse CCA and SNPs 885, 1176, 1216, 6935
and 6961 for PLSC). The average weight of these additional SNPs is given in column |w¯SNP|
for additional SNPs. For Bayesian IBFA, weights of the 27th component are illustrated. In
contrast to Sparse CCA and PLSC, no additional SNPs were detected.
method
|w¯MRI| for |w¯MRI| for |w¯SNP| for |w¯SNP| for |w¯SNP| for
causal voxels non-causal voxels causal SNPs additional SNPs non-causal SNPs
Sparse CCA 0.0021 0.0003 0.1695 0.2986 0.0009
Bayesian IBFA 2.1414 0.9828 0.0439 - 0
PLSC 0.0054 0.0030 0.0322 0.0335 0.0080
2.4.2 Results on experimental data
To verify the findings on simulated data, I used the three multivariate methods Sparse
CCA, Bayesian IBFA and PLSC to analyze the experimental genetic neuroimaging
data set introduced in Section 2.3.2. Note that I only applied PLSC and Sparse CCA,
since using simulated brain imaging and SNP data, I showed that Bayesian IBFA
failed to reflect meaningful associations for voxel numbers higher than 500 times sam-
ple size (Section 2.4.1.1). Prior to the statistical analysis, I corrected for diagnosis
type (schizophrenia, bipolar disorder or other psychosis) as in the original publication.
Since only five SNPs were included, for Sparse CCA I computed five components and
applied the out-of-sample correlation coefficient and the predictive squared correlation
coefficient for model selection. Both provided evidence that only the first Sparse CCA
component should be considered, with a canonical correlation of 0.5565 and a P -value
of 0.0721 obtained by permutation testing (Fisher, 1971). Although the canonical cor-
relation was non-significant, it exhibited a stable prediction performance. The ratio
of the out-of-sample correlation, estimated on the test data by 10-fold CV, to the
overall correlation of latent variables accounted for approximately 0.35. For PLSC,
I considered only SNP and voxel weights of the first component, since the first com-
ponent already explained 72.76% of summed squared cross-block correlations. The
overall covariance of latent variables of 65.8063 was significant by permutation testing
(P = 0.0276∗) and the predictive power was high (ratio of the out-of-sample covariance
to overall covariance of 0.62).
An illustration of SNP weight profiles of the first Sparse CCA and PLSC component
is provided in Figure 17. According to the bootstrap method (Efron, 1979, 1981, 1982;
Efron and Tibshirani, 1993), exactly the same three SNPs in high LD (rs10014254,
rs11722038 and rs17529323) as reported in the original publication by Ousdal and
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others (2012) were reliable. In contrast to Ousdal and others (2012), who found the
strongest relation for rs10014254, the three SNPs were contributing equally to the
canonical correlation or covariance, respectively. The remaining two SNPs, rs382013
and rs437633, were zero-weighted (Sparse CCA) or only had a marginal positive and
negative weight (PLSC), respectively.
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Figure 17: SNPs associated to amygdala activity during fMRI face-matching task using
Sparse CCA and PLSC
(a) SNP weight profile of the first Sparse CCA component. (b) SNP weight profile of the
first PLSC component. Three SNPs in high linkage disequilibrium, rs10014254, rs11722038
and rs17529323, are reliable according to the bootstrap method, as shown in red.
In the original publication, Ousdal and others (2012) reported a significantly increased
activation in right (x = 16, y = −8, z = −16) and left (x = −26, y = −4, z = −14)
amygdala for T-allele carriers (CT or TT) of rs10014254 compared to homozygous
CC-individuals (Section 2.3.2). Using Sparse CCA and PLSC, all reliable voxels ac-
cording to the bootstrap method were positively weighted. Since SNPs were recoded by
counting the number of minor alleles per person, they reflect brain regions that, during
the emotional face-matching task, were directly associated to the SNPs rs10014254,
rs11722038 and rs17529323. This is in line with Ousdal and others (2012). An illus-
tration of the voxel weight profiles of Sparse CCA and PLSC is given in Figure 18. I
was able to replicate the findings reported by Ousdal and others (2012). Three SNPs
in high LD, rs10014254, rs11722038 and rs17529323, were significantly associated to
amygdala activity in both hemispheres (x = −22, y = −4, z = −12; x = 18, y = −4,
z = −12). Homozygous minor allele individuals (TT for rs10014254, GG for rs11722038
and CC for rs17529323) exhibited an increased activation compared with heterozygous
individuals, and heterogeneous individuals exhibited an increased activation compared
with homozygous major allele individuals (CC for rs10014254 and AA for rs11722038
and rs17529323). However, since I considered the whole-brain for multivariate analysis
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instead of selecting amygdala as region of interest, I also found some other brain regions
to be associated to the three SNPs. These brain regions included cerebellum (x = −28,
y = −54, z = −20; x = 22, y = −54, z = −16), left hippocampus (x = −32, y = −10,
z = −14), left lingual gyrus (x = −20, y = −46, z = −4), right putamen (x = 28,
y = 4, z = −2) and left lateral occipital cortex (x = −30, y = −66, z = 28). Average
Sparse CCA and PLSC weights for detected brain regions are presented in Table 9.
(a) Voxel weight profile of Sparse CCA
(b) Voxel weight profile of PLSC
Figure 18: Voxels associated to the SNPs rs10014254, rs11722038 and rs17529323 dur-
ing fMRI face-matching task using Sparse CCA and PLSC
(a) Voxel weight profile of the first Sparse CCA component. (b) Voxel weight profile of
the first PLSC component. I found an association with fMRI activity in bilateral amygdala
(x = −22, y = −4, z = −12; x = 18, y = −4, z = −12), bilateral cerebellum (x = −28,
y = −54, z = −20; x = 22, y = −54, z = −16), left hippocampus (x = −32, y = −10,
z = −14), left lingual gyrus (x = −20, y = −46, z = −4), right putamen (x = 28, y = 4,
z = −2) and left lateral occipital cortex (x = −30, y = −66, z = 28). For PLSC, only voxels
with top 50% weights are shown.
Table 9: Average Sparse CCA and PLSC weights for the fMRI face-matching task
The table shows average Sparse CCA and PLSC weights for detected brain regions (amygdala,
cerebellum, hippocampus, lingual gyrus, putamen and lateral occipital cortex) and average
weights for all other voxels in the brain. For Sparse CCA, only these brain regions were
provided with a non-zero weight. In contrast, for PLSC, all voxels got a weight different from
zero and detected regions were defined as those with top 50% weights. In addition, the table
illustrates average weights for detected SNPs (rs10014254, rs11722038 and rs17529323) and
the remaining SNPs (rs382013 and rs437633).
method
|w¯MRI| for |w¯MRI| for non- |w¯SNP| for |w¯SNP| for non-
detected voxels detected voxels detected SNPs detected SNPs
Sparse CCA 0.0126 0 0.5774 0
PLSC 0.0059 0.0017 0.5768 0.0296
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After multivariate analysis using Sparse CCA and PLSC, the latent variables of both
the fMRI and the SNP data set were searched for group differences regarding the
diagnosis type. However, no differences were found, which is in line with the findings
reported by Ousdal and others (2012).
2.5 Discussion
2.5.1 Results on simulated data
2.5.1.1 The impact of dimensionality of data sets
Using simulated endophenotype data of increasing dimensionality and candidate SNPs,
the first aim of this thesis was to identify, how many non-informative variables might
be included in addition to the causal variants to still be able to discover meaningful
associations. When mean and covariance parameters of experimental fMRI contrast
images were used to generate highly collinear endophenotypes, Bayesian IBFA pro-
vided meaningful results until voxel numbers exceeded 500 times sample size, whereas
Sparse CCA and PLSC were able to identify causal relations for all simulated dimen-
sionalities (Section 2.4.1.1). To discuss whether the failure of Bayesian IBFA for higher
voxel numbers was related to the dimensionality of the fMRI data or to the degree of
collinearity between simulated voxels, a second data set containing linearly indepen-
dent endophenotypes was generated and the number of considered variables was again
stepwise increased. Bayesian IBFA was applicable till the number of simulated en-
dophenotype variables exceeded 300 times sample size. For larger data sets, Bayesian
IBFA weights were no longer significant (i.e. different from zero). Sparse CCA and
PLSC gave meaningful results for higher dimensionalities. However, when the number
of simulated endophenotypes exceeded 300 times sample size, it became difficult to
identify causal patterns using model selection tools (Section 2.4.1.2).
The comparison of the results on linearly independent and highly collinear endopheno-
types revealed that all three methods increased in performance when simulated vari-
ables were highly collinear due to the increasing number of causal variants itself. For
linearly independent endophenotypes, the number of causal variables was chosen to
be 300 for all simulated dimensionalities. With growing dimensionality, the number
of non-informative endophenotypes was increased, such that there were much more
non-informative than causal variables. In contrast, for simulated highly collinear en-
dophenotypes, an increase in dimensionality in turn indirectly raised the number of
causal voxels, since the number of voxels in collinearity with causal voxels, and hence
the total number of voxels associated with the causal SNPs, was enhanced. Conse-
quently, the ratio of causal to non-informative variables was higher. Since all three
methods faced computational challenges for data sets containing high-dimensional lin-
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early independent endophenotypes, but only Bayesian IBFA failed for high-dimensional
collinear data sets, it could be carefully assumed that Bayesian IBFA is susceptible to
the degree of collinearity between simulated variables, not to the dimensionality of the
phenotype data itself. However, to verify this conclusion, further simulations are neces-
sary, focusing on linearly independent variables but for which the information content
is also enhanced with increasing dimensionality.
To further compare Sparse CCA, Bayesian IBFA and PLSC with respect to their perfor-
mance in more realistic genetic neuroimaging settings, the simulation series on highly
collinear endophenotypes was extended by also considering a large number of SNPs.
Specifically, the dimensionality of the genotype data was increased to 10,000 SNPs,
resembling the number of SNPs genotyped on a small human SNP array. PLSC was
the only method for which it was possible to detected causal voxels and SNPs using
model selection tools (Section 2.4.1.3). However, for higher SNP numbers of current
whole-genome scans together with whole-brain imaging data, PLSC is highly inefficient,
since the cross-product matrix is decomposed using SVD, which in turn implies long
processing times. Thus, a prior dimensionality reduction step is highly recommended
to accommodate the large numbers of variables.
2.5.1.2 Significance of associations
Furthermore, I wanted to discuss whether the causal relations detected by Sparse CCA,
Bayesian IBFA and PLSC were also statistically significant. To address this question,
permutation tests (Fisher, 1971) were used.
For highly collinear endophenotypes of increasing dimensionality, Sparse CCA and
Bayesian IBFA provided significant correlations between latent variables for up to
50,000 or 1,000 voxels, respectively (Section 2.4.1.1). The covariances of PLSC la-
tent variables were significant for all simulated dimensionalities, since PLSC is less
prone to effects of resampling (Section 2.2.1.4). Similarly, for simulations contain-
ing linearly independent endophenotypes, canonical correlations of Sparse CCA and
Bayesian IBFA latent variables were significant for up to 10,000 or 1,000 variables,
respectively, whereas the covariances of PLSC latent variables were significant for up
to 50,000 endophenotypes (Section 2.4.1.2). When both the endophenotype and the
SNP data set were high-dimensional, I only detected significant covariances between
PLSC latent variables (Section 2.4.1.3).
For association analyses such as in genetic neuroimaging, it has been shown that the
strength of the correlation between brain imaging variables, even though not neces-
sarily related to the SNPs, can overpower the permutation tests and identify false
positive associations (Kovacevic and others , 2013). I therefore performed split-half re-
liability testing to access the reliability of PLSC latent variables. For highly collinear
endophenotypes of increasing dimensionality, latent variables were reliable for all simu-
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lated voxel numbers other than 40,000 and 70,000 voxels (Section 2.4.1.1). In contrast,
for simulations containing linearly independent endophenotypes, latent variables were
in general not reliable with one exception for 1,000 endophenotypes (Section 2.4.1.2).
This finding supports that PLSC is appropriate, in particular, when the endophenotype
data set comprises highly collinear variables. When applying PLSC, however, split-half
reliability testing should always be considered in addition to traditional permutation
testing to assure that identified brain-SNP-associations are truly reliable.
2.5.1.3 Number of components to consider
In earlier publications, authors have mainly focused on the first (e.g. Witten and oth-
ers , 2009; Witten and Tibshirani, 2009) or the first two pairs (e.g. Le Floch and others ,
2012; Lin and others , 2013) of canonical correlations or covariances, respectively. My
goal was to find out whether this is sufficient.
For data sets containing highly collinear endophenotypes, when I considered only one
causal relation of affected voxels and SNPs, both Sparse CCA and PLSC displayed the
causal pattern in the first component, associated with the highest canonical correlation
or covariance, for all simulated dimensionalities. Using Bayesian IBFA the representa-
tion varied considerably (Section 2.4.1.1 and 2.4.1.3). When the endophenotype data
was modeled using standard normal distribution incorporating two causal relations, the
stronger causal pattern was always represented in the first component, associated with
the highest canonical correlation or covariance. For low-dimensional data sets of 1,000
endophenotypes, the less strong causal pattern was displayed in the component of sec-
ond highest canonical correlation or covariance by all three methods. However, when
more non-informative variables were added to the phenotype data set, the represen-
tation of the less strong causal pattern was shifted to backmost components (Section
2.4.1.2). Thus, when methods like Sparse CCA and PLSC are used, for which the
component number is not automatically learned by the model, more components than
expected should be considered, since causal relations might be represented in back-
most components. Even for highly collinear variables, for which I detected only one
causal relation that was represented in components of highest canonical correlation or
covariance, respectively, additional components might be informative. Consequently,
appropriate model selection tools are mandatory, which are discussed in Section 2.5.1.4.
2.5.1.4 Approaches for performance evaluation
Using simulated data, a further goal was to address methods suitable for model selec-
tion. I considered the predictive squared correlation coefficient and the model selection
procedure CHull with the out-of-sample correlation coefficient or out-of-sample covari-
ance, estimated by 10-fold CV, as goodness of fit measure. For PLSC, I examined as
many components as necessary to explain at least 80% of summed squared cross-block
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correlations.
When simulated endophenotypes were highly collinear, the proportion of explained
summed squared cross-block correlations strongly reduced the number of PLSC com-
ponents to consider (Section 2.4.1.1). Thus, for PLSC the criterion is recommended
for a first data reduction. In contrast, for data sets containing linearly independent
endophenotypes, the proportion of explained summed squared cross-block correlations
was no sufficient model selection criterion, since for PLSC I always needed to consider
many (21 and more) components (Section 2.4.1.2).
Regarding model selection with the predictive squared correlation coefficient Q2 and
CHull, the applicability of these tools was very similar for PLSC and Sparse CCA.
Both methods were appropriate tools for model selection. CHull appeared to be even
more accurate, since for Sparse CCA and PLSC the average of latent variables Z1 and
Z2 was computed to estimate Q
2, which might be prone to outliers.
In contrast to Sparse CCA and PLSC, the out-of-sample correlation coefficient, and
therefore CHull, was in general not suitable for detection of causal Bayesian IBFA com-
ponents, since the representation of causal relations varied strongly across the folds of
CV. The predictive squared correlation coefficient Q2, however, was advisable for model
selection in Bayesian IBFA.
According to my results, the choice of appropriate model selection tools depends on
the multivariate strategy selected for analysis. Therefore, it is recommended to al-
ways consider several tools for model selection. Both CHull and the predictive squared
correlation coefficient Q2 were demonstrated to be suitable approaches.
2.5.1.5 Which method to choose?
In contrast to other studies focusing on whole-genome SNP data, the major goal of
this thesis was to state under which circumstances it is advisable to use either Sparse
CCA, Bayesian IBFA or PLSC with respect to whole-brain imaging data, since the
covariance structure between brain imaging variables is expected to be much stronger
than the covariance structure between various SNPs. For direct comparison of the
three methods, I computed the ratio of the out-of-sample correlation (out-of-sample
covariance), estimated by 10-fold CV, to the overall correlation (covariance) of latent
variables.
For data sets containing highly collinear brain imaging variables as endophenotypes,
Bayesian IBFA cannot be recommended, since the number of components automati-
cally learned by the ARD prior was always excessively high, such that additional post-
processing steps were necessary to differentiate between causal and non-informative
components. This was true for both candidate SNP and high-dimensional SNP array
simulations (Section 2.4.1.1 and 2.4.1.3, respectively). In contrast, in candidate SNP
applications, both Sparse CCA and PLSC were appropriate for very high numbers of
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simulated voxels and resulting weights were much alike (Section 2.4.1.1). Among these
two, the predictive power was higher for Sparse CCA when voxel numbers were below
400 times sample size (Figure 7). Hence, Sparse CCA is recommended for candidate
endophenotype, candidate SNP association studies. When voxel numbers were above
500 times sample size, the predictive power of PLSC exceeded that of Sparse CCA. Fur-
thermore, in more realistic genetic neuroimaging settings, containing high-dimensional
brain imaging and high-dimensional SNP array data, PLSC was the only method that
was able to detect causal voxels and SNPs (Section 2.4.1.3). Thus, PLSC seems to be
the most appropriate tool for multivariate correlation analysis of genetic neuroimaging
data.
The reason why PLSC appeared to be the most appropriate method for acquiring mul-
tivariate associations between brain imaging and genetic data is that SVD is directly
performed on the cross-product matrix X
′
1X2, which, in contrast to the CCA-like mod-
els, is not corrected for within-set covariances prior to the decomposition. Thus, there
is no need for additional assumptions to account for the non-invertibility issue of CCA,
and PLSC results are most probably more accurate. On the other hand, PLSC has
two disadvantages compared to the CCA methods. First, it is impossible to assess the
height of the association of latent variables, since for PLSC the covariance of latent
variables is maximized instead of the correlation, which is an unstandardized measure.
Moreover, latent variables of different PLSC components are not mutually orthogonal
like the latent variables of Sparse CCA and Bayesian IBFA, such that interpretability
is deteriorated. However, for genetic neuroimaging data, brain imaging variables are
naturally highly collinear, such that causal relations are likely to be represented in the
first component (Section 2.4.1.1 and 2.4.1.3). Thus, PLSC results may be interpreted
like CCA results.
Interestingly, in contrast to genetic neuroimaging data, for which I actually aimed to
provide guidance on the use of multivariate methods, Bayesian IBFA outperformed
Sparse CCA and PLSC for data sets containing linearly independent endophenotypes.
Bayesian IBFA was the only method that was able to detect both of the constituted
causal patterns (Section 2.4.1.2). Consequently, when the variables of the phenotype
data set are expected to be linearly independent, Bayesian IBFA is recommended as
long as variable numbers are below 300 times sample size. For higher numbers of vari-
ables, results should be interpreted with caution, since it became difficult to identify
causal patterns using model selection tools for all considered strategies.
2.5.2 Results on experimental data
When searching for associations between fMRI data, recorded during emotional face-
matching task, and SNP data (Section 2.3.2) using Sparse CCA and PLSC, I was
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successfully replicating the findings previously reported by Ousdal and others (2012).
I found that three SNPs in high LD, rs10014254, rs11722038 and rs17529323, were
significantly associated with amygdala activity. These SNPs are located upstream of
the Paired-like homeobox 2b (PHOX2B) gene. Since the PHOX2B gene is known
to regulate the expression of enzymes necessary for the biosynthesis of monoamines,
such as dopamine and norepinephrine (Brunet and Pattyn, 2002), I was able to con-
firm the authors’ hypothesis that the monoaminergic signaling pathway plays a central
role in the regulation of amygdala activity. In contrast to Ousdal and others (2012),
who reported the most significant association with rs10014254, Sparse CCA and PLSC
analysis revealed that all three SNPs contributed equally to the canonical correlation
or covariance, respectively. However, since I used multivariate strategies, I had to ex-
clude participants for which genotype values were missing for any SNP, such that the
three SNPs were in even higher LD. In line with Ousdal and others (2012), I also found
that homozygous minor allele carriers exhibited an increased amygdala activation com-
pared with heterozygous individuals and homozygous major allele carriers, since SNP
and voxel weights exposed a direct relation. Therefore, I verified the applicability of
Sparse CCA and PLSC in experimental genetic neuroimaging settings.
Compared to the analysis using MULM, as performed by Ousdal and others (2012), the
use of Sparse CCA and PLSC was advantageous, since I included whole-brain voxels
instead of focusing on the amygdala peak voxel only. Therefore, during the emo-
tional face-matching task, I did not only find an association of the SNPs rs10014254,
rs11722038 and rs17529323 with amygdala activity, but also with some additional brain
regions. These brain regions included cerebellum, left hippocampus, left lingual gyrus
and right putamen. All these brain regions have been shown to be increasingly acti-
vated during processing of emotional faces. An enhanced activation of putamen, cere-
bellum and amygdala was reported by Fusar-Poli and others (2009) and Schraa-Tam
and others (2012) during processing of negative emotional faces. Fusar-Poli and others
(2009) based their findings on quantitative voxel-based meta-analyses of fMRI studies
in healthy participants, which all employed various paradigms considering emotional
faces. Schraa-Tam and others (2012) performed a fMRI experiment, in which healthy
participants were asked to observe and imitate negative emotional human faces. Hip-
pocampus and amygdala (Benedetti and others , 2011), putamen (Surguladze and oth-
ers , 2010) and lingual gyrus (Demenescu and others , 2013) have further been shown to
be increasingly activated in response to negative facial expression in chronic schizophre-
nia patients, in response to moderate fear in patients with diagnosis of bipolar disorder,
and in response to angry and fearful faces in patients diagnosed with panic disorder,
respectively, compared to healthy controls. In my analysis, however, increased activa-
tion in amygdala, hippocampus, putamen and lingual gyrus was not limited to patients
with diagnosis of schizophrenia spectrum disorder or bipolar disorder, since the analy-
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sis of latent variables did not reveal any significant differences between patients of the
diagnostic groups, which was in line with the original publication (Ousdal and others ,
2012).
I could not confirm by the literature so far that individual differences in activation of
cerebellum, hippocampus, lingual gyrus and putamen might be explained by vari-
ation of PHOX2B SNPs like rs10014254, rs11722038 and rs17529323. However, I
found evidence for hippocampus to be associated with another gene influencing the
monoaminergic signaling pathway, the gene that encodes the enzyme monoamine oxi-
dase A (MAOA). MAOA degrades monoamines such as norepinephrine, dopamine and
serotonin and plays a critical role in the regulation of their neurotransmission (Brum-
mett and others , 2007). The MAOA gene contains a polymorphism in its promoter
region, called the MAOA-upstream variable number of tandem retreats (uVNTR) poly-
morphism, which is known to affect transcriptional efficiency (Brummett and others ,
2007). Lee and Ham (2008) investigated the relationship of this polymorphism and
brain responses to negative facial stimuli using fMRI in healthy Korean women. They
reported a greater brain activity in the left amygdala in participants with the low
activity allele in sad versus neutral condition. In the angry versus neutral condition,
participants with the low activity allele, however, showed greater brain activity in the
right hippocampus and right anterior cingulate cortex. Since activation in left amyg-
dala has been shown to be associated with higher level cognitive processes such as
cognitive representations of fear and conscious emotional learning (Morris and others ,
1998), and hippocampus activation has been associated with declarative memory pro-
cesses (Knight and others , 2004), the authors discussed that simultaneous activations
of hippocampus and amygdala reflect an interaction in the associative processing of
facial emotional stimuli in declarative memory. This might also be true for my data.
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3 Random projection for efficient dimen-
sionality reduction in genetic neuroimag-
ing studies2
3.1 Objectives
In recent years, the advent of great technological advances in genetic neuroimaging
research has produced a wealth of high-dimensional data. For example, the growth in
cost- and time-efficient sequencing techniques enabled the implementation of genetic
association studies that survey the entire human genome. To analyze genome-wide
association data, computationally efficient analysis frameworks are pivotal. Multivari-
ate statistical methods have commonly been used in this field, since they are able to
combine the information from multiple markers and multiple sources simultaneously
into the analysis. However, computation times become excessively long with increasing
data dimensionality, posing a serious practical problem for many applications.
An approach for mitigating high-dimensional data analysis is dimensionality reduc-
tion. In genetic neuroimaging applications, univariate filters and PCA have been used
as pre-processing steps (Section 1.5) and have been shown to be able to solve critical
over-fitting issues (Le Floch and others , 2012). However, both strategies present major
limitations. As discussed by Le Floch and others (2012), univariate filters are not the
optimal choice, since they cannot account for interdependencies between variables. The
genetic and the neuroimaging variants are, however, naturally highly collinear. PCA
has two major limitations. First, PCA explicitly depends on the input data, since it
uses an optimization criterion to transform the original variables into a set of orthog-
onal principal components (Goel and others , 2005; Sulic´ and others , 2010). Second
and most importantly, it is computationally expensive, since its runtime is quadratic
in the number of dimensions (Menon, 2007). Thus, in genetic neuroimaging, where the
data sets may capture the whole brain and the whole genome, respectively, PCA is
infeasible in case there is no powerful compute server available in the lab.
In contrast to PCA, RP is a method that is especially attractive for dimensionality
reduction in high-dimensional settings. It uses a random matrix with unit Euclidean
column norms to find a lower-dimensional subspace that approximately preserves the
distances between all pairs of data points in the original space. Importantly, RP de-
pends on sample size only and is independent of the number of variables in the data
sets, ensuring computational efficiency. Note that Multidimensional scaling (MDS;
Kruskal, 1964) is a further dimensionality reduction technique that attempts to pre-
2The chapter largely follows the original publication (Grellmann and others, 2016).
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serve pairwise distance among the data points in the original space. However, as PCA,
MDS explicitly depends on the input data and has therefore an unfavorable runtime
compared to RP.
For the second part of this thesis, the goal was to propose a new approach that uses
RP for dimensionality reduction to efficiently assess the relationship between genetic
variation and brain imaging measures as an example for high-dimensional genotype-
phenotype association problems. In particular, the aim was to incorporate RP into
PLSC, which has been shown to be a promising technique for combined analysis of
SNP and neuroimaging data in a systematic comparison of multivariate techniques
performed by us (Section 2 and Grellmann and others , 2015). I named the new method
PLSC-RP. Using both simulated and experimental data, I evaluated the performance of
PLSC-RP with respect to its ability to preserve the accuracy of the results. Traditional
PLSC served as a reference for that purpose. The data sets I considered to illustrate
the PLSC-RP methodology were chosen to contain either whole-brain neuroimaging
measures as intermediate phenotypes together with candidate SNPs, or whole-genome
SNPs as genotypes together with candidate endophenotypes, or both. For the first
application (high-dimensional endophenotypes), I used RP for dimensionality reduc-
tion of the brain imaging data. Likewise, for the second application (high-dimensional
genotypes), RP was applied such that the dimensionality of the SNP data was reduced.
Finally, I introduced RP for dimensionality reduction of both the brain imaging and
the genetic data. In a statistical sense, neuroimaging measures are scaled metrically,
whereas SNPs are counts. Thus, I was able to detect, whether dimensionality reduc-
tion using RP is independent of statistical data type. Establishing RP for multivariate
analysis of high-dimensional genotype-phenotype-associations is, to my knowledge, a
strategy never used before. Importantly, compared to previous applications of RP in
a number of data mining and biological studies (Bingham and Mannila, 2001; Goel
and others , 2005; Liu and Fieguth, 2012; Palmer and others , 2015; Papadimitriou and
others , 1998; Sulic´ and others , 2010, Section 1.5), I had to address two additional prob-
lems. First, in order to be able to evaluate the contribution of a single genotypic or
phenotypic variable, the multivariate associations detected by PLSC-RP must be in-
terpretable in the original spaces after dimensionality reduction. In contrast, previous
applications exploited RP such that learning, classification or clustering were carried
out directly in the compressed domain (e.g. Liu and Fieguth, 2012; Palmer and others ,
2015). Second, in genetic neuroimaging studies both the genetic and the neuroimaging
data are naturally high-dimensional. Thus, RP needs to be applied for dimensionality
reduction in both domains. The PLSC-RP method I introduce in the second part of
this thesis is favorable since it fulfills both requirements: the back-transformation of
results after dimensionality reduction is straightforward, and it can be applied to re-
duce the number of both the genetic and phenotypic variables.
84
Claudia Grellmann 3 DIMENSIONALITY REDUCTION USING RP
As part of this thesis, I explicitly applied PLSC-RP for efficient assessment of genome-
wide SNP and whole-brain neuroimaging associations. However, the application of
PLSC-RP is not limited to the combined analysis of brain imaging phenotypes and
genetic variants. With the growing demand for combining very high-dimensional data
from multiple sources in an extending range of scientific disciplines, PLSC-RP will be
of interest for a wide variety of applications.
3.2 Materials and methods
3.2.1 Random Projection
Random Projection (RP) is a dimensionality reduction technique, which uses a random
matrix with unit Euclidean column norms to find a lower-dimensional subspace that
approximately preserves the distances between all pairs of data points in the original
space (Bingham and Mannila, 2001; Dasgupta, 2000; Kaski, 1998; Lin and Gunopulos,
2003; Vempala, 2004). The concept of RP is as follows: Given a data matrixX ∈ RN×d,
where N is the total number of points and d is the original dimension, RP transforms
X to a lower dimensional space via the transformation:
XRP = X ·R, (18)
where R ∈ Rd×k is a random matrix with unit Euclidean column norms and XRP ∈
RN×k is the low-dimensional subspace with desired lower dimension k.
The basic idea for RP is derived from the Johnson-Lindenstrauss lemma (Johnson and
Lindenstrauss, 1984).
Lemma 3.2.1 (Johnson-Lindenstrauss lemma) Given  > 0 and any integer N ,
let k be a positive integer such that k ≥ k0 = O
(
log(N)
2
)
. For every set P of N points
in Rd, there exists f : Rd 7→ Rk such that for all u,v ∈ P
(1− )‖u− v‖2 ≤ ‖f(u)− f(v)‖2 ≤ (1 + )‖u− v‖2, (19)
where f(u) and f(v) are the projections of u and v.
Lemma 3.2.1 states that a set of N points in a high-dimensional space can be mapped
onto a k > k0 = O
(
log(N)
2
)
-dimensional subspace such that the distances between
the points are approximately preserved, i.e. not distorted more than by a factor of
1± , for any  > 0. Note that the dimensionality reduction according to Johnson and
Lindenstrauss (1984) depends on the number of points N only, since k is logarithmic
in N and independent of the original dimension d. A proof of this lemma was provided
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by several authors (Dasgupta and Gupta, 1999; Frankl and Maehara, 1988; Indyk and
Motwani, 1998).
3.2.2 Partial Least Squares Correlation
PLSC is a correlation technique that analyzes the association between two data sets
by building orthogonal linear combinations of original variables. The method is com-
prehensively described in Section 2.2.1.4.
3.3 Introduction of PLSC-RP for fast and efficient
multivariate correlation analysis
3.3.1 Random Projection for dimensionality reduction in Par-
tial Least Squares Correlation
Assume that X1 ∈ RN×d1 and X2 ∈ RN×d2 are two data sets, where N is the sample
size and d1 and d2 are the number of variables in X1 and X2, respectively. Both X1
and X2 are column-wise standardized. To model the relationship between X1 and
X2, PLSC successively builds latent variables z1i = X1 · w1i and z2i = X2 · w2i ,
such that at each step the covariance between the pair of latent variables z1i and z2i ,
i = 1, . . . , p, p = min(d1, d2), is maximized (Section 2.2.1.4).
When the number of columns in X1 and X2 is high, PLSC will be computationally
expensive. To address the association between X1 and X2 using a computationally
more efficient approach, I applied RP for dimensionality reduction prior to PLSC. I
denoted the PLSC analysis after dimensionality reduction using RP as PLSC-RP anal-
ysis. RP can be used to reduce the number of variables in X1 (i.e. the neuroimaging
measures), to reduce the number of variables in X2 (i.e. the genetic measures), or
both. Therefore, the high-dimensional matrices X1 and/or X2 are multiplied with
orthonormal random matrices R1 and/or R2. The elements of the random matrices
are generated according to the following algorithm (Dasgupta, 2000):
1. Assign to each entry of the matrix an independently and identically distributed
(i.i.d.) N (0, 1) value.
2. Orthogonalize the k columns of the matrix using the Gram–Schmidt algorithm
(Bjo¨rck, 1967).
3. Normalize the columns of the matrix to unit length.
Orthogonalization is important to preserve distances between the original points in the
low-dimensional space (Kaski, 1998). Unfortunately, enforcing the random matrices to
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be orthogonal requires the Gram–Schmidt algorithm, which is computationally expen-
sive (Sulic´ and others , 2010). However, it has been shown that in high-dimensional
spaces, there exists a much larger number of nearly orthogonal than truly orthogo-
nal vectors (Hecht-Nielsen, 1994). Thus, high-dimensional random matrices might be
sufficiently close to orthogonal (Lin and Gunopulos, 2003) and the orthogonalization
step might be avoided without affecting the distance preserving properties of Random
Projections.
The algorithm introduced by Dasgupta (2000) suggests to generate the elements of R
using a standard normal distribution. Two simpler algorithms for generating sparse
random matrices have been proposed by Achlioptas (2001). Multiplying the input
matrices with sparse rather than dense random matrices increases multiplication effi-
ciency. For proof of concept of PLSC-RP, however, I decided to generate the elements
of the random matrices by a standard normal distribution (Dasgupta, 2000). This
way, I avoided potential inaccuracies in my results due to sparsity, which I later cannot
evaluate when comparing PLSC-RP to its state-of-the-art counterpart PLSC. I mod-
ified the algorithm by Dasgupta (2000) by omitting the orthogonalization using the
Gram–Schmidt algorithm, since in my application random matrices were consistently
high-dimensional.
3.3.2 PLSC-RP for dimensionality reduction in X1 OR X2
Assume that X1 is high-dimensional. RP transforms X1 to a lower dimensional space
via the following transformation:
X1RP = X1 ·R, (20)
whereR ∈ Rd1×k is a random matrix andX1RP ∈ RN×k is the low-dimensional subspace
of X1 with desired lower dimension k. I determined the dimensionality of the low-
dimensional subspace matrix X1RP according to the Menon theorem (Menon, 2007),
which guarantees the preservation of pairwise distances with probability of at least
1−N−β if  ∈ [3
4
, 3
2
]
for
k ≥ k0 := 16 + 8β
2
· log(N). (21)
The parameter  controls the desired accuracy of distance preservation, while β controls
the probability of success. For my applications, I selected  = 1.0 and 1−N−β = 0.95
(yielding β = 0.6505). Note that for the accuracy of the distance preservation  also
values  < 3
4
or  > 3
2
are possible. However, for  ∈ [3
4
, 3
2
]
the Menon bound adapts
best to the lowest reduced dimension of the projection. Accordingly, the term PLSC-
RP denotes the process of building latent variables z1RPi = X1RP · w1RPi and z2i =
X2 · w2i , such that the covariance between the pair of latent variables z1RPi and z2i
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is maximized,
max
|w1RPi |=|w2i |=1
cov(z1RPi , z2i), (22)
where i = 1, . . . , p, p = min(k, d2).
Equation 22 yields weights W2 for data set X2, which are approximations for the
weights computed using traditional PLSC, since X1RP is only a compressed represen-
tation of X1. However, for the reduced data set, weights W1RP of the low-dimensional
subspace X1RP are obtained. To evaluate the contribution of each single variable in
X1, the weightsW1RP are transformed back to the original space, that isW1. Since the
weightsW2 obtained by SVD on the cross-product matrixX
′
1RP
X2 are approximations
for the weights obtained by performing SVD on X
′
1X2, the original weights W1 are
obtained by inserting the weights W2 into the equation for the SVD and rearranging
it as follows:
w1i =
1
si · |w2i|2
·A ·w2i , (23)
where A = X
′
1X2 is the cross-product matrix, si is the singular value of component i,
i = 1, . . . , p, p = min(k, d2), when performing SVD based on X
′
1RP
X2, and component
i is the component explaining the largest proportion of summed squared cross-block
correlations (Bookstein, 1994; McIntosh and others , 1996). The derivation of equation
23 is embodied in equation S1, S2 and S3 of Appendix B. Applying RP to reduce the
number of variables in X2 follows the same logic:
1. dimensionality reduction of X2 using RP,
2. multivariate association analysis of X1 and the compressed data set X2RP using
PLSC,
3. back-transformation of weights W2RP to the original space W2.
PLSC-RP will be significantly faster than traditional PLSC, since it operates on a
matrix with a much smaller number of columns (X1RP ∈ RN×k rather thanX1 ∈ RN×d1
with k  d1). Importantly, permutation testing (Fisher, 1971) can also be performed
on the low-dimensional space.
3.3.3 PLSC-RP for dimensionality reduction in X1 AND X2
Assume that both X1 and X2 are high-dimensional. RP transforms X1 and X2 to
lower dimensional spaces via the following transformation:
X1RP = X1 ·R1,
X2RP = X2 ·R2.
(24)
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The dimensionality of X1RP and X2RP is determined according to Menon (2007). Note
that if X1 and X2 have the same number of variables, it is sufficient to generate a
joint random matrixR for transformation. In general, however, the number of variables
differs between X1 and X2.
Subsequently, PLSC is applied in order to successively build latent variables z1RPi =
X1RP · w1RPi and z2RPi = X2RP · w2RPi , such that the covariance between the pair of
latent variables z1RPi and z2RPi is maximized, i = 1, . . . , p, p = min(k1, k2). Since the
dimensionality in X1 and X2 is reduced by RP, PLSC-RP yields weights W1RP and
W2RP for the low-dimensional subspaces X1RP and X2RP . To evaluate the contribution
of each single variable in X1 and X2, the weights W1RP and W2RP are transformed
back to the original space, that is W1 and W2, as follows:
w1i =
1
si · |w2RPi |2
· cov(X1,X2RP) ·w2RPi ,
w2i =
1
si · |w1RPi |2
· (cov(X1RP ,X2))
′ ·w1RPi ,
(25)
where si is the singular value of component i, i = 1, . . . , p, p = min(k1, k2), when
performing SVD based on X
′
1RP
X2RP , and component i is the component explaining
the largest proportion of summed squared cross-block correlations (Bookstein, 1994;
McIntosh and others , 1996). The derivation of equation 25 is again elucidated in
Appendix B (equations S4, S5 and S6).
3.3.4 Comparison of PLSC and PLSC-RP
To evaluate the performance of PLSC-RP, I compared its weight profiles to the weight
profiles of PLSC applied to the same original data set. For measuring similarity, I
considered three similarity measures: Pearson correlation sP (Anderberg, 1973), the
cosine measure sC (Anderberg, 1973) and the extended Jaccard similarity sJ (Strehl
and Ghosh, 2000). In case the similarity measures sP, sC and sJ equal 1, the weight
profiles of traditional PLSC and PLSC-RP are exactly similar.
In addition to the similarity measures, I used Analysis of Variances (ANOVA; Chambers
and others , 1992) for comparison of PLSC and PLSC-RP weight profiles. The ANOVA
model represents a perfect linear relationship between the weights of PLSC and PLSC-
RP, in case the intercept equals 0 and the slope equals 1.
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3.3.5 Permutation testing
Permutation testing is used to assess the significance of the covariance between the
pair of latent variables
• z1i and z2i , i = 1, . . . , p, p = min(d1, d2) (traditional PLSC),
• z1RPi and z2i , i = 1, . . . , p, p = min(k, d2) (PLSC-RP on X1RP and X2),
• z1RPi and z2RPi , i = 1, . . . , p, p = min(k1, k2) (PLSC-RP on X1RP and X2RP),
respectively. For this purpose, observations, i.e. rows of input matrices, are randomly
reassigned without replacement and PLSC (PLSC-RP, respectively) is recalculated. At
each permutation, the statistic (i.e. the covariance of latent variables) is then compared
to the statistic obtained on the original data with probability value equal to the number
of times the statistic of permuted data exceeds the original value (Section 2.2.2.1).
3.4 Data sets
3.4.1 PLSC-RP for high-dimensional phenotype measures de-
rived from neuroimaging
To illustrate the PLSC-RP methodology for association analysis of brain imaging and
genetic data, I first used the simulation series described in Section 2.3.1.1. The data
set contained high-dimensional simulated brain imaging measures of increasing voxel
numbers (1,000 to 90,000 voxels) and 50 candidate SNPs, recoded by counting the
number of minor alleles per person. The sample size of all data matrices was N = 100.
Since the brain imaging data was simulated using a multivariate normal distribution,
it was scaled metrically and enabled the evaluation of the performance of PLSC-RP
for continuous variables.
In order to perform PLSC-RP, I applied RP to reduce the number of voxels and kept
the raw SNP matrix, since the goal was to search for linear relations between high-
dimensional fMRI measures and a comparably small number of SNPs. To determine the
dimensionality of the low-dimensional fMRI subspace matrices, I adopted the Menon
theorem (Menon, 2007). The Menon lower bound equaled k = 97.6486 (Section 3.3.2
Equation 21). For all subspaces with dimensionality greater than k, it guarantees the
preservation of pairwise distances between original data points with desired accuracy
and probability. Thus, I reduced the number of voxels to 100 dimensions for all con-
sidered dimensionalities of the fMRI data set. After back-transformation, the weight
profiles of PLSC-RP were compared to the weight profiles obtained using traditional
PLSC on the same original data set.
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In order to verify the findings on simulated data, I considered the experimental neu-
roimaging genetics data set introduced in Section 2.3.2. The data set contained whole-
brain fMRI images collected during emotional face-matching task in 208 individuals
from the Norwegian population and genotype information on five SNPs (rs10014254,
rs11722038, rs17529323, rs382013 and rs437633). PLSC-RP analysis was performed
as follows. Since the dimensionality of the fMRI data was high in comparison to the
number of SNPs, I applied RP to reduced the number of voxels and retained raw SNPs.
Specifically, I reduced the dimensionality of the fMRI matrix to 208 dimensions, similar
to sample size, to match the simulation application above (dimensionality of the simu-
lated brain imaging matrix was reduced to 100 dimensions according to Menon (2007),
equal to N = 100). Afterwards, the results of PLSC-RP were compared both, to the
results obtained using traditional PLSC and to the findings in the original publication
(Ousdal and others , 2012).
3.4.2 PLSC-RP for high-dimensional genotypes
In Section 3.4.1, PLSC-RP was used to optimize runtime in an association analy-
sis containing high-dimensional phenotype measures. As phenotype measures, brain
imaging data was considered, which is scaled metrically. In many applications, how-
ever, high-dimensional data is considered that is not continuous. To promote a wider
application of PLSC-RP, I considered a second data set, containing genome-wide SNPs
as genotypes together with candidate phenotype measures. SNP information statisti-
cally represents count data, since SNPs were recoded by counting the number of minor
alleles per person.
To illustrate PLSC-RP for count data, I used a data set that has been published previ-
ously by Breitfeld and others (2013). For the original study, participants were recruited
from the Sorbs population, a self-contained population in Germany. The phenotype
inventory consisted of standardized questionnaire information for past medical history,
of anthropometric data (weight, height, waist-to-hip ratio) and of serum vaspin (Hida
and others , 2005; Silverman and others , 2001) measures extracted from blood after an
overnight fast. Vaspin (visceral adipose tissue-derived serine protease inhibitor) is an
adipokine potentially linking obesity, insulin resistance and type 2 diabetes (Breitfeld
and others , 2013; Klo¨ting and others , 2006; Youn and others , 2008). In total, 907
Sorbs (544 women) were included in the study. SNP genotyping was performed using
an array-based whole-genome assay. For quality control, only SNPs that fulfilled the
following criteria were included:
• missing rate per SNP smaller than 5% (Section 1.2.2.4),
• deviation from the Hardy-Weinberg equilibrium P > 0.0001 (Section 1.2.2.3) and
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• MAF greater 1% (Section 1.2.2.2).
Genome-wide association with serum vaspin was assessed by linear regression in PLINK
(Purcell and others , 2007), correcting for age, gender and BMI. The authors reported
a significant association between serum vaspin concentrations and six SNPs on chro-
mosome 14, rs11160190 (P = 2.4 × 10−15), rs6575436 (P = 2.1 × 10−8), rs4905203
(P = 2.2 × 10−10), rs1956713 (P = 1.2 × 10−9), rs1956721 (P = 3.6 × 10−9) and
rs11621467 (P = 9.2 × 10−10). The SNP rs11160190 maps to the intergenic region
between vaspin (i.e. serpinA12) and serpinA4 (another member of the serine protease
inhibitor family), rs6575436 is directly located in vaspin, rs11621467 maps into the
intergenic region between serpinA11 and serpinA1, and the remaining three SNPs are
downstream of vaspin. Thus, the authors were able to show that genetic variants in
the vaspin gene play a major role in the regulation of circulating serum vaspin con-
centrations. A more detailed description of participants, phenotyping, genotyping and
statistical analysis is provided in the original publication (Breitfeld and others , 2013).
In contrast to the data set described in Section 3.4.1 (high-dimensional fMRI images),
for the current data set, I considered only two experimental phenotypes (serum vaspin
concentration and body height), while the genotype data contained whole-genome SNP
information (359,845 SNPs for 865 individuals (497 women) after quality control and
removal of missing data). Hence, RP was applied to reduce the number of SNPs and the
raw phenotype matrix was kept. I adopted the analysis strategy from Section 3.4.1. For
PLSC-RP, I reduced the dimensionality of the SNP matrix to 865 dimensions, similar
to sample size, in order to match previous applications (Section 3.4.1). After back-
transformation, the weight profiles of PLSC-RP were compared to the weight profiles
obtained using traditional PLSC considering all 359,845 SNPs. The findings from the
original publication (Breitfeld and others , 2013) served as a reference.
3.4.3 PLSC-RP for high-dimensional neuroimaging measures
and high-dimensional SNPs
In Section 3.4.1 and 3.4.2, I illustrated the PLSC-RP methodology when either the
neuroimaging or the SNP data set was high-dimensional. However, in genetic neu-
roimaging research both data sets are naturally high-dimensional. Therefore, I gener-
ated simulation data, containing high-dimensional fMRI measures as phenotypes and
high-dimensional SNPs as genotypes, as described previously in Section 2.3.1. I sim-
ulated the brain imaging data using multivariate normal distribution with mean and
covariance parameters estimated from experimental fMRI contrast images. SNPs were
generated using the gs algorithm (Li and Chen, 2008). In particular, I simulated fMRI
and SNP data of six dimensionality combinations.
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1–4 I stepwise increased the dimensionality of both the fMRI and the SNP data set,
such that they contained 1,000, 10,000, 20,000 or 40,000 voxels and SNPs.
5 The dimensionality of the fMRI data was higher than the dimensionality of the
SNP data with 50,000 voxels and 1,000 SNPs, respectively.
6 The dimensionality of the fMRI data was lower than the dimensionality of the
SNP data with 1,000 voxels and 50,000 SNPs, respectively.
The sample size was chosen to be 100 for both data matrices and all combinations of
simulated data. For each dimensionality combination, a linear relationship between
one randomly selected voxel and three SNPs with MAF greater 0.2 was induced, such
that the pairwise correlation between that voxel, voxels in collinearity with the selected
voxel and the selected SNPs was on average 0.3. Since the simulated data contained
high-dimensional brain imaging and high-dimensional genetic measures, RP was used
to reduce both the number of voxels and the number of SNPs. To determine the dimen-
sionality of the low-dimensional subspace matrices of the two modalities, I adopted the
Menon theorem (Menon, 2007) and reduced the number of variables to 100 dimensions
for all considered dimensionality combinations.
3.5 Quality control of PLSC-RP results
3.5.1 Comparison of PLSC-RP with / without Gram–Schmidt
orthogonalization
For dimensionality reduction using RP, random matrices need to be orthogonalized in
order to preserve distances between the original points in the low-dimensional space.
Unfortunately, Gram–Schmidt orthogonalization is computationally expensive. How-
ever, it has been shown by Hecht-Nielsen (1994) that in high-dimensional spaces,
there already exists a large number of nearly orthogonal vectors, such that high-
dimensional random matrices are sufficiently close to orthogonal and orthogonaliza-
tion using the Gram–Schmidt algorithm can be omitted. In order to quantify whether
Gram–Schmidt orthogonalization is necessary in high-dimensional genetic neuroimag-
ing data sets, I reran PLSC-RP on the simulated data sets introduced in Section
3.4.1 (high-dimensional phenotype measures derived from neuroimaging) once using
the Gram–Schmidt algorithm to orthogonalize random matrices and once without or-
thogonalization. I selected this data set, since orthogonalization was feasible within a
reasonable timeframe. The random matrices for the analyses with and without Gram–
Schmidt orthogonalization were the same but differed from the random matrices in
Section 3.4.1. I compared
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1. the weights of traditional PLSC and of PLSC-RP using random matrices that
were orthogonalized using Gram–Schmidt algorithm,
2. the weights of traditional PLSC and of PLSC-RP when I omitted Gram–Schmidt
orthogonalization,
3. the weights of PLSC-RP using random matrices with and without Gram–Schmidt
orthogonalization,
using the similarity measures Pearson correlation, cosine measure and extended Jaccard
similarity as well as ANOVA, following the procedure described in Section 3.3.4.
3.5.2 Variability of PLSC-RP results
For PLSC-RP, the dimensionality of data matrices is reduced using RP. Thus, the
results will vary slightly in every run of the algorithm due to the random draw of the
random matrices R in Equation 20 or R1 and R2 in Equation 24. In order to quantify
this variability, I reran the analyses from the previous sections (Sections 3.4.1, 3.4.2
and 3.4.3) ten times each using different random matrices in every run of PLSC-RP.
Specifically, for each phenotypic and genetic variable, I computed the variance of PLSC-
RP weights as well as the average percentage deviation of weights over the ten runs.
3.6 Results
3.6.1 PLSC-RP for high-dimensional neuroimaging measures
- continuous data
First, I compared the performance of traditional PLSC and PLSC-RP on simulated
brain imaging data of increasing dimensionality and candidate SNPs (Section 2.3.1.1
and 3.4.1). My findings are reported in Grellmann and others (2016). More detailed
results of traditional PLSC have already been presented in Section 2.4.1.1.
To evaluate the performance of PLSC-RP relative to its benchmark PLSC, I compared
the two strategies with respect to the causal component, as defined by CHull using the
cumulative out-of-sample covariance as measure of fit, the significance of the covariance
between latent variables, as assessed by permutation testing, and the runtime (Table
10). For both methods and for all simulated dimensionalities, causal voxels and SNPs
were represented in the first component, which is associated with the highest covariance,
and covariances between latent variables were significant. However, PLSC and PLSC-
RP differed considerably in runtime. Importantly, the higher the number of simulated
voxels, the more efficient was the dimensionality reduction to 100 dimensions using RP.
At maximum, runtime was reduced from 4.2 hours to 35.8 seconds using a standard
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computer with usual processing power and memory (physical memory: 192 Gi, physical
CPUs: two Intel Xeon E5630 CPUs with frequency 2.53GHz and 4 cores).
Table 10: PLSC and PLSC-RP results for high-dimensional neuroimaging data
The dimensionality of the simulated fMRI data was increased stepwise from 1,000 to 90,000
voxels. The number of SNPs was constant. The table contrasts the results of traditional
PLSC (top row) and PLSC after dimensionality reduction of the fMRI data set to 100 dimen-
sions using RP (bottom row) with regard to the component representing the causal pattern,
the P -value of permutation testing for the causal component, and total processing time for
performing 5000 permutations (in seconds). The last column illustrates the proportion of
processing times of PLSC-RP (black) compared to traditional PLSC (gray).
type of dim. of dim. of causal
P -value
processing
ratio
PLS analysis fMRI data SNP data comp. time
PLSC 1,000
50 1
0.0024∗∗ 199.325s
PLSC-RP 100 0.0012∗∗ 34.163s
PLSC 10,000
50 1
0.0133∗ 1738.054s
PLSC-RP 100 0.0125∗ 37.207s
PLSC 20,000
50 1
0.0002∗∗∗ 3958.958s
PLSC-RP 100 0.0002∗∗∗ 31.708s
PLSC 30,000
50 1
0.0114∗ 5949.062s
PLSC-RP 100 0.0106∗ 32.225s
PLSC 40,000
50 1
0.0116∗ 7595.316s
PLSC-RP 100 0.0784∗ 33.495s
PLSC 50,000
50 1
0.0006∗∗∗ 8735.047s
PLSC-RP 100 0.0002∗∗∗ 33.495s
PLSC 70,000
50 1
0.0040∗∗ 11671.470s
PLSC-RP 100 0.0084∗∗ 35.421s
PLSC 90,000
50 1
0.0132∗ 15112.120s
PLSC-RP 100 0.0118∗ 35.767s
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
I further compared PLSC and PLSC-RP with regard to how the individual voxels
and SNPs were weighted. A sample illustration of voxel and SNP weights of PLSC
for 90,000 simulated voxels and of PLSC-RP, when the dimensionality of the fMRI
data set was reduced to 100 dimensions, is provided in Figure 19. Using both PLSC
and PLSC-RP, causal voxels and SNPs, as highlighted in yellow and red, received the
highest weights. Note that in Figure 19, SNP 33 was detected by neither PLSC nor
PLSC-RP, since its association to the causal voxel was weaker than for the other two
causal SNPs by chance (Section 2.4.1.1).
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Figure 19: PLSC and PLSC-RP weights for high-dimensional neuroimaging data
(a) Voxel weight profile and (c) SNP weight profile of the causal PLSC component for 90,000
simulated voxels. (b) Voxel weight profile and (d) SNP weight profile of the causal PLSC-RP
component after dimensionality reduction of the fMRI data set to 100 dimensions. PLSC
and PLSC-RP provide a weight for each voxel and each SNP. The causal voxel and causal
SNPs (red), and voxels in collinearity with the causal voxel (yellow), receive higher weights
than non-causal voxels and SNPs (blue). For visualization purpose, the voxel weight profiles
of PLSC and PLSC-RP (a,b) are zoomed in on a range of 100 voxels around the causal voxel.
Average weights for causal and non-causal voxels and SNPs of PLSC and PLSC-RP
are presented in Table 11. It indicates that voxel and SNP weights were highly similar
across strategies for all simulated dimensionalities of the fMRI data set. This was
confirmed by three similarity measures (Table 12). For all simulated dimensionalities
of the fMRI data set, I observed a Pearson correlation of sP ≈ 1, a cosine measure of
sC ≈ 1 and an extended Jaccard similarity of sJ ≈ 1. In addition, the intercepts of
the ANOVA models were approximately equal to 0 and the slopes were approximately
equal to 1 (Table 12). All P -values were smaller than 2 · 10−16.
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Table 11: Average PLSC and PLSC-RP weights for high-dimensional neuroimaging
data
The table shows average PLSC weights and average PLSC-RP weights for causal voxels and
causal SNPs as compared to non-causal voxels and non-causal SNPs. Causal voxels and
causal SNPs receive higher weights than non-causal voxels and SNPs. Average weights are
very similar for PLSC and PLSC-RP.
dimensionality
PLS analysis
|w¯MRI| for |w¯MRI| for |w¯SNP| for |w¯SNP| for
of MRI data causal voxels non-causal voxels causal SNPs non-causal SNPs
1,000
PLSC 0.0503 0.0256 0.3395 0.0976
PLSC-RP 0.0506 0.0255 0.3314 0.0995
10,000
PLSC 0.0152 0.0078 0.3863 0.0901
PLSC-RP 0.0152 0.0078 0.3710 0.0911
20,000
PLSC 0.0116 0.0054 0.3440 0.0934
PLSC-RP 0.0114 0.0055 0.3266 0.0919
30,000
PLSC 0.0104 0.0044 0.3877 0.0881
PLSC-RP 0.0104 0.0045 0.3856 0.0898
40,000
PLSC 0.0089 0.0041 0.3663 0.0928
PLSC-RP 0.0086 0.0041 0.3533 0.0937
50,000
PLSC 0.0084 0.0039 0.3143 0.0993
PLSC-RP 0.0086 0.0039 0.3123 0.1019
70,000
PLSC 0.0061 0.0033 0.3325 0.1005
PLSC-RP 0.0058 0.0034 0.3226 0.0973
90,000
PLSC 0.0058 0.0029 0.2873 0.1074
PLSC-RP 0.0057 0.0029 0.2772 0.1091
Table 12: Similarity of PLSC and PLSC-RP weights for high-dimensional neuroimaging
data
PLSC-RP weight profiles were compared to the weight profiles obtained using traditional
PLSC by applying three similarity measures, Pearson correlation, the cosine measure and the
extended Jaccard similarity. In addition, ANOVA was used for comparison. The ANOVA
model represents a perfect linear relationship between the weights of PLSC and PLSC-RP,
in case the intercept equals 0 and the slope equals 1.
dim.
similarity coefficients ANOVA for similarity coefficients ANOVA for
for fMRI data fMRI data for SNP data SNP data
Pear-
cosine
extended inter-
slope
Pear-
cosine
extended inter-
slope
son’s r Jaccard cept son’s r Jaccard cept
1,000 0.9998 0.9998 0.9997 0.0007 0.9823 0.9979 0.9978 0.9957 -0.0015 0.9980
10,000 0.9966 0.9979 0.9958 -0.0002 1.0078 0.9883 0.9887 0.9777 0.0023 0.9853
20,000 0.9935 0.9961 0.9922 -0.0001 0.9834 0.9805 0.9806 0.9620 0.0023 0.9829
30,000 0.9948 0.9972 0.9944 -0.0001 0.9822 0.9819 0.9824 0.9654 -0.0006 0.9817
40,000 0.9869 0.9912 0.9826 -0.0004 0.9409 0.9727 0.9723 0.9460 0.0047 0.9754
50,000 0.9982 0.9993 0.9986 -0.0001 0.9797 0.9906 0.9908 0.9818 0.0022 0.9940
70,000 0.9800 0.9935 0.9872 -0.0003 1.0707 0.9741 0.9743 0.9499 -0.0038 0.9791
90,000 0.9974 0.9990 0.9980 −9.11 · 10−5 0.9768 0.9914 0.9910 0.9821 -0.0041 0.9906
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To verify the findings on simulated data, I compared the results of traditional PLSC
and PLSC-RP regarding experimental genetic neuroimaging data collected during emo-
tional face-matching task in a group of psychiatric patients and a group of healthy
controls from the Norwegian population (Section 2.3.2 and 3.4.1, Ousdal and others ,
2012). For both PLSC and PLSC-RP, I considered only SNP and voxel weights of the
first component, since it already explained a large proportion of summed squared cross
block correlations (72.76% and 69.08% for PLSC and PLSC-RP, respectively). The
covariance of latent variables was significant by permutation testing (P = 0.0276 and
P = 0.0490 for PLSC and PLSC-RP, respectively). I found that using both, PLSC
and PLSC-RP, exactly the same three SNPs (rs10014254, rs11722038 and rs17529323)
as reported by Ousdal and others (2012) in the original publication were reliable. An
illustration of voxels related to these SNPs is provided in Figure 20. I was able to
replicate an association with amygdala activity in both hemispheres (Ousdal and oth-
ers , 2012). Importantly, I found additional brain regions involved during emotional
face-matching task, including cerebellum, left hippocampus, left lingual gyrus, right
putamen and left lateral occipital cortex. Note that the results of traditional PLSC
have already been introduced in Section 2.4.2.
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PLSC-RP
computation time 13.4 seconds
PLSC
computation time 2.4 hours
a
b
Figure 20: Voxels associated to the SNPs rs10014254, rs11722038 and rs17529323 dur-
ing fMRI face-matching task using PLSC and PLSC-RP
(a) Voxel weight profile of PLSC considering whole-brain. (b) Voxel weight profile of PLSC-
RP after dimensionality reduction of the fMRI data set to 208 dimensions. Only voxels with
top 50% weights are shown. PLSC and PLSC-RP weights are highly overlapping and largest
weights are provided for voxels located in amygdala (x = −22, y = −4, z = −12, x = 18,
y = −4, z = −12), cerebellum (x = −28, y = −54, z = −20, x = 22, y = −54, z = −16),
hippocampus (x = −32, y = −10, z = −14), lingual gyrus (x = −20, y = −46, z = −4),
putamen (x = 28, y = 4, z = −2) and lateral occipital cortex (x = −30, y = −66, z = 28).
Figure 20 illustrates that the voxel weight profiles of PLSC and PLSC-RP were highly
similar. This was confirmed by three similarity measures (Pearson correlation sP =
0.9991, cosine measure sC = 0.9992 and Jaccard similarity sJ = 0.9985) as well as
ANOVA (intercept = 2.14 ·10−5, slope = 0.9948 and P < 2 ·10−16), and is summarized
in Table 13. PLSC-RP was, however, remarkably faster than PLSC, reducing runtime
from 2.4 hours to 13.4 seconds.
Table 13: Average PLSC and PLSC-RP weights for the fMRI face-matching task
Average weights for causal and non-causal voxels and SNPs are highly similar for PLSC and
PLSC-RP.
PLS |w¯MRI| for |w¯MRI| for |w¯SNP| for |w¯SNP| for
analysis causal voxels non-causal voxels causal SNPs non-causal SNPs
PLSC 0.0059 0.0017 0.5768 0.0296
PLSC-RP 0.0059 0.0017 0.5757 0.0467
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3.6.2 PLSC-RP for high-dimensional SNPs - count data
In Section 3.6.1, I showed that PLSC-RP is remarkably faster than PLSC when applied
to high-dimensional neuroimaging measures. Next, I illustrate the performance of
PLSC-RP for association analysis of a data set containing genome-wide SNPs together
with candidate phenotype measures (Section 3.4.2, Breitfeld and others , 2013). In
contrast to the brain imaging data in Section 3.6.1, which was scaled metrically, SNP
information statistically represents count data, since SNPs were recoded by counting
the number of minor alleles per person.
I observed that both PLSC and PLSC-RP revealed a two component solution. In the
first component of the phenotype weight profile, serum vaspin level was highly weighted
(|wvaspin| = 0.7068 for both PLSC and PLSC-RP). Body height was most contributing
to the second component (|wheight| = 0.9994 for PLSC and |wheight| = 0.9996 for PLSC-
RP). Both components were significant by permutation testing (Pvaspin < 2.2 × 10−16
and Pheight = 0.02 for both PLSC and PLSC-RP). Since the out-of-sample covariance
was much higher for the first component (covvaspin = 6.69 and covheight = 0.89), I
restricted my interpretation to associations with serum vaspin. The overall runtime for
PLSC was 36.4 hours. PLSC-RP reduced it to 4.8 minutes.
An illustration of the SNPs, which were associated with serum vaspin concentrations
in the Sorbs, is provided in Figure 21. According to the bootstrap method, exactly
the same SNPs on chromosome 14 that were reported in the original publication by
Breitfeld and others (2013) were reliable, including rs11160190, rs6575436, rs4905203,
rs1956713 and rs11621467. I did not find an association for rs1956721 because I had to
exclude this SNP due to its low call rate. The SNP weight profiles of PLSC and PLSC-
RP were highly similar (Pearson correlation sP = 0.9999, cosine measure sC = 0.9999,
Jaccard similarity sJ = 0.9999, ANOVA intercept = −1.95 · 10−8, slope = 0.9999993
and P < 2 · 10−16, Table 14).
100
Claudia Grellmann 3 DIMENSIONALITY REDUCTION USING RP
PLSC 
 computation time 36.4 hours
SNP
SN
P 
we
ig
ht
287,001 287,034 287,067 287,100
−
0.
01
0
0.
00
0
0.
00
5
0.
01
0
l
l
l
l
ll
ll
llllll
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
lll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
lll
l
l
l
l
l
l
l
lll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
ll
l
l
rs11621467
rs4905203
rs1956713
rs6575436
rs11160190
a      SNP weight profile of PLSC
PLSC−RP 
 computation time 4.8 min
SNP
SN
P 
we
ig
ht
287,001 287,034 287,067 287,100
−
0.
01
0
0.
00
0
0.
00
5
0.
01
0
l
l
l
l
ll
ll
llllll
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
lll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
lll
l
l
l
l
l
l
l
lll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
lll
l
l
l
ll
l
l
rs11621467
rs4905203
rs1956713
rs6575436
rs11160190
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Figure 21: SNPs associated with serum vaspin concentration using PLSC and PLSC-
RP
(a) SNP weight profile of PLSC applied to the original data set containing 359,845 SNPs.
(b) SNP weight profile of PLSC-RP after dimensionality reduction of the SNP data set to
865 dimensions. Reliable SNPs according to the bootstrap method are plotted in red. For
visualization purpose, the SNP weight profiles are zoomed in on a range representing causal
variants.
Table 14: Average SNP weights for PLSC and PLSC-RP in the Sorbs
The table shows average PLSC weights and average PLSC-RP weights for causal and non-
causal SNPs. In addition, it is illustrated how serum vaspin and body height are weighted in
the first component of the phenotype weight profile.
PLS |wVaspin| |wHeight| |w¯SNP| for |w¯SNP| foranalysis causal SNPs non-causal SNPs
PLSC 0.7068 0.0285 0.0093 0.0013
PLSC-RP 0.7068 0.0294 0.0093 0.0013
3.6.3 PLSC-RP for high-dimensional neuroimaging measures
and high-dimensional SNPs - continuous and count data
According to the results presented in Section 3.6.1 and 3.6.2, PLSC-RP provides sta-
tistically highly similar results to PLSC when dimensionality reduction of either one
of the two data sets searched for association is performed. However, PLSC-RP will be
of universal application if it addresses both at the same time. Therefore, I compared
the results of PLSC-RP to the results obtained using traditional PLSC for simulation
data containing high-dimensional fMRI measures and high-dimensional SNPs (Section
3.4.3).
As for the simulation results on high-dimensional neuroimaging data (Section 3.6.1),
causal voxels and SNPs were represented in the first component for all dimensionality
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combinations and for both PLSC and PLSC-RP (Table 15). The covariances between
latent variables were non-significant, since chance correlations have a considerable effect
in multivariate models, such as PLSC, when variable numbers in both data sets are ex-
cessively high compared to sample size. In terms of runtime, PLSC-RP was remarkably
faster than traditional PLSC. At maximum, runtime was reduced from ca. 3,757 hours
to 1.2 minutes. Note that only 250 or 100 permutations were performed for 20,000
or 40,000 simulated voxels and SNPs, respectively, which is insufficient to achieve a
confident precision of the test. However, for data sets with very high dimensionality, a
much larger number of permutations is infeasible without having access to a powerful
compute server. In fact, the actual P -value of permutation testing was not of primary
interest for this study, since simulated data was analyzed, for which the underlying
properties are known. Instead, the goal was to provide evidence that PLSC-RP results
are highly similar to the results obtained using traditional PLSC, even though process-
ing time is substantially reduced. For real data applications, however, resampling is
much more important in order to verify evinced associations.
Table 15: PLSC and PLSC-RP results for high-dimensional neuroimaging and high-
dimensional SNP data
Simulated fMRI and SNP data of six different dimensionality combinations was generated.
The table contrasts the results of traditional PLSC on the raw data (top row) and PLSC-RP
for reduced voxel and SNP data sets of 100 dimensions, respectively (bottom row). Results
are compared with regard to the component representing the causal pattern, the P -value of
permutation testing for the causal component, and total processing time for performing 5000
permutations (1000 permutations for 10,000 simulated voxel and SNPs, 250 permutations for
20,000 simulated voxels and SNPs, and 100 permutations for 40,000 simulated voxels and
SNPs due to runtime). The last column illustrates the proportion of processing times of
PLSC-RP (black) compared to traditional PLSC (gray).
type of dim. of dim. of causal
P -value
processing
ratio
PLS analysis fMRI data SNP data comp. time
PLSC 1,000 1,000
1
0.2116 5.3h
PLSC-RP 100 100 0.1440 1.11min
PLSC 10,000 10,000
1
0.3182 652.6h
PLSC-RP 100 100 0.4582 1.07min
PLSC 20,000 20,000
1
0.4554 1184.7h
PLSC-RP 100 100 0.5322 1.15min
PLSC 40,000 40,000
1
0.333 3756.6h
PLSC-RP 100 100 0.5184 1.17min
PLSC 50,000 1,000
1
0.1951 149.2h
PLSC-RP 100 100 0.2344 1.28min
PLSC 1,000 50,000
1
0.3358 184.8h
PLSC-RP 100 100 0.1586 1.09min
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001
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Sample illustrations of voxel and SNP weights for 1,000 voxels and 50,000 SNPs (di-
mensionality combination 6) are provided in Figure 22. In general, using both PLSC
and PLSC-RP, causal voxels and SNPs got the highest weights. Weight profiles of
PLSC and PLSC-RP were comparably similar (Table 16 and 17). However, compared
to the applications of RP for dimensionality reduction of high-dimensional continuous
(Section 3.6.1) or high-dimensional count data (Section 3.6.2), the degree of similarity
was reduced, on average, from 0.99 to 0.94. The two approaches, PLSC and PLSC-RP,
mainly differed in terms of weights provided for non-causal voxels and SNPs, whereas
the weights for causal variables were approximately equal. Note that in Figure 22 the
magnitude of PLSC and PLSC-RP voxel and SNP weights is comparably similar (es-
pecially for causal variables), whereas the direction of weights is reversed. However,
the direction of weights is irrelevant, as long as the sign of both voxel and SNP weights
is reversed for PLSC-RP compared to PLSC.
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Figure 22: PLSC and PLSC-RP weights for high-dimensional neuroimaging and high-
dimensional SNP data
(a) Voxel weight profile and (c) SNP weight profiles of the causal PLSC component for 1,000
simulated voxels and 50,000 simulated SNPs. (b) Voxel weight profile and (d) SNP weight
profiles of the causal PLSC-RP component after dimensionality reduction of both data sets
to 100 dimensions. The causal voxel and causal SNPs (red), and voxels in collinearity with
the causal voxel (yellow), receive higher weights than non-causal voxels and SNPs (blue). In
addition to the causal SNPs, several other SNPs were found to be highly weighted, such as
SNP 49,279 (bottom row, highlighted in yellow). For visualization purpose, the voxel weight
profiles (a,b) and the SNP weight profiles (c,d) are zoomed in on a range representing causal
variants.
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In addition to the causal SNPs highlighted in red in Figure 22, several other SNPs
were provided with high weights by PLSC and PLSC-RP, including e.g. SNP 14,891,
SNP 20,330, SNP 22,630, SNP 23,349 and SNP 49,279 in the case of dimensionality
combination 6. All of these SNPs were actually linked to the causal voxel, as revealed by
means of Pearson correlation (rSNP 14,891 = −0.3857, rSNP 20,330 = −0.3471, rSNP 22,630 =
−0.3230, rSNP 23,349 = −0.3293 and rSNP 49,279 = 0.3825). For the other dimensionality
combinations (1-5), additional SNPs provided with high weights are summarized in
Table 16.
Table 16: Average PLSC and PLSC-RP weights for high-dimensional neuroimaging
and high-dimensional SNP data
Causal voxels and causal SNPs receive higher weights than non-causal voxels and SNPs.
Average weights are very similar for PLSC and PLSC-RP. In addition to the causal SNPs,
some other SNPs are provided with high weights by PLSC and PLSC-RP. The average weight
of these additional SNPs is given in column
”
|w¯SNP| for additional SNPs“. All additional SNPs
are actually linked to the causal voxel, as revealed by means of Pearson correlation.
dim. dim. type of |w¯MRI| for |w¯MRI| for |w¯SNP| for |w¯SNP| for |w¯SNP| for
of MRI of SNP PLS causal non-causal causal additional non-causal
data data analysis voxels voxels SNPs SNPs SNPs
1,000 1,000
PLSC 0.0405 0.0288 0.0947 0.10001 0.0246
PLSC-RP 0.0435 0.0279 0.0985 0.09951 0.0245
10,000 10,000
PLSC 0.0158 0.0077 0.0370 0.03482 0.0080
PLSC-RP 0.0151 0.0078 0.0368 0.03582 0.0079
20,000 20,000
PLSC 0.0116 0.0054 0.0256 0.02923 0.0056
PLSC-RP 0.0106 0.0056 0.0240 0.03083 0.0056
40,000 40,000
PLSC 0.0092 0.0041 0.0179 0.01894 0.0040
PLSC-RP 0.0092 0.0040 0.0187 0.01824 0.0040
50,000 1,000
PLSC 0.0078 0.0040 0.1073 0.11165 0.0244
PLSC-RP 0.0070 0.0039 0.0952 0.10725 0.0246
1,000 50,000
PLSC 0.0395 0.0290 0.0150 0.01786 0.0036
PLSC-RP 0.0361 0.0293 0.0142 0.01756 0.0036
1 Additional SNPs for 1,000 simulated voxels and SNPs: SNP 269 (r = −0.3292), SNP 748
(r = −0.2948), SNP 782 (r = −0.2829), SNP 969 (r = 0.2753).
2 Additional SNPs for 10,000 simulated voxels and SNPs: SNP 4,140 (r = 0.3389), SNP 6,337
(r = 0.3306), SNP 7,224 (r = 0.3211), SNP 7,460 (r = −0.2912), SNP 7,635 (r = 0.3302),
SNP 8,745 (r = 0.3499).
3 Additional SNPs for 20,000 simulated voxels and SNPs: SNP 697 (r = −0.3219), SNP 4,174
(r = −0.4237), SNP 10,351 (r = 0.4265), SNP 14,898 (r = 0.3773), SNP 19,682 (r = −0.3739).
4 Additional SNPs for 40,000 simulated voxels and SNPs: SNP 21,145 (r = 0.4424),
SNP 23,796 (r = −0.3801), SNP 23,932 (r = 0.2900), SNP 25,536 (r = −0.3392),
SNP 33,245 (r = −0.3861).
5 Additional SNPs for 50,000 simulated voxels and 1,000 SNPs: SNP 235 (r = 0.3342),
SNP 841 (r = −0.3228).
6 Additional SNPs for 1,000 simulated voxels and 50,000 SNPs: SNP 14,891 (r = −0.3857),
SNP 20,330 (r = −0.3471), SNP 22,630 (r = −0.3230), SNP 23,349 (r = −0.3293),
SNP 49,279 (r = 0.3825).
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Table 17: Similarity of PLSC and PLSC-RP weights for high-dimensional neuroimaging
and high-dimensional SNP data
The table summarizes the results of the comparison of PLSC and PLSC-RP weight profiles
using three different similarity measures, Pearson correlation, the cosine measure and the
extended Jaccard similarity. In addition, ANOVA was used for comparison.
dim. dim. similarity coefficients ANOVA for similarity coefficients ANOVA for
of of for fMRI data fMRI data for SNP data SNP data
fMRI SNP Pear-
cosine
extended inter-
slope
Pear-
cosine
extended inter-
slope
data data son’s r Jaccard cept son’s r Jaccard cept
1,000 1,000 0.9378 0.9890 0.9782 0.0039 0.8771 0.9886 0.9886 0.9774 -0.0002 0.9887
10,000 10,000 0.9691 0.9829 0.9664 0.0008 0.9260 0.9845 0.9845 0.9695 3.61 · 10−5 0.9846
20,000 20,000 0.8816 0.9150 0.8432 -0.0019 0.7638 0.9402 0.9402 0.8872 −4.58 · 10−5 0.9402
40,000 40,000 0.8252 0.8945 0.8092 0.0004 0.8373 0.9306 0.9307 0.8704 −5.77 · 10−6 0.9306
50,000 1,000 0.8865 0.9618 0.9265 -0.0012 0.7378 0.9522 0.9928 0.9857 0.0004 0.9525
1,000 50,000 0.9554 0.9928 0.9857 -0.0001 0.9888 0.9895 0.9895 0.9793 −1.03 · 10−5 0.9895
3.6.4 Comparison of PLSC-RP with / without Gram–Schmidt
orthogonalization
In order to quantify whether orthogonalization using Gram–Schmidt algorithm is es-
sential or whether random matrices are already sufficiently close to orthogonal in high-
dimensional genetic neuroimaging analyses, I reran the analyses from Section 3.4.1
once using the Gram–Schmidt algorithm to orthogonalize random matrices and once
without orthogonalization. Specifically, I compared
1. the weights of traditional PLSC and of PLSC-RP using random matrices that
were orthogonalized using Gram–Schmidt algorithm,
2. the weights of traditional PLSC and of PLSC-RP when I omitted Gram–Schmidt
orthogonalization,
3. the weights of PLSC-RP using random matrices with and without Gram–Schmidt
orthogonalization.
Results are illustrated in Table 18.
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Table 18: Similarity of weights of traditional PLSC and of PLSC-RP using random
matrices with and without Gram–Schmidt orthogonalization
The Table compares the weights of traditional PLSC and of PLSC-RP with and without
Gram–Schmidt orthogonalization using three similarity measures (Pearson correlation, the
cosine measure and the extended Jaccard similarity) as well as ANOVA. (A) Comparison of
weights of traditional PLSC and of PLSC-RP using random matrices that were orthogonalized
using Gram–Schmidt algorithm. (B) Comparison of weights of traditional PLSC and of
PLSC-RP when Gram–Schmidt orthogonalization was omitted. (C) Comparison of weights
of PLSC-RP using random matrices with and without Gram–Schmidt orthogonalization.
dim. comp.
similarity coefficients ANOVA for similarity coefficients ANOVA for
for fMRI data fMRI data for SNP data SNP data
Pear-
cosine
extended inter-
slope
Pear-
cosine
extended inter-
slope
son’s r Jaccard cept son’s r Jaccard cept
1,000
A 0.9954 0.9977 0.9954 0.0019 0.9505 0.9891 0.9890 0.9783 0.0012 0.9891
B 0.9940 0.9969 0.9939 0.0022 0.9421 0.9861 0.9861 0.9725 0.0009 0.9861
C 0.9998 0.9999 0.9998 -0.0003 0.9923 0.9994 0.9994 0.9988 0.0003 0.9994
10,000
A 0.9981 0.9987 0.9975 -0.0002 1.0147 0.9919 0.9920 0.9841 0.0034 0.9872
B 0.9976 0.9983 0.9966 -0.0003 1.0201 0.9905 0.9905 0.9812 0.0044 0.9846
C 0.9998 0.9998 0.9997 0.0001 1.0056 0.9996 0.9996 0.9992 -0.0009 0.9984
20,000
A 0.9965 0.9979 0.9959 6.22 · 10−5 1.0037 0.9914 0.9915 0.9832 -0.0008 0.9909
B 0.9967 0.9981 0.9961 4.55 · 10−5 1.0023 0.9918 0.9919 0.9840 -0.0011 0.9910
C 0.9999 0.9999 0.9999 −1.74 · 10−5 0.9984 0.9999 0.9999 0.9999 -0.0003 0.9997
30,000
A 0.9932 0.9972 0.9944 −1.32 · 10−4 0.9807 0.9800 0.9806 0.9619 0.0002 0.9809
B 0.9930 0.9972 0.9944 −1.39 · 10−4 0.9799 0.9794 0.9800 0.9608 0.0004 0.9805
C 0.9999 0.9999 0.9999 5.60 · 10−6 0.9993 0.9999 0.9999 0.9999 -0.0002 1.0002
40,000
A 0.9855 0.9896 0.9793 −4.75 · 10−4 0.9295 0.9666 0.9667 0.9356 −7.68 · 10−4 0.9665
B 0.9860 0.9900 0.9802 −4.63 · 10−4 0.9313 0.9682 0.9683 0.9385 −8.41 · 10−4 0.9680
C 0.9999 0.9999 0.9999 1.03 · 10−5 1.0013 0.9999 0.9999 0.9998 −8.85 · 10−5 0.9999
50,000
A 0.9942 0.9977 0.9955 −2.17 · 10−4 0.9584 0.9831 0.9821 0.9648 -0.0078 0.9750
B 0.9940 0.9977 0.9954 −2.24 · 10−4 0.9571 0.9826 0.9816 0.9639 -0.0080 0.9744
C 0.9999 0.9999 0.9999 6.70 · 10−6 0.9988 0.9999 0.9999 0.9999 0.0001 0.9998
70,000
A 0.9944 0.9984 0.9967 9.79 · 10−5 0.9765 0.9896 0.9894 0.9791 -0.0039 0.9943
B 0.9943 0.9983 0.9967 9.47 · 10−5 0.9772 0.9894 0.9892 0.9787 -0.0040 0.9943
C 0.9999 0.9999 0.9999 3.67 · 10−6 1.0008 0.9999 0.9999 0.9999 0.0002 1.0002
90,000
A 0.9935 0.9977 0.9955 −1.07 · 10−4 0.9718 0.9858 0.9858 0.9720 −8.68 · 10−4 0.9856
B 0.9934 0.9977 0.9954 −1.07 · 10−4 0.9716 0.9856 0.9856 0.9716 −9.41 · 10−4 0.9853
C 0.9999 0.9999 0.9999 −4.33 · 10−7 0.9999 0.9999 0.9999 0.9999 −7.29 · 10−5 0.9999
Table 18 shows that the similarity between the weights of traditional PLSC and PLSC-
RP using Gram–Schmidt algorithm for orthogonalization was only slightly higher than
(for 1,000, 10,000 and 40,000 voxels) or close to identical to (for 20,000, 30,000, 50,000,
70,000 and 90,000 voxels) the similarity between the weights of traditional PLSC and
PLSC-RP when Gram–Schmidt orthogonalization was omitted. Furthermore, the sim-
ilarity between the weights of PLSC-RP with and without Gram–Schmidt orthogo-
nalization was higher than the similarity between the weights of either method and
traditional PLSC. More specifically, the higher the dimensionality of the simulated
fMRI data and therefore the higher the number of rows of the random matrices, the
higher was the similarity between the weights of PLSC-RP with and without Gram–
Schmidt orthogonalization (e.g. Pearson correlation for 1,000 voxels sPMRI = 0.9998 and
sPSNP = 0.9923, Pearson correlation for 10,000 voxels s
P
MRI = 0.9998 and s
P
SNP = 0.9996,
Pearson correlation for 20,000 voxels or more sPMRI = 0.9999 and s
P
SNP = 0.9999).
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Therefore, an orthogonalization becomes less necessary, the more voxels and/or SNPs
are considered. This further supports my approach to omit the Gram-Schmidt algo-
rithm for the experimental data sets introduced in Section 3.4.1 and 3.4.2, since voxel
and SNP numbers exceeded the variable numbers in the simulation study.
3.6.5 Variability of PLSC-RP results
In order to quantify the variability of PLSC-RP results, I reran the analyses presented
in the previous sections (Sections 3.6.1, 3.6.2 and 3.6.3) ten times each using different
random matrices in every run of PLSC-RP. The results are illustrated in Table 19. It
shows that the variability of PLSC-RP weights was very small in general. For simulated
fMRI data of 90,000 voxels and 50 candidate SNPs (Figure 19), it averaged 7.93·10−8±
5.58 ·10−8 for voxel weights and 7.77 ·10−4±3.84 ·10−4 for SNP weights. For simulated
high-dimensional fMRI and high-dimensional SNP data (Figure 22), it accounted for,
on average, 5.05 · 10−5 ± 3.27 · 10−5 for voxel weights and 1.13 · 10−6 ± 9.19 · 10−7 for
SNP weights. For experimental genotype-phenotype data, the variability of PLSC-RP
results was even smaller. In the fMRI face-matching task (Figure 20), it averaged
4.10 · 10−9± 5.15 · 10−9 for voxel weights and 7.38 · 10−4± 1.09 · 10−3 for SNP weights.
However, the variability of the causal SNPs rs10014254, rs11722038 and rs17529323
was very low with 5.92 · 10−7 ± 1.72 · 10−9 on average. The variability of non-causal
SNPs was considerably higher and accounted for, on average, 2.41 · 10−3 ± 8.03 · 10−4.
For the SNPs associated with serum vaspin concentration in the Sorbs (Figure 21), I
determined similar variability results. For phenotype weights, I determined an average
variance of 3.69 · 10−4 ± 4.63 · 10−4 and for SNP weights 1.29 · 10−9 ± 1.84 · 10−9.
The variability of the causal SNPs rs11621467, rs4905203, rs1956713, rs6575436 and
rs11160190 was even smaller with 1.02 · 10−9 ± 6.73 · 10−10 on average.
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Table 19: Variability of PLSC-RP phenotype and genotype weights
The variability of PLSC-RP phenotype and genotype weights was assessed by performing ten
runs of PLSC-RP with different choices of random matrices on the same data sets. The Table
illustrates the exact weight, the variability and the average percentage deviation of weights
for selected phenotype variables and SNPs, respectively. Weights and variability estimates
of phenotypes and SNPs with minimum variability are shown in the top row, followed by
weights and variability estimates of causal phenotypes and SNPs, and finally weights and
variability estimates of phenotypes and SNPs with maximum variability.
High-dimensional neuroimaging data
voxel weight variance = 7.93 · 10−8 ± 5.58 · 10−8,
SNP weight variance = 7.77 · 10−4 ± 3.84 · 10−4
sequence
voxel / SNP voxel / SNP variance average percentage
number weight of weights deviation of weights
low voxel 69,627 −0.0053647 2.42 · 10−9 4.02%
... voxel 52,777 (causal) −0.0064222 6.45 · 10−8 4.41%
high voxel 2,481 0.0001969 5.11 · 10−7 72.22%
low SNP 8 0.1002331 1.77 · 10−4 5.16%
... causal SNPs −0.2771739 9.72 · 10−4 ± 4.51 · 10−4 6.52%
high SNP 24 0.0196767 1.95 · 10−3 37.52%
Functional MRI face-matching task
voxel weight variance = 4.10 · 10−9 ± 5.15 · 10−9,
SNP weight variance = 7.38 · 10−4 ± 1.09 · 10−3
sequence
voxel / SNP voxel / SNP variance average percentage
number weight of weights deviation of weights
low voxel 77,179 −0.0010709 1.17 · 10−13 0.04%
... causal voxels −0.0059789 2.85 · 10−9 ± 2.67 · 10−9 0.50%
high voxel 98,449 −0.0006442 8.75 · 10−8 28.80%
low SNP 1, 2 and 3 (causal) −0.5757151 5.92 · 10−7 ± 1.72 · 10−9 0.15%
high SNP 4 and 5 0.0426746 2.41 · 10−3 ± 8.03 · 10−4 12.14%
Serum vaspin concentration
phenotype weight variance = 3.69 · 10−4 ± 4.63 · 10−4,
SNP weight variance = 1.29 · 10−9 ± 1.84 · 10−9
sequence
phenotype / SNP phenotype / SNP variance average percentage
number weight of weights deviation of weights
low vaspin 0.7067676 1.02 · 10−4 0.87%
high height 0.0294468 9.04 · 10−4 10.27%
low rs16960334 −0.0002319 1.82 · 10−15 0.02%
... causal SNPs 0.0092556 1.02 · 10−9 ± 6.73 · 10−10 0.18%
high rs16824418 −0.0004946 7.51 · 10−8 5.59%
High-dimensional neuroimaging and high-dimensional SNP data
voxel weight variance = 5.05 · 10−5 ± 3.27 · 10−5,
SNP weight variance = 1.13 · 10−6 ± 9.19 · 10−7
sequence
voxel / SNP voxel / SNP variance average percentage
number weight of weights deviation of weights
low voxel 792 0.0419922 3.89 · 10−6 4.80%
... voxel 793 (causal) 0.0408320 1.22 · 10−5 11.09%
high voxel 516 0.0003213 1.70 · 10−4 78.17%
low SNP 10,840 0.0045882 2.76 · 10−8 4.33%
... causal SNPs 0.0142486 6.49 · 10−7 ± 2.33 · 10−7 4.62%
high SNP 49,164 0.0006524 1.08 · 10−5 88.81%
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3.7 Discussion
3.7.1 Accuracy of PLSC-RP results depending on the number
of original variables
In chapter 3, I introduced a new method for efficiently performing multivariate correla-
tion analysis of high-dimensional genotype-phenotype association data, which I termed
PLSC-RP. In a simulation series containing high-dimensional brain imaging measures of
increasing voxel numbers as phenotypes and candidate SNPs as genotypes, I compared
PLSC-RP to its state-of-the-art counterpart PLSC and I demonstrated that they pro-
vide statistically highly similar results, independent of the number of simulated voxels.
Importantly, the higher the dimensionality, the more the processing time was reduced
using PLSC-RP instead of PLSC.
PLSC-RP is independent of the original dimensionality, because dimensionality re-
duction is performed according to the Johnson-Lindenstrauss lemma (Johnson and
Lindenstrauss, 1984). The Johnson-Lindenstrauss lemma states that when we pick a
random subspace with reduced dimension k of an originally high-dimensional data set,
the pairwise distances between the original data points are preserved relative to an er-
ror , which we are willing to accept. Thereby, the reduced dimension k is logarithmic
in the sample size N , which implies that random projections, and thus PLSC-RP, are
independent of the original dimensionality. Since a reasonably high sample size N is
sufficient to ensure the accuracy of results, regardless of the number of original vari-
ables, PLSC-RP is optimal in large scale settings. This includes genetic neuroimaging
studies, where the high number of variants in the human genome and the high num-
ber of voxels in the brain complicate the identification of variations that are causally
related to a particular disease (Schork and others , 2007).
In order to verify the results on simulated data, I applied traditional PLSC and PLSC-
RP to an experimental genetic neuroimaging data set that has been published previ-
ously by Ousdal and others (2012). I was able to replicate literature findings using
both PLSC and PLSC-RP, whereby detailed results of traditional PLSC have already
been presented in Section 2.4.2. PLSC-RP was again significantly faster than PLSC.
Regarding the results of PLSC-RP on the SNP data set, I found three SNPs located
upstream of the Paired-like homeobox 2b (PHOX2B) gene (rs10014254, rs11722038
and rs17529323) to be significantly associated to amygdala activity during the emo-
tional face-matching task and thus replicated the findings of Ousdal and others (2012).
With respect to the findings on the neuroimaging data set, I found additional brain
regions, including cerebellum, left hippocampus, left lingual gyrus and right putamen,
to be involved during the task, since whole brain measures were considered for analysis
instead of the amygdala peak voxels only. This is in line with the results presented in
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Section 2.5.2.
3.7.2 Accuracy of PLSC-RP results depending on the data
type
I further compared PLSC-RP to traditional PLSC on a data set containing genome-
wide SNPs as genotypes together with candidate phenotype measures (body height
and serum vaspin concentration extracted from blood, specifically). In contrast to the
brain imaging measures, which I selected as high-dimensional phenotypes in the first
application and which were scaled metrically, SNP information statistically represents
count data, since PLSC was performed under the assumption of an additive genetic
model. I showed that also for count information PLSC-RP provides statistically equiv-
alent results to traditional PLSC, despite significant savings in runtime. Therefore,
dimensionality reduction using RP is independent of statistical data type. Using both
PLSC and PLSC-RP, I was further able to replicate literature findings (Breitfeld and
others , 2013). In the original publication, six SNPs on chromosome 14, mapping be-
tween serpinA1 and serpinA4, were shown to be significantly associated to serum vaspin
measures. With the exception of one SNP that I had to exclude due to its low call
rate, I verified these findings. I did not find any additional SNPs, since the authors in
the original publication (Breitfeld and others , 2013) already performed a genome-wide
screening.
3.7.3 Accuracy of PLSC-RP results for both high-dimensional
neuroimaging and high-dimensional SNP data
In genetic neuroimaging, both the neuroimaging and the SNP data sets are naturally
high-dimensional, and for time-efficient analysis, RP is needed for dimensionality re-
duction of both domains. Therefore, I finally applied PLSC-RP on a simulated data
set containing both high-dimensional brain imaging and high-dimensional SNP mea-
sures of different dimensionality combinations. I showed that PLSC-RP was able to
detect causal voxels and SNPs with high accuracy, despite slightly reduced similarity
to the results provided by PLSC, compared to the applications of PLSC-RP and PLSC
for either high-dimensional neuroimaging measures or high-dimensional SNPs. Again,
PLSC-RP was significantly faster than PLSC. At maximum, runtime was reduced from
22 weeks to 1.2 minutes. Thus, the usage of PLSC-RP is highly recommendable even
if both data sets are high-dimensional.
111
Claudia Grellmann 3 DIMENSIONALITY REDUCTION USING RP
3.7.4 Comparison of PLSC-RP with / without Gram–Schmidt
orthogonalization
For dimensionality reduction using RP, random matrices need to be orthogonal. To
quantify whether Gram–Schmidt orthogonalization is necessary or whether high-dimen-
sional random matrices are sufficiently close to orthogonal without orthogonalization,
I repeated the analyses from Section 3.4.1 once using the Gram–Schmidt algorithm
to orthogonalize random matrices and once without orthogonalization. I showed that
the weights of PLSC-RP using Gram–Schmidt algorithm and the weights of PLSC-RP
when orthogonalization was omitted were close to identical for all simulated fMRI data
sets. Thus, the quality of PLSC-RP results is not dependent on the Gram-Schmidt
algorithm in high-dimensional association analyses, such that a preceding orthogonal-
ization of random matrices can be safely omitted. This is also suggested, since the
Gram-Schmidt algorithm is computationally expensive. I further observed that the
similarity was slightly higher, the higher the dimensionality of the simulated fMRI
data. Therefore, an orthogonalization becomes less necessary, the more voxels and/or
SNPs are considered. In genetic neuroimaging, where the data sets usually capture
the whole brain or the whole genome, respectively, the Gram-Schmidt algorithm can
be omitted. However, for smaller data sets, an orthogonalization of random matrices
is recommended.
3.7.5 Variability of PLSC-RP results, accuracy of distance
preservation and processing performance
Since the dimensionality reduction in PLSC-RP depends on the choice of random
matrices, the algorithm produces slightly different results in every run. I quantified this
variability by repeating the analyses from Section 3.4.1, 3.4.2 and 3.4.3 ten times each,
using different random matrices in every run of PLSC-RP. I showed that the variability
of PLSC-RP weights was very small in general. The highest variability I determined for
a single genotypic or phenotypic variable was 0.0025. On average, however, variability
was much lower. Thus, PLSC-RP is appropriate for both exploratory analyses, in order
to detect causal SNPs and phenotypes maximizing the joint covariance in an association
study, and replication analyses, when multiple runs of the algorithm are performed.
Repeatability of PLSC-RP results is assured even if different random matrices are
selected for dimensionality reduction in every run of the algorithm.
I further observed that the variability of PLSC-RP results was smaller the higher the
sample size of the data sets. For the two simulation experiments introduced in Section
3.4.1 and 3.4.3, the sample sizes were chosen to be 100, and the variability of PLSC-RP
weights including all voxels and SNPs was between 1.95·10−3 and 2.42·10−9. In contrast,
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when PLSC-RP was used to search for genome-wide SNPs associated with serum vaspin
concentration (Section 3.4.2), sample size was equal to 865, and the variability of PLSC-
RP weights including the phenotypes serum vaspin concentration and body height as
well as all SNPs was between 9.04 · 10−4 and 1.82 · 10−15. Dimensionality reduction in
PLSC-RP depends on the sample size N , and, according to the Johnson-Lindenstrauss
lemma, it assures to preserve the distances between the original data points when N is
logarithmic in the reduced dimension k (Johnson and Lindenstrauss, 1984). I reduced
the the number of voxels and/or SNPs to dimensions similar to sample size in all
applications. Table 20 shows that the higher the sample size, the higher the accuracy
of distance preservation for a given probability of success.
Table 20: Accuracy of the distance preservation  depending on sample size N and
reduced dimension k for a given probability of success 1−N−β in PLSC-RP
I determined the accuracy of the distance preservation  according to the Menon theorem in
Equation 21 for a fixed probability of success 1−N−β = 0.95 and a fixed reduced dimension
k similar to sample size. Accordingly, the higher the sample size, the higher also the accuracy
of distance preservation. Bold entries in the table indicate sample sizes that occurred in any
analysis performed for this thesis.
N 100 200 208 500 865 1,000 2,000 5,000 8,000 10,000
k 100 200 208 500 865 1,000 2,000 5,000 8,000 10,000
1−N−β 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95
 0.9882 0.7374 0.7251 0.4968 0.3909 0.3667 0.2698 0.1790 0.1448 0.1309
For the two simulation experiments in Section 3.4.1 and 3.4.3 with sample sizes equal to
100, I reduced the dimensionality of the brain imaging (and the SNP data) to k = 100
dimensions with probability of success 1−N−β = 0.95, yielding a distance preservation
accuracy  of 0.9882 ( ≈ 1). When I employed PLSC-RP to search for genome-wide
SNPs associated with serum vaspin concentration (Section 3.4.2), k and N were equal
to 865, such that the accuracy of the distance preservation  reduced to 0.3909, which is
much more precise. Thus, the higher the sample size (and the higher the k), the higher
is also the accuracy of distance preservation. The higher the accuracy of the distance
preservation, the higher is the degree of similarity between the results of PLSC-RP and
traditional PLSC, and likewise, the higher is also the degree of similarity between the
results of multiple runs of PLSC-RP using different random matrices.
When sample sizes are high, an alternative to increasing the accuracy of distance
preservation for PLSC-RP is to improve its processing performance. For the simula-
tion experiments in Section 3.4.1 and 3.4.3, I reduced the dimensionality of the brain
imaging and/or the SNP data according to Equation 21 to k = 97.6486 with sam-
ple size N = 100, distance preservation accuracy  = 1.0, and probability of success
1 −N−β = 0.95. Thus the ratio of reduced dimension to sample size was k
N
= 0.9765
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(Table 21). For an increased sample size of e.g. N = 1, 000 and same choices of  and
1−N−β, the reduced dimension equals k = 134.4899, and the ratio of k to N reduces
to k
N
= 0.1345. Similarly, for applications with N = 10, 000, the ratio amounts to
k
N
= 0.0171 for k = 171.3313 (Table 21), which is considerably lower than the ratio of
k to N for applications with sample size N = 100. The smaller the ratio of k to N ,
the more efficient PLSC-RP and the lower the processing time needed for association
analysis.
Table 21: Ratio of reduced dimension k to sample size N depending on the sample size
for a given accuracy of the distance preservation  and probability of success 1−N−β
in PLSC-RP
I determined the reduced dimension k according to the Menon theorem in Equation 21 for
a fixed accuracy of the distance preservation  = 1.0 and a fixed probability of success
1 − N−β = 0.95. Accordingly, the higher the sample size, the lower the ratio of reduced
dimension to sample size kN , and therefore the faster PLSC-RP. Bold entries in the table
indicate sample sizes that occurred in any analysis performed for this thesis.
N 100 200 208 500 865 1,000 2,000 5,000 8,000 10,000
 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
1−N−β 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.95
k 97.6486 108.7389 109.3665 123.3996 132.1695 134.4899 145.5803 160.2409 167.7610 171.3313
k
N
0.9765 0.5437 0.5280 0.2468 0.1528 0.1345 0.0728 0.0320 0.0210 0.0171
3.8 Potential applications
For this thesis, I applied PLSC-RP to efficiently assess the association between genome-
wide SNPs and whole-brain neuroimaging measures. Combining neuroimaging data
with genetic information is a rapidly growing research approach, enabling the inte-
gration of information from two of the major methodological advances introduced in
the past 30 years, namely sequencing of the entire human genome and fMRI in hu-
mans. However, the application of PLSC-RP is not limited to the combined analysis of
genotypes and brain imaging phenotypes. It opens up a wide range of possible uses far
beyond genetic neuroimaging. PLSC-RP might be considered for fusion of several brain
imaging techniques, such as MRI, DTI, PET or SPECT, in order to profit from the
benefits of each modality (Sui and others , 2012). It is suitable for the integrated analy-
sis of disease status and multiple types of
’
omics‘ data, such as genomics, epigenomics,
and transcriptomics, aiming to understand signs of malfunction that cause diseases.
Furthermore, it can be applied to investigate how concentrations of biomolecules in
different tissues or different species, such as mice and humans, are associated to each
other. Beyond life science, PLSC-RP might e.g. be used in machine learning to seman-
tically analyze mixed web images and their associated text (Vinokourov and others ,
2003), or in finance and investment research to examine the relationship between a set
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of financial risk-taking measures and a set of personal attributes (West and Worthing-
ton, 2013). To summarize, PLSC-RP is appropriate for any integrative analysis which
combines information from multiple sources and has therefore a multitude of poten-
tial applications. Since PLSC-RP depends on sample size only and is independent of
the number of variables, it is especially attractive for large-scale association studies or
data sharing projects, as realized by multi-center imaging genetic consortia such as the
Functional Bioinformatics Research Network (fBIRN; Potkin and others , 2003), the
Alzheimer’s Disease Neuroimaging Initiative (ADNI; Mueller and others , 2005), the
Cohorts for Heart and Aging in Genomic Epidemiology (CHARGE; Psaty and others ,
2009), Imaging Genetics (IMAGEN; Schumann and others , 2010), the consortium for
Pediatric Imaging, Neurocognition, and Genetics (PING; Jernigan and others , 2011),
Imaging Genetics for Mental Disorders (IMAGEMEND; Meyer-Lindenberg, 2013) or
Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA; Stein and oth-
ers , 2014).
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4 Conclusion and future directions
4.1 Conclusion
Since the year 2000, when the initial publication on brain imaging and genetics was
released (Bookheimer and others , 2000), genetic neuroimaging has been constantly
growing. In terms of content it developed from candidate approaches towards a dis-
covery science, and regarding methods, unfavorable but easy to implement univariate
approaches have more and more been replaced by powerful but statistically more de-
manding multivariate frameworks. In this thesis, I introduced Sparse CCA, Bayesian
IBFA and PLSC for high-dimensional multivariate association analysis in genetic neu-
roimaging. I elaborately compared the three approaches in order to express a clear
statement on which method to choose depending on the properties of the underlying
data sets. In addition, I supplied tools for performance evaluation, component number
selection and verification of results, which have so far been missing in genetic neu-
roimaging literature. Thus, in this thesis I provided application-oriented guidelines
for researchers working in genetic neuroimaging, which facilitate the decision on the
selection of appropriate statistical methods based on data properties.
For comparison of Sparse CCA, Bayesian IBFA and PLSC, I particularly focused on
the analysis of whole-brain neuroimaging data, since the covariance structure between
brain imaging variables is expected to be much stronger than the covariance structure
between various SNPs. To also provide an outlook on how Sparse CCA, Bayesian
IBFA and PLSC perform in more realistic genetic neuroimaging settings, I extended
my simulations by considering both whole-brain neuroimaging and high-dimensional
SNP array data. Brain imaging variables are naturally highly collinear. However, since
one might take advantage of multivariate strategies for fusion of other, less correlated
data sets with genetic variation, such as cognitive or clinical diagnostic measures, I also
generated endophenotypes that did not comprise many dependencies. This has never
been done before. Interestingly, my suggestion on which method to choose depended
strongly on the degree of collinearity between endophenotype variables.
For data sets containing linearly independent endophenotypes, I showed that Bayesian
IBFA is recommended as long as the number of endophenotype variables is below 300
times sample size. Bayesian IBFA automatically learned how many components to
consider and was the only method that was able to detect two independent causal
patterns between simulated variables of the two data sets. For higher numbers of vari-
ables, however, I showed that results should in generally be interpreted with caution,
since the identification of causal patterns using model selection tools became difficult
for all three multivariate approaches.
For data sets containing highly collinear brain imaging variables as endophenotypes, my
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results indicated that Bayesian IBFA cannot be recommended since additional post-
processing steps were necessary to differentiate between causal and non-informative
components. This was true for both candidate SNPs and high-dimensional SNP array
simulations. In contrast, Sparse CCA was proven to be an appropriate method for can-
didate phenotype, candidate SNP studies. I showed that its predictive power was high
when voxel numbers were below 400 times sample size and 50 candidate SNPs were
simulated. PLSC was the only non-iterative and therefore the fastest method among
the considered strategies and when voxel numbers were above 500 times sample size its
predictive power exceeded that of Sparse CCA. In addition, it was the only method for
which it was possible to detected causal voxels and SNPs using model selection tools in
more realistic genetic neuroimaging settings containing both, large numbers of voxels
and large numbers of SNPs. Thus, PLSC proved to be the most appropriate tool for
multivariate analysis of brain imaging and genetic data.
The results I presented in the first part of this thesis have a direct impact on re-
searchers in genetic neuroimaging, since they facilitate the decision on the selection of
appropriate statistical methods depending on data properties. This is an important
and necessary step, since before performing an analysis, one should always be carefully
concerned about which method is most appropriate to answer the research question.
However, the existing methods to detect multivariate brain-SNP-associations will soon
be insufficient and far too inefficient, since genetic neuroimaging is a continuously de-
veloping research area. The growth in cost- and time-efficient sequencing techniques
as well as recent advances in neuroimaging technology allow researchers an even more
detailed view on structural or functional variations within the brain or the genome. On
the one hand, this enables the implementation of genetic neuroimaging studies that in
detail survey the entire human genome and brain, but also serious practical problems
arise when computation times become excessively long. PLSC, for example, which has
been proven to be an adequate multivariate analysis technique for fusion of genetic
and neuroimaging data, becomes infeasible for truly high-dimensional data sets, since
SVD is directly performed on the cross-product matrix, which is in case of whole-brain
neuroimaging and whole-genome SNP measures a matrix of several hundred thousand
by several hundred thousand dimensions. Therefore, a prior dimensionality reduction
step is highly recommended to accommodate the large number of voxels and SNPs. In
the second part of this thesis, I proposed a new statistical algorithm, named PLSC-RP,
which facilitates the time-efficient analysis of high-dimensional problems like the anal-
ysis of genotype-phenotype associations. PLSC-RP integrates Random Projection for
dimensionality reduction into PLSC to represent the originally high-dimensional data
sets in lower dimensional spaces. Subsequently, PLSC is used for multivariate analysis
of compressed data sets, and results are transformed back to the original spaces for
interpretation.
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I used PLSC-RP for integrative analysis of data sets containing high-dimensional brain
imaging measures, which are scaled metrically, or high-dimensional SNPs, which statis-
tically represent count data, in order to evaluate its performance for different statistical
data types. The application of PLSC-RP reduced computation times from hours to
seconds. Nonetheless, the accuracy of the results was not impaired by these substantial
savings in processing time. More precisely, PLSC-RP results were statistically equiv-
alent to the results obtained using its state-of-the-art counterpart PLSC, and were
further data type independent, since I was able to drastically reduce the dimensional-
ity of the continuous brain imaging and the counted SNP data.
Finally, I applied PLSC-RP for analysis of data sets containing both high-dimensional
brain imaging and high-dimensional SNP measures. Again, PLSC-RP provided highly
similar results to traditional PLSC, despite substantial savings in processing time.
With combining PLSC and RP, I made two major contributions to the analysis of
genetic neuroimaging data. First, in genetic neuroimaging studies, the number of
variables usually exceeds the number of observations, such that multivariate methods
encounter critical over-fitting issues (Le Floch and others , 2012). PLSC-RP, however,
uses Random Projection for dimensionality reduction in order to circumvent this prob-
lem. Previous studies (Hibar and others , 2011b; 2011c; Hua and others , 2015; Le
Floch and others , 2012) also contributed to this end by implementing univariate filters
or PCA as pre-processing step. However, they performed dimensionality reduction on
either the genetic or the neuroimaging data set. In contrast, to illustrate the PLSC-RP
methodology, I systematically used a two-stepped approach. First, I applied PLSC-RP
for multivariate analysis of data sets containing either high-dimensional neuroimaging
measures or high-dimensional SNPs. Then, I considered data sets containing a com-
bination of high-dimensional neuroimaging measures and high-dimensional SNPs, and
performed dimensionality reduction on both domains. This has not been done before.
My second and most important contribution is related to computational efficiency.
Previous studies (Hibar and others , 2011b; 2011c; Hua and others , 2015; Le Floch and
others , 2012) implemented univariate filters or PCA as pre-processing step, which are
computationally very expensive procedures. In contrast, PLSC-RP is able to dramat-
ically reduce runtime and enables researchers to analyze truly high-dimensional data
sets, even if there is no powerful compute server available in the lab.
4.2 Outlook
In this thesis, I presented and discussed appropriate and powerful multivariate ap-
proaches for association analysis of neuroimaging and SNP data, and I proposed a
new technique incorporating dimensionality reduction in order to improve the com-
putational efficiency of multivariate statistics. Based on my findings, there is great
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potential for future development in genetic neuroimaging.
When searching for links between neuroimaging measures and genetic variability, most
genetic neuroimaging studies have focused on SNPs, since SNPs constitute the most
common type of genetic variation in the human genome (Crawford and Nickerson,
2005; Tse and Cronican, 2009; Wang and others , 1998). However, the exploration of
the functionality of an identified SNP on molecular, cellular or system level is challeng-
ing, since SNPs affect only one single nucleotide base (Stein, 2015). Therefore, a great
frontier in genetic neuroimaging is the investigation of other sources of genetic variabil-
ity, so-called copy-number polymorphisms (CNPs) or copy-number variations (CNVs;
Iafrate and others , 2004; Sebat and others , 2004) and their effect on brain imaging
phenotypes (Cook Jr. and Scherer, 2008; Heinzen and others , 2010; Liu and Calhoun,
2014; Medland and others , 2014; Meyer-Lindenberg, 2012; Stein, 2015; Swaminathan
and others , 2011). CNPs or CNVs represent variations in the number of copies of
a sequence within the DNA (Cook Jr. and Scherer, 2008; Ziegler and others , 2008).
CNVs are defined in terms of segment length, which ranges from one kilobase to several
megabases. In contrast, CNPs are explained with regard to the frequency of variation
(Ziegler and others , 2008). CNVs affect the gene function in several ways. They can
be copy-number gains (duplications or insertional transpositions), losses (deletions),
gains or losses of the same locus, or multiallelic or complex rearrangements (Cook Jr.
and Scherer, 2008; Meyer-Lindenberg, 2010; Redon and others , 2006). Usually, they
encompass one or more gene, and thus include more nucleotides per genome than the
total number of SNPs (Redon and others , 2006). Since CNVs have been found sig-
nificantly more frequently in patients with neuropsychiatric diseases than in controls
(Stein, 2015), they are good candidates in genetic neuroimaging research for detection
of disease susceptibility (Cook Jr. and Scherer, 2008).
The main problem when searching for the effects of CNVs on the brain arises from the
relative rarity of these variants in the population. Sample sizes required for rare variant
association analyses are much larger than those required for common variant analyses
to achieve sufficient power (Zuk and others , 2014). However, acquiring neuroimaging
data in a large cohort is costly and practically impossible for a single neuroimaging
center (Poline and others , 2010). Therefore, in recent years multi-center projects were
initiated to collect whole-brain imaging data on thousands of subjects. Some of these
large-scale brain imaging consortia have also collected and published GWA data:
• the Functional Bioinformatics Research Network (fBIRN; Potkin and others ,
2003). The fBIRN was one of the first multi-site fMRI studies. Motivated by
inconsistencies found in fMRI studies of schizophrenia, fMRI data on 253 patients
and controls was collected using the same fMRI protocol across multiple universi-
ties around the United States (fBIRN Phase 2; Medland and others , 2014; Potkin
and others , 2003; Turner, 2014). In addition, behavioral, demographic, clinical
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and genetic data has been assessed.
• the Alzheimer’s Disease Neuroimaging Initiative (ADNI; Mueller and others ,
2005). The ADNI is a worldwide longitudinal project with the aim to define
the progression of AD and to validate the use of biomarkers for diagnosis and
treatment of the disease. For the ADNI, healthy elderly people and patients with
MCI or AD have been investigated using MRI and PET images, genetics, cog-
nitive tests, and other biomarkers of AD. ADNI1, the first phase of the ADNI,
included 800 participants. For ADNI-GO and ADNI2, 850 additional participants
have been recruited (Medland and others , 2014).
• the Cohorts for Heart and Aging in Genomic Epidemiology (CHARGE; Psaty
and others , 2009). The CHARGE cover several large cohorts, e.g. the Framing-
ham Heart study, the Rotterdam Study, the Icelandic Age Gene/Environment
Susceptibility study (AGES), Atherosclerosis Risk in Communities (ARIC) and
the Cardiovascular Health Study (CHS). Their main focus is on genetic analyses
of neuroimaging and cardiovascular health data, including stroke. Information
on about 29,000 individuals has been collected (Medland and others , 2014).
• the Imaging Genetics study (IMAGEN; Schumann and others , 2010). The IMA-
GEN project investigates the genetic and neurobiological basis of impulsivity, re-
inforcer sensitivity and emotional reactivity in a cohort of 2,223 fourteen-year-old
adolescents and their parents with longitudinal follow-ups. Using self-report ques-
tionnaires, behavioural assessment, interviews, neuroimaging as well as genetic
analyses, the overall goal is to determine the predictive capability of emotional,
rewarding and impulsive aspects for the development of frequent psychiatric dis-
orders.
• the consortium for Pediatric Imaging, Neurocognition, and Genetics (PING;
Jernigan and others , 2011). For the consortium PING about 1,400 children,
aged between three and twenty years, have been recruited in order to investigate
the genetic basis of individual differences in brain structure and connectivity,
cognition, and personality.
• Imaging Genetics for Mental Disorders (IMAGEMEND; Meyer-Lindenberg, 2013).
The IMAGEMEND project, a primarily European study with an emphasis on
mental disorders such as schizophrenia, bipolar disorder and ADHD, comprises
neuroimaging, genetic, environmental and clinical information of 13,000 partic-
ipants. Its overall goal is to improve the clinical management and etiological
pathomechanisms of mental illnesses.
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• the Enhancing Neuroimaging Genetics through Meta-Analysis study (ENIGMA;
Stein and others , 2014). The ENIGMA is a collaborative network performing
large-scale neuroimaging and large-scale genetics meta-analytic studies in major
brain diseases across the lifespan, including schizophrenia, bipolar illness, major
depression and ADHD. It integrates data from 70 institutions worldwide in order
to increase statistical power and to identify consistent genetic effects. ENIGMA
studies have analyzed neuroimaging data from 13,171 subjects. Additional infor-
mation was provided by the CHARGE for replication of findings, in a total circa
29,000 subjects.
By collecting data on a huge number of subjects, multi-center imaging genetic consortia
enable researchers to discover new genetic variants altering the structure or function
of the brain, which in turn manifests as an illness. However, huge data collections are
computationally challenging and require to adapt, or even to create, statistical methods
suitable for large samples and heterogeneous data. Interestingly, PLSC-RP, which I
introduced in this thesis, is a statistical method that benefits from large sample sizes
in two ways. A high N can either be used to drastically reduce the dimensionality
of the data relative to sample size, such that PLSC-RP is more efficient and lower
computational requirements are needed for association analysis (Table 21). On the
other hand, the number of original variables can be reduced to dimensions similar to
sample size. When sample sizes are high, this will result in a very precise accuracy of
distance preservation (Table 20).
The paragraphs on rare variant association analyses of large-scale multi-center data
introduced potential applications of PLSC-RP due to its favorable properties. However,
also concerning the methodological background of PLSC-RP there is great potential
to future development. Since individual phenotype variation is not solely determined
by genetics but an interaction of genetic and environmental factors, a further frontier
in genetic neuroimaging research is to combine intermediate phenotypes, genotypes,
environmental and possibly additional factors, such as disease or cognitive status, into
a common analytical framework. This refers to the so-called 5-O approach, the GenO-,
NeurO-, EndophenO-, BehaviO-, and EnvirO-approach, as introduced by Ge and others
(2013). The 5-O approach requires integration of data from the genotypic (e.g. SNPs
or CNVs), the neuronal (e.g. electrophysiological recordings), the endophenotypic (e.g.
features extracted from structural, functional or diffusion weighted MR images), the
behavioral (e.g. psychometric and experimental cognitive psychology tasks), and the
environmental (e.g. stress) level. Therefore, multi-modal modeling tools are needed
that are able to access the association of more than two data sets. This means, a
further question arising from this thesis is how to extend PLSC-RP to be suitable for
simultaneous analysis of 5-O data. These extensions would help to better understand
the pathways through which genetic factors exert their effects on the brain, resulting
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in a neuropsychiatric disorder. As George Bray, Professor for Clinical Obesity and
Metabolism at Pennington Biomedical Research Center, wrote in a publication about
the epidemic of obesity:
”
the genetic background loads the gun, but the environment
pulls the trigger“ (Bray, 2004).
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Appendix A - Glossary
Alzheimer’s Disease Neuroimaging Initiative (ADNI) (Mueller and others ,
2005)
ADNI is a worldwide longitudinal project aimed to provide valuable scientific insight
into pathology, prevention and treatment of AD. Since 2005, ADNI researchers collect,
validate and utilize data such as MRI and PET images, genetics, cognitive tests, cere-
brospinal fluid and blood biomarkers as predictors for the disease.
Emotional face-matching task (Carre and others , 2010; Hariri and others , 2002;
Ousdal and others , 2012)
In the emotional face-matching task, participants are presented with two stimuli that
have to be matched to a target stimulus. Stimuli are either human faces expressing
anger of fear (face-matching task) or geometrical shapes (sensorimotor control task).
Endophenotype concept (Gottesman and Gould, 2003)
An endophenotype or intermediate phenotype is a quantitative marker that is highly
heritable, that is reliably correlated with the disease, and that can be measured in
all individuals, both affected and unaffected. Furthermore, endophenotype and illness
must co-segregate within families. In unaffected family members, the endophenotype
can be found at a higher rate than in the general population.
False discovery rate (FDR) (Benjamini and Hochberg, 1995)
The FDR is a procedure to control the type I error rate. It is defined as the expected
proportion of erroneously rejected null hypotheses, i.e. FDR = E(Q). If R > 0, than
Q = V
R
, where V is the number of false positives (type I errors) and R is the number
of rejected hypotheses. If R = 0, than Q = 0.
Family-wise error rate (FWER) (Dudoit and others , 2003; Shaffer, 1995)
In statistical hypothesis testing, a type I error occurs, when the null hypothesis is
rejected although it is true. The probability of a type I error is usually controlled at
level α. However, when statistical tests are used repeatedly, there is an increase in the
type I error rate, known as the multiple testing problem. The FWER is a strategy to
statistically correct for type I errors. It is defined as the probability of at least one
type I error, i.e. FWER = Pr(V ≥ 1), where V is the number of false positives or type
I errors. A frequently used method to control the FWER is the Bonferroni procedure
(Dunn, 1959). The Bonferroni procedure rejects any hypothesis H0 with unadjusted
P -value less than or equal to α
m
, where m is the number of tests performed.
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Monetary incentive delay task (MID) (Knutson and others , 2000; Lutz and Wid-
mer, 2014)
The MID task consists of the announcement of an incentive cue, which is linked with
a certain contingency to receive this incentive. Participants are required to react to a
target stimulus presented after the incentive cue. Whether the announced reward is
delivered depends on the participants’ reaction.
N-back working memory task (Gevins and Cutillo, 1993)
The n-back task is a performance task used in cognitive neuroscience to investigate
the neural basis of working memory processes in humans. Participants are asked to
monitor a series of stimuli and to respond whenever a stimulus is presented that is the
same as the one presented n trials previously, where n is a pre-specified integer, usually
1, 2, or 3. Various types of stimuli (visual, auditory, olfactory) may be employed in
order to address different processing systems in the brain.
Spatial working memory paradigm (Rose and others , 2012)
In the spatial working memory task, participants have to indicate whether the spatial
location of a white dot and a red circle, relative to a white fixation cross, is either
the same (match) or different (no match). There are three conditions in the task. In
the
”
no delay“ condition, both the white dot and the red circle appear simultaneously.
During the
”
1-dot“ condition, the white dot and the red circle are separated by a 3-
seconds delay. In the
”
3-dot“ condition, three white dots are shown, followed by a red
circle after 3 seconds.
Sternberg item recognition paradigm (SIRP) (Manoach and others , 1999)
The SIRP is a working memory task which involves the presentation of a set of target
digits to memorize, followed by a memory maintenance period during which the subject
are required to remember the list of items. During the retrieval period, participants
are presented with probes (single digits) and have to indicate whether the probes were
targets of the memorized set.
Stop-signal reaction-time (SSRT) task (Logan and Cowan, 1984)
The SSRT task is a neurocognitive task designed to provide a measure of the time
taken by the brain to inhibit or suppress inappropriate motor responses. Therefore, in
some trials, a stop signal is presented after the stimulus and before the response, and
participants are required to try to stop their responses.
Warrior/worrier model (Goldman and others , 2005)
The warrior/worrier model is an explanation for the maintenance of the Val108Met
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polymorphism in the COMT gene. The Val and the Met allele have counterbalancing
effects on cognition, stress resilience and anxiety. While the Val allele (warrior) leads to
better stress resiliency, but also modest reduction of executive cognitive performance,
the Met allele (worrier) predicts a progressively lower pain threshold, stronger affective
response to pain and inability of the endogenous brain opioid system to become acti-
vated following pain. Thus, each COMT allele confers an environment-specific selective
advantage.
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Appendix B - Supplementary Equations
PLSC-RP for dimensionality reduction in X1 OR X2
For traditional PLSC, SVD is used to decompose the cross-product matrix A of X1
and X2, which are both standardized column-wise, into three matrices:
cov(X1,X2) = A = X
′
1X2 = W1SW
′
2. (S1)
Assumed thatX1 is high-dimensional, RP transformsX1 to a lower dimensional space
via the following transformation:
X1RP = X1 ·R, (S2)
where R is a random matrix and X1RP is the low-dimensional subspace of X1 with
desired lower dimension k. In case PLSC is performed to decompose the cross-product
matrix of X1RP and X2, weights W2 for data set X2 and weights W1RP for the reduced
data set X1RP are obtained. To transform the weights W1RP back to the original space,
that is W1, the equation for the SVD is rearranged as follows:
Starting point for the rearrangement: the PLSC equation
cov(X1,X2) = A = X
′
1X2 = W1SW
′
2.
When both sides of the equation are extended by w2i , one obtains
A ·w2i = W1SW ′2 ·w2i .
Since W2 is column-wise orthogonal, we have
A ·w2i = w1isiw′2i ·w2i .
Rearranging yields
1
si
·A ·w2i = w1i ·w′2i ·w2i .
Since the L2-norm for a vector a is given by
|a| = √a21 + a22 + . . .+ a2n,
|a|2 = a21 + a22 + . . .+ a2n,
one obtains the weights w1i , i = 1, . . . , p, p = min(k, d2), as follows:
w1i =
1
si · |w2i|2
·A ·w2i . (S3)
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PLSC-RP for dimensionality reduction in X1 AND X2
Assumed that both X1 and X2 are high-dimensional, RP transforms X1 and X2
to lower dimensional spaces via the following transformation:
X1RP = X1 ·R1,
X2RP = X2 ·R2.
(S4)
In case PLSC is performed to decompose the cross-product matrix of X1RP and X2RP ,
weights W1RP and W2RP for the low dimensional subspaces are obtained. To trans-
form the weights W1RP back to the original space W1, the equation for the SVD is
rearranged as follows:
Starting point for the rearrangement: the PLSC equation
cov(X1,X2RP) = W1SW
′
2RP
.
When both sides of the equation are extended by w2RPi , one obtains
cov(X1,X2RP) ·w2RPi = W1SW
′
2RP
·w2RPi .
Since W2RP is column-wise orthogonal, we have
cov(X1,X2RP) ·w2RPi = w1isiw
′
2RPi
·w2RPi .
Rearranging yields
1
si
· cov(X1,X2RP) ·w2RPi = w1i ·w
′
2RPi
·w2RPi .
Thus, for the weights w1i , i = 1, . . . , p, p = min(k1, k2), one obtains
w1i =
1
si · |w2RPi |2
· cov(X1,X2RP) ·w2RPi . (S5)
Following the same logic, the weights W2RP are transformed back to the original space
W2 by rearranging the equation for the SVD as follows:
Starting point for the rearrangement: the PLSC equation
cov(X1RP ,X2) = W1RPSW
′
2.
When both sides of the equation are extended by w
′
1RPi
, one obtains
w
′
1RPi
· cov(X1RP ,X2) = w′1RPi ·W1RPSW
′
2.
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Since W1RP is column-wise orthogonal, we have
w
′
1RPi
· cov(X1RP ,X2) = w′1RPi ·w1RPi · si ·w
′
2i
.
Rearranging yields
1
si
·w′1RPi · cov(X1RP ,X2) = w
′
1RPi
·w1RPi ·w
′
2i
.
Thus, for the weights w2i , i = 1, . . . , p, p = min(k1, k2), one obtains
w
′
2i
=
1
si · |w1RPi |2
·w′1RPi · cov(X1RP ,X2),
w2i =
1
si · |w1RPi |2
· (cov(X1RP ,X2))
′ ·w1RPi .
(S6)
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FFA Fractional anisotropy
fBIRN Functional Bioinformatics Research Network
fMRI Functional Mgnetic Resonance Imaging
G
G Guanine
GM Gray matter
GWA Genome-wide association
H
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I
IBFA Inter-Battery Factor Analysis
ICA Independent Component Analysis
IMAGEMEND Imaging Genetics for Mental Disorders
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PparaICA Parallel Independent Component Analysis
PC Principal component
PCA Principal Component Analysis
PCReg Principal Component Regression
PET Positron Emission Tomography
PING Pediatric Imaging, Neurocognition, and Genetics
PLS Partial Least Squares
PLSC Partial Least Squares Correlation
PLSR Partial Least Squares Regression
PMD Penalized matrix decomposition
PRESS Predictive residual sum of squares
Q
Q2 Predictive squared correlation coefficient
R
ROI Region of interest
RP Random projection
S
sMRI Structural Magnetic Resonance Imaging
SNP Single nucleotide polymorphism
Sparse CCA Sparse Canonical Correlation Analysis
SPECT Single-Photon Emission Computed Tomography
SS Sum of squares
SVD Singular value decomposition
T
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Gene Nomenclature
A
APOE Apolipoprotein E
B
BDNF Brain-derived neurotrophic factor
C
CLU Clusterin
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F
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M
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V1 Matrix of weights specific to X1 (Bayesian IBFA)
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X1RP Low-dimensional subspace of X1
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 Distance preservation factor (RP)
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